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Abstract 
-------------------------------------------------------------------------------------------------------------- 
 
Studies of gas phase protein complexes using mass spectrometry and ion-mobility mass 
spectrometry are becoming increasingly commonplace in the field of structural biology.  
These studies apply the combined speed, mass sensitivity and structural resolution of a 
single instrumental method, that of mass spectrometry.  Work presented here has used a 
range of gas, and solution phase methods.  These methods have made it possible to 
investigate the oligomers and structural conformations of three proteins required, within 
their respective organisms, to ensure viability.   
Mutations of the human serine protease inhibitor, α1-antitrypsin, are known to 
promote polymerogenic intermediates under biologically relevant conditions.  Using  
ion-mobility mass spectrometry we have characterised the structure and stability of the 
K154N slow polymerisation mutant.  The results obtained have shown that this mutant 
populates an increased stability structural intermediate upon incubation at biologically 
relevant temperatures. 
Saccharomyces cerevisiae Sgt1 dimers mediate binding between Hsp90 and Skp1, 
to initiate chromosome separation.  Mutations of the Sgt1 dimerization domain are known 
to inhibit Sgt1: Skp1 binding, arresting the cell cycle at the G2/M interface.  Work here has 
shown that this dimer is stabilised by an Ascomycota specific structural loop within the 
dimerisation domain, with potential contributions from other domains.  Using tandem mass 
spectrometry, we have shown that Sgt1 dimers do not represent the structural minimum for 
Skp1 binding.   
The Escherichia coli DNA binding protein, CbpA, promotes chromosome 
compaction that arrests the cell cycle during the stationary phase, and phosphate starvation 
conditions, producing structural aggregates exceeding 60 nm.  The organisation of both 
CbpA and DNA within these aggregates remains currently unresolved therefore, mass 
spectrometry combined with ion-mobility mass spectrometry has been applied to resolve 
these interactions.  Although unsuccessful in observing gas phase CbpA-DNA oligomers 
using a variety of conditions and methods, investigations have produced ion-mobility 
constraints for computational modelling of the biologically relevant CbpA dimer.  
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1. Of Mountains and Molehills: the Development of Mass 
Spectrometry and Ion Mobility for the Study of Noncovalent 
Complexes 
-------------------------------------------------------------------------------------------------------------- 
 
As mass spectrometry continues past its recent centenary, the development of the field 
continues to grow at an ever expanding rate, driving the high mass range further, mass 
resolution ever greater, and analysis capabilities in continuously branching directions.  
Indeed if the father of the field, Joseph J. Thomson, could compare the mass of ions and 
level of information that can be obtained from instruments he used a little over 100 years 
ago, to what can be acquired now, chances are that we may indeed cite his words as  
‘like comparing mountains to molehills.’ 
 
1.1. The Birth of the Field 
 
Whilst investigating cathode rays by deflection in electric and magnetic fields,  
Joseph J. Thomson produced results that enabled measurement of the z/m (charge-to-mass 
ratio) of an electron (Thomson 1897).  For his work, Thomson, won the 1906 Nobel Prize 
in Physics (The Nobel Prize in Physics 1906).  As his work and interests progressed, 
Thomson initiated studies of anode rays, constructing his first mass spectrograph 
instrument in 1907 (Thomson 1907).  This instrumental set up used a fluorescent screen to 
detect and record the trajectory of hydrogen ions, under the influence of magnetic 
deflection proportional to the z/m value (Budzikiewicz & Grigsby 2006).  Resulting from 
these, and additional, observations Thomson would subsequently conclude that there was a 
“different type of positive ion for each element” (Thomson 1913).   
In collaboration with Francis W. Aston, the 1907 design was updated in 1910 to 
improve the operating vacuum providing increases in mass resolution (Budzikiewicz & 
Grigsby 2006).  This updated instrument was used to progress the studies of anode rays, in 
addition to initiating analysis of the inert gasses.  Accompanying the expected mass value 
for Neon at m/z (mass-to-charge ratio) 20, their results indicated a further mass line at  
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m/z 22, in addition to evidence of doubly charged species.  Summarising these data in a 
lecture given in 1913 (Thomson 1914), Thomson discussed the potential application of this 
value stating “that was has been called neon is not a simple gas but a mixture of two gases.”  
The unexpected mass value at m/z 22 was, however, unresolved and resulted in a level of 
discussion, with several hypotheses proposed by both Thomson and Aston to explain this 
unexpected result (Audi 2006).  Due to the low mass resolving power of the instruments 
available at the time, no proposed hypothesis was conclusively proven. 
In the years following Thomson’s mass spectrograph studies of Ne and H ions, 
Thomson would develop what can be argued to represent the first mass spectrometer 
(Thomson 1912).  Ion rays where deflected under the influence of a constant electric field.  
This was followed in space by a magnetic field that could be modified to direct the 
trajectory of ions proportional to the analyte m/z.  Magnetic deflection directs the charged 
analyte towards a physical slit in front of a faraday cup, which detects the charge of the ion.  
Using this instrumentation, Thomson produced the first mass spectrum of CO2
+
, with 
evidence of CO
+
, O
+
, C
+
, and H
+
 species (Fig. 1.1) (Budzikiewicz & Grigsby 2006). 
As instrumental advancements continued, Aston developed the velocity focusing 
mass spectrograph providing further increases in resolving power (Aston 1919) that would 
finally settle the discussion regarding the unknown mass at m/z 22 started almost a decade 
earlier.  Using this updated instrument, Aston determined that the previously inconclusive 
value was the isotope 
22
Ne, and represents the first conclusive evidence of stable atom 
isotopes.  This is not excluding a further weaker line (0.3 %), indicating the existence a 
further isotope of neon, 
21
Ne (Aston 1920a).  In combination with further work for his 
development of the whole number rule (Aston 1920b), Aston would win the 1922 Nobel 
Prize in Chemistry (The Nobel Prize in Chemistry 1922). 
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Figure 1.1. The First Mass 
Spectrum of CO2 
The first mass spectrum of CO2 
obtained by Joseph J. Thomson 
(1912).  Peaks (heights 
normalised to the most intense 
peak) represent ion masses 
corresponding to (left to right) 
H
+
 (4 %), C
+
 (20 %), O
+
 (18 %), 
CO
+
 (100 %), and CO2
+
 (80 %). 
Figure reproduced from Budzikiewicz & 
Grigsby 2006 
 
1.1.1. Progression of Mass Spectrometry to a Higher Prominence 
 
For the vast majority of its early applications, mass spectrometry was confined within the 
field of physics as investigators applied the technique to answer a number of questions 
regarding isotopes and the fundamental nature of the atom.  Studies such as these 
subsequently drove the development of mass spectrometers with greater resolving power, 
and extended mass ranges.   
These studies and separations of isotopes would later propel mass spectrometry to a 
higher prominence with the out break of World War II, and initiation of the Manhattan 
Project
1
 by the UK, USA, and Canadian governments (Griffiths 2008).  In 1940 Alfred Nier 
had shown, using mass spectrometry, that 
235
U was responsible for the slow neutron 
fissionable component of natural uranium, with the method used outlined in Nier (1989).  
Mass spectrometry was applied within the Manhattan Project to measure the stable and 
non-stable isotope abundances of uranium (and later plutonium), as a post processing tool 
                                                 
1
 The Manhattan Project was initiated with the aim to utilise fissionable materials that would lead to the 
development the world’s first atomic weapons (Nier 1989). 
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to analyse the effectiveness of various enrichment methods.  It has been said that without 
Nier or, the availability of mass spectrometry, the Manhattan Project would never have 
been completed within the required time-scale (De Laeter 1996, and Nier 1989).  
As an individual, Nier was one of the first individuals to heavily promote the 
technique outside of the physics community.  This includes the first biological application 
of mass spectrometry, preparing enriched 
13
C samples for tracer studies.  It has been 
suggested that it is because of Niers’ tireless efforts that mass spectrometry was propelled 
to the tool that it has become today, used within the fields of all the classical sciences 
(Griffiths 2008). 
 
1.2. Electrospray Ionisation and MALDI: ‘Wings for Molecular Elephants’ 
 
Other than the mass analyser itself, arguably the most important component of any mass 
spectrometer is its ionisation source.  These sources impart a level of charge on the analyte 
permitting detection of the sample within the instrument.  Prior to the mid-to-late nineteen 
eighties however, ionisation methods required for mass analysis had been too harsh for 
larger biological macromolecules and complexes to be transferred into the gas phase intact 
and therefore remained primarily a tool of physicists and chemists.   
Upon the development of Matrix-Assisted Laser Desorption/Ionisation (MALDI, 
section 1.2.1.) in 1988 by Karas & Hillenkamp (1988), with similar methods developed by 
Tanaka and co-workers (1988),
2
 and the electrospray ionisation (ESI, section 1.2.2.) source 
for biological applications in 1989 by Fenn et al. (1989), the potential to study these macro 
molecules and complexes was suddenly possible.  These methods would open the doors to 
an almost completely new field of structural and biological mass spectrometry (Hilton & 
Benesch 2012).  Combination of these two techniques “[conferring] the greatest benefit on 
mankind,” (Nobel 1895) attributed Fenn and Tanaka, the 2002 Nobel Prize in Chemistry3 
(The Nobel Prize in Chemistry 2002). 
 
                                                 
2
 Laser desorption ionization of “ultra fine metal plus liquid [glycerol + organic solvents] matrix method” 
within which the sample was diluted (Tanaka et al. 1988).  
3
 Awarded in combination with Kurt Wüthrich for his development of NMR techniques for determining 3D 
structures of biological macromolecules in solution (The Nobel Prize in Chemistry 2002). 
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1.2.1. The Fundamentals of Matrix-Assisted Laser Desorption/Ionisation 
 
The development of MALDI by Karas & Hillenkamp (1988), provided a drastic 
improvement in the potential to study high mass ions, combined with improved sensitivity 
compared to previously developed methods such as fast atom bombardment and secondary 
ion mass spectrometry.  This mass range increased from species of 10 kDa using these 
previous methods, to proteins of 35 kDa (Karas & Hillenkamp 1988, Karas & Krüger 2003, 
and Tanaka et al. 1988).   
 
 
Figure 1.2. Principles of the MALDI Ionisation Source 
The analyte of interest (red squares) is mixed with a suitable organic matrix which absorbs energy at certain 
wavelengths.  This mixture is affixed to a metal plate and dried, embedding the analyte throughout the 
matrix.  The analyte/matrix loaded plate is then placed within a vacuum, a charge applied to the plate which 
acts as the anode/cathode for ion formation (depicted as the anode), and irradiated using a pulsed laser  
(e.g. UV laser) (Karas & Hillenkamp 1988). Irradiation heats the matrix promoting localised sublimation, 
allowing entry of charge laden analyte/matrix clusters into the gas phase under the influence of a charge 
gradient (Dreisewerd 2003).  The analyte sequentially undergoes desolvation, allowing secondary ionisation 
mechanisms to occur (see Fig. 1.3) (Karas & Krüger 2003). 
 
Prior to ionisation, the analyte is first dissolved in a solvent suspended small 
organic matrix, such as, 2,5-dihydroxy benzoic acid (Jackson et al. 2007), or  
α-cyano-4-hydroxy-cinnamic acid (Pittenauer & Allmaier 2009).  This mixture is 
subsequently dried, and ionised via the action of a pulsed laser (outlined in greater detail in 
1. Of Mountains and Molehills: the Development of Mass Spectrometry and Ion Mobility 
for the Study of Noncovalent Complexes 
 
27 
Fig. 1.2), and sequestered into the gas phase through charge potential differences.  The 
matrix functions to absorb the majority of the laser energy, whilst permitting transfer of 
analyte/matrix clusters into the gas phase, without degradation of the analyte (Chughtai & 
Heeren 2010). 
 
 
Figure 1.3. Positive Mode MALDI 
Secondary Ionisation Mechanisms 
MALDI supports a range of secondary 
ion formation mechanisms, which 
occur within the laser induced plume 
i.e. the solid to gas phase transition 
(Zenobi & Knochenmuss 1998).   
a) Ionisation by the proton transfer 
mechanism, progresses by matrix 
proton (H
+
) donation to the analyte.  
This occurs due to the analyte having a 
higher proton affinity than the matrix 
(Knochenmuss & Zenobi 2003).   
b) Under suitable analyte/matrix 
combinations the electron transfer 
mechanism supports a model where the 
matrix sequesters an electron from the 
analyte, producing a charged radical analyte.  This method however is not widely observed using UV laser 
source (Knochenmuss & Zenobi 2003, Macha et al. 1999, and McCarley et al. 1998).  c) The cation 
transfer mechanism, supports a model whereby a charged adduct (in this case Na
+
) is transferred from the 
matrix to the analyte, imparting its charge signal.  Comparatively proteins and peptides have a lower 
affinity for adducts such as Na
+
 compared to H
+
. Therefore when the matrix has a higher affinity for H
+
 
than the analyte, Na
+
 derived charge can become the predominant species (Knochenmuss & Zenobi 2003). 
 
Ionisation of the analyte is not conclusively understood, and can be explained by 
several different means, separated in terms of primary (direct) or secondary (gas phase) 
ionization mechanisms.  Primary ionization mechanisms are understood to occur as a result 
of two methods, photochemical processes (i.e. direct influence of the laser resulting in 
radical formation), or an anion/cation excess that directly ionises the analyte  
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(Karas & Krüger 2003, and Zenobi & Knochenmuss 1998).  Mechanisms of secondary 
ionisation are outlined in figure 1.3. 
As extended understanding of the MALDI source is of little relevance to the 
investigation presented here, for a larger overarching review on the method the author 
directs the reader to the following review articles by Karas & Krüger (2003), and  
Zenobi & Knochenmuss (1998).  
 
1.2.2. The Development and Fundamentals of Electrospray Ionisation 
 
The fundamental basis of ESI was not a new one in the 1980’s with Dole and co-workers 
(1968) having previously demonstrated that a negatively charged solution (60 % Benzene, 
2 % Acetone) could be used to spray a dilute aromatic polymer solution into the gas phase 
for analysis (Dole et al. 1968).   
John Fenn, to whom the development of ESI for biological applications is 
attributed, started working with the technique in the early/mid 1980’s, hypothesising its use 
for large organic molecules in Yamashita & Fenn (1984).  Evidence supporting Fenn’s 
hypotheses quickly followed, and in 1985 he presented the first evidence of gas phase 
peptide analysis (all less than 1500 Da) by ESI (Whitehouse et al. 1985).  By 1989 further 
developments had allowed Fenn and co-workers to clearly demonstrate the use of ESI for 
the analysis of large non-native proteins that exceeded 130 kDa  
(Bovine albumin; 133 kDa) (Fenn et al. 1989). 
The principle of ESI for mass spectrometric analysis relies on several key factors.  
First and foremost is the use of a suitable, low vapour pressure solvent such as: acetonitrile, 
isopropanol or, methanol (Fenn et al. 1989).  This buffer is used to suspend a dilute 
concentration of the analyte of interest (mM to nM concentrations) prior to injection into 
the ESI capillary source (inner diameter 100 nm, Yamashita & Fenn 1984).  Upon injection 
(Fig. 1.4a), a solvent dependent voltage is applied to the capillary (Kebarle & Verkerk 
2009), inducing an electrospray aerosol through the formation of a Taylor cone.  This 
Taylor cone dependent electrospray allows the solvent suspended analyte to enter the gas 
phase for mass spectrometric analysis via a charge gradient.   
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Figure 1.4. Principles of Electrospray Ionisation and Taylor Cone Theory 
a) A dilute sample of analyte (red spheres) is injected (few nL/min in nESI to, ml/min values in liquid 
chromatography-mass spectrometry, Karas et al. 2000) into the capillary source.  A voltage difference 
between the capillary and counter-electrode, at 3 to 6 kV over a distance of 0.5-2 cm (Smith et al. 1990), 
induces formation of the Taylor cone (b).  This enables production of a fine aerosol spray which undergoes 
desolvation (Fig. 1.5), aided by a heated desolvation gas (initial temperatures 46-76 °C increased to vaporise 
90-95 % of the solvent, Fenn et al. 1989) as it transfers into the vacuum of the gas phase.   
b) Taylor cone formation occurs due to the application of a current to a solvent, resulting in electrostatic 
repulsion that deforms the upper surface producing a convex meniscus.  As the electrostatic charge 
accumulates, the angle of the meniscus increases and above a critical field  
(i.e. electrostatic repulsion > surface tension) becomes unstable and the jet is initiated.  Subsequently an 
analyte laden, charged aerosol is produced (Luedtke et al. 2008, and Wilm & Mann 1994). 
 
 Deformation of liquid droplets under the force of electric fields, was first 
demonstrated in 1964 by Sir Geoffrey Taylor (Taylor 1964), and is explained in terms of 
the cone theory that bears his name.  The basis of this theory is that solvent deformation at 
the ESI source cone results in an aerosol production (Fig. 1.4b), providing a suitable 
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surface area for ion desolvation to occur.  Production of desolvated ions from the Taylor 
cone aerosol is believed to manifest under one of two proposed models: the charged residue 
model (Fig. 1.5a), and the ion desorption model (Fig. 1.5b).  Both of these models are 
dependent on the Rayleigh limit (Eq. 1.1) (Rayleigh 1882) that defines the limit value on 
droplet total surface charge (Gomez & Tang 1994, and Kebarle & Verkerk 2009).   
3
0
22 8 Dq   (Eq. 1.1) 
q
 
charge on droplet surface, ε0 the permittivity of medium surrounding the droplet, γ the liquid surface tension, 
and D the droplet diameter. 
The key components of this definition are the surface tension force of the droplet, 
and the coulombic repulsion of like-like charges on the droplet surface.  When the former 
exceeds the latter, the droplet remains intact.  As the droplet loses mass (and diameter) 
through solvent evaporation, the coulombic repulsion value equals and eventually 
overcomes the surface tension, causing droplet fission (Gomez & Tang 1994, and  
Last et al. 2002).  
The charged residue model (Fig. 1.5a), originally proposed by Dole et al. (1968) 
upon the development of ESI, explains charged analyte production through repeated solvent 
evaporation and coulombic fission events.  Current evidence (De La Mora 2000) supports 
that this is the mechanism by which native-like, macroions such as globular proteins are 
generated within the gas phase. 
The ion desorption model (also known as the ion evaporation model, Fig. 1.5b), was 
originally proposed by Iribarne & Thomson (1976) and later supported by Hager and  
co-workers (1994).  This model states that the production of ions occurs through the direct 
desorption of charged analyte once the radii of the electrospray aerosol droplet drops below 
10 nm.  This model also requires that the droplet maintains a suitable surface charge density 
at a value less than the Rayleigh stability limit.  Current reports suggest that this is the 
mechanism by which small organic and inorganic ions are generated within the gas phase 
(Cole 2000, Felitsyn et al. 2002, and Kebarle & Peschke 2000).   
It has been suggested however that both methods may occur in tandem.  Whilst 
initial desolvation events occur by the charged residue model, once the mass of droplet 
reaches the 10 nm threshold size, direct desorption of the ion is able to occur (Cole 2000).   
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Figure 1.5. Mechanisms of ESI Analyte Desolvation and Ion Formation 
Both the (a) charged residue, and (b) ion desorption/evaporation models are initiated upon ejection of 
charged solvent (blue spheres) suspended analyte (red spheres) from the Taylor cone aerosol (Fig. 1.4b).  
This suspended analyte loses mass via solvent evaporation, whilst maintaining a similar level of charge to 
the initial droplet. a) The charged residue model occurs due to increasing internal coulombic repulsion 
resulting from decreasing solvent levels.  Below a critical mass the charge repulsion exceeds the surface 
tension holding the droplet together.  Passage of this limit promotes droplet fission.  This evaporation/fission 
cycle is repeated several times between aerosol formation and mass analysis.  This cycle typically results in 
a single molecule (dependent on starting concentration, Sun et al. 2007), of one or more charges, within 
each solvent droplet (Cole 2000, and Heck & van den Heuvel 2004).  b) The ion desorption/evaporation 
model dictates that as a droplet loses mass from desolvation the increased electrostatic charge drives 
expulsion of analyte from the solvent.  The analyte is expelled with added charge, and little excess buffer 
bound. Desorption has little influence on the overall solvent mass (Iribarne & Thomson 1976). 
 
ESI however, is not without its limitations for the study of large native-like 
biomolecules and complexes, including protein, DNA and RNA.  These are typically cited 
as the use of organic solvents and high temperatures to aid desolvation, which reduce the 
native like oligomeric and conformational state of the analyte.  The required high flow rates 
can further limit the application of ESI when available sample is limited (Hilton &  
Benesch 2012, and Karas et al. 2000).   
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There are however, observations of ESI applied to the study of native-like proteins.  
In the early 1990s scientists within the Chait research group produced the first evidence for 
native-like proteins in the gas phase.  Studying bovine cytochrome C (11.7 kDa, 
Chowdhury, Katta & Chait 1990) and equine myoglobin (17 kDa, Katta & Chait 1991), 
using a variety of pH values, investigations highlighted the appearance of charge state 
distributions (CSD) at higher m/z values compared to the non-native.  These high m/z CSD 
values are indicative of the native-like state due to the reduced solvent accessible area that 
inhibits higher charge levels. 
 
1.2.2.1. The Continued Development and Miniaturisation of Electrospray Ionisation  
 
Miniaturisation of the ESI source in the early-to-mid nineteen nineties, led to the 
development of micro-electrospray (inner diameter 5-50 μm) by Emmet & Caprioli (1994) 
and Gale & Smith (1993), and sequentially removed certain limitations imposed by 
standard ESI.  Further refinements of the design by Wilm & Mann (1994) resulted in the 
development of the nano-electrospray ionisation (nESI) source. 
In contrast to previous techniques, nESI provided a reduced capillary inner diameter 
of 1-2 μm (from 100 μm, Yamashita & Fenn 1984) enabling a drastically reduced flow rate 
of ~20 nL/min (from 1-20 μL/min, Fenn et al. 1989).  This reduced capillary size 
additionally produced droplets with a smaller diameter from the Taylor cone aerosol, 
removing the requirement for harsh desolvation conditions (e.g. desolvation gas 
temperature) that can affect the native state of large biomolecules/complexes  
(Wilm & Mann 1996).  
The lower sample flow would typically be identified as a limiting factor, expected 
to result in decreased ion signal intensity due to the reduced effective sample concentration 
(i.e. sample reaching mass detector).  In contrast the opposite phenomenon is observed, 
with improved counts and peak resolution.  Juraschek and co-workers (1999) showed that 
these improvements resulted from the improved salt tolerance exhibited by the smaller 
droplet size, by comparing mass spectra of NaCl containing solutions of peptides using 
both ESI and nESI.  With droplet size as the primary cause of the improved tolerance, the 
work highlighted that the reduced diameter prevented large increases in salt concentration 
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during desolvation.  These decreases additionally improved sensitivity by reducing singly-
charged specie sample loss (Juraschek et al. 1999).  
With the reduced droplet diameter and improved salt tolerance of nESI, the 
requirement to use organic solvents and acids, in tandem with high source temperatures to 
permit suitable sample desolvation were removed (Hilton & Benesch 2012).  In lieu neutral 
aqueous volatile buffers such as, ammonium acetate (AmAc) and ammonium bicarbonate 
could be used (Felitsyn et al. 2002).  Buffers such as these aid the preservation of the native 
like conformation of proteins in the gas phase, required for the study of noncovalent 
oligomeric complexes and fundamental for the study of conformational dynamics of ions 
using mobility separation (section 1.4) (Hilton & Benesch 2012, van den Heuvel & Heck 
2004, and Winston & Fitzgerald 1997).  
Typical nESI source emitter tips
4
 are currently produced using borosilicate glass 
capillaries that are shaped to produce the desired exit diameter (1-2 μm).  In-house 
production of these nESI emitter tips is becoming increasingly common, with instruments 
such as the P-97 (Sutter Instruments, CA, USA) commonplace within mass spectrometry 
research groups.   
To ionise samples these nESI emitter tips classically used a platinum wire housed 
within the capillary to ionise the analyte laden solvent.  Subsequent observations by  
Wang and co-workers (2003) indicated that this method of sample ionisation combined 
with the low sample flow typical of nESI, results in the electrochemical breakdown of 
water (Oxidation in positive mode, reduction in negative mode) (Kitova et al. 2012, and 
Wang et al. 2003).  Operation in positive mode (typical of native protein ionisation) 
therefore leads to decreases in the pH over time (as much as 1 pH unit within 30 minutes), 
resultant from the production of H3O
+
 ions (Wang et al. 2003).  These changes in pH can 
adversely influence electrostatic and ligand binding interactions, which are undesirable in 
native mass spectrometry studies. 
Today, the most common method for nESI emitter tip production is to coat shaped 
capillaries with a thin layer of gold, or a gold/palladium mix (such as those used by 
Tito et al. 2000).  This coat conducts the charge required for production of the Taylor cone 
and sequential analyte ionisation.  Current literature however, fails to indicate if nESI 
                                                 
4
 Also referenced within the literature as ‘needles’ as early as 1996 (Wilm & Mann 1996) 
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capillaries produced using this method suffer the same electrochemical oxidation of water 
properties that the platinum wire-in-capillary source tips have been shown to suffer.  
Additionally the use of chip based nESI ionisation sources, such as those developed 
by Advion (NY, USA) have also become common-place.  These chip based sources permit 
high throughput sample analysis using a programmable automated system.  Early designs, 
much like the wire in capillary methods, were identified to suffer from pH increases 
resulting from the oxidation of water due to electrical conductance of the source tips used 
to deliver the sample.  Since these issues were highlighted however, internal wall coated 
source tips have been developed that no longer suffer from this problem due to a reduced 
ionisation surface area (van Berkel & Kertesz 2012). 
 
1.3. Mass Analysis 
 
Arguably as important as the ionisation source, the mass analyser is required to obtain 
information regarding mass from the charged analyte.  A variety of principles exist to 
separate ions based on their m/z value, including: the quadrupole (section 1.3.2.) that uses 
m/z dependent trajectory stability, ion traps which use resonance frequency (Douglas 2009, 
and March 2009), or the time-of-flight (ToF) analyser (section 1.3.3.) that separates ions 
according to mass dependent velocity over a set distance through a field free region 
(Guilhaus 1995).  Each of these mass analysers (along with those not listed), differ with 
respect to the following definitions of suitability:  
Mass accuracy; difference between measured and theoretical m/z. 
Mass range; limit of m/z mass detection where z = 1. 
Resolving power; ability to distinguish between two peaks at similar m/z value 
(covered more extensively in section 1.3.1).   
Speed; rate at which the analyser acquires results over a set mass range (units per 
time period stated). 
No mass analyser however provides a suitable mix of the above characteristics for 
all situations.  Whilst instruments such as Fourier transform-ion cyclotron resonance mass 
spectrometers provide excellent mass accuracy and resolution at low mass values, they lack 
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the mass range required for high mass studies.  In contrast, ToF instruments exhibit this 
suitable mass range, but lack the resolution of the former (Domon and Aebersold 2006). 
 
1.3.1. Mass Resolution and Resolving Power 
 
Experimental method and design has in the past century driven the development of mass 
spectrometers with greatly improved mass resolving power.  Since the development of the 
first mass spectrometers around the turn of the twentieth century, the resolving power (R) 
of mass spectrometers has shown rapid growth, and a select example of this progress is 
briefly highlighted below:  
Parabola mass spectrograph, R = 13 (Thomson 1913) 
Velocity focusing mass spectrograph, R = 130 (Aston 1919) 
Second-order focusing mass spectrograph, R = 2000 (Aston 1937) 
Fourier transform-ion cyclotron resonance-mass spectrometer, R = 8x10
6
 (Shi et al. 
1998). 
The R value can be described using equation 1.2 (Gross 2004, and Marshall et al. 
2002): 
m
m
R


  (Eq. 1.2) 
m, represents the mass of the peak of interest on the m/z scale, Δm, represents the resolution defined by  
Eq. 1.3 
The Δm of a mass spectrum is described in the terms of the difference in mass 
between two points, measured in Da (Eq. 1.3, Fig. 1.6) (de Hoffmann & Stroobant 2007): 
12 mmm   (Eq. 1.3) 
Therefore at a constant R value, Δm will decrease as the m/z value increases  
(Fig 1.7).  Consequently, manufacturers of mass spectrometers usually quote their 
instrument values as 1 in R, at a defined m/z range (Gross 2004).  This definition is 
somewhat limited, as instrumental set ups that utilise the ToF (section 1.3.3.) for mass 
analysis which have fixed R values across the entire mass range, and therefore do not suffer 
from the phenomena outlined in figure 1.7. 
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Figure 1.6. Determining Δm Using The Modern 
(R50%) and Classical (R10%) Methods  
a) The modern determination of the R value, 
especially since the advent of the linear 
quadrupole, ToF, and ion-trap mass analysers, 
calculates Δm from the values m1 and m2 at the full 
width at half maximum (FWHM) of a single peak.  
b) The classical method measures Δm when the 
valley between two peaks is sufficient to exist at a 
level proportional to 10 % of the relative height, 
and termed R10%.  Additionally the R10% is only 
fulfilled if the peak width at R5% equals the mass 
difference of the corresponding ion (Gross 2004). 
 
 
Figure 1.7. Effect of the m/z Value on the Ability to Distinguish Between Two Neighbour Ion Peaks at 
a Constant R50% 
The R50% at a set value of 500 supports that as the m/z value increases from 250, to 500, and 1000, the mass 
difference at FWHM value increases, proportional to Δm.  This leads to increased levels of peak 
superimposition at higher m/z values. Therefore ion peaks at m/z 500 require an R50% value of 1000 to 
resolve down to the baseline, if Δm50% = Δm0% / 2. 
 
1. Of Mountains and Molehills: the Development of Mass Spectrometry and Ion Mobility 
for the Study of Noncovalent Complexes 
 
37 
1.3.2. The Quadrupole Mass Analyser  
 
The linear quadrupole for mass spectrometric applications was first described by  
Paul
5
 & Steinwedel (1953) and is currently applied to a range of applications, including ion 
guide, filter, and mass analyser (Douglas 2009).  The principle design of the quadrupole 
centres around four parallel rods of circular (Fig. 1.8), or hyperbolic section, through which 
direct currents are applied with alternating radio potentials (Douglas 2009, and El-Aneed  
et al. 2009).   
Opposing rods share the same charge state, whilst neighbour rods the alternate, with 
the opposing charges labelled +Φ0 and -Φ0 (Fig. 1.8).  These charges are defined using 
equation 1.4 in the positive, and negative respectively (Collings & Douglas 1997, and 
Douglas 2009). 
)cos(0 tVU    (Eq. 1.4) 
Φ0 is the rod charge potential, ω the angular frequency, U is the maximum DC voltage applied 
between pole pairs, and V the zero to peak amplitude (AC voltage). 
 The combination of U and V, whilst having no influence on the acceleration along 
the z axis, which remains constant, can be used to produce a region of stable ion trajectory 
potentials.  This effectively filters ions based on the x/y acceleration potential, connected 
with mass and charge (Fig. 1.9) (Blaum 2006, and Douglas 2009).   
By correctly filtering ions based on their stability, using optimal U and V values, the 
quadrupole can select species based on their m/z value which are sequentially detected by 
the ion detector.  Application of a scanning range that comprises a range of U and V values 
can be applied used to produce a full mass spectrum within the quadrupole mass analyser. 
In contrast, quadrupole analysis lacking modification of these values to scan across the 
desired mass range produces a limited mass range that is able to filter ions (Chernuschevich 
et al. 2001, and Collings & Douglas 1997).   
 
                                                 
5
 An individual who would later help develop the 3D ion-trap (Paul & Steinwedel 1960), and combined with 
the development of the penning ion-trap by Dehmelt (1968) would be jointly awarded the 1989 Nobel Prize in 
Physics “for the development of the ion-trap technique” (The Nobel Prize in Physics 1989). 
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Figure 1.8. Basic Representation of the Linear Quadrupole  
“Ions travelling along the z axis are subjected to the influence of a total electric field made up of a 
quadrupolar alternative field superimposed on a constant field resulting from the application of the potentials 
on the rods” defined using equation 1.4 (de Hoffmann & Stroobant 2007).  With reference to the U and V 
values that are used to determine Φ0, changes allow ions with different m/z values to traverse the quadrupole 
(See Fig. 1.9).  Furthermore changes to the strength and frequency of the alternate field, in addition to fixed 
changes in the field radius (r0) of the x/y axis can be applied to modify the mass range and ion transferral 
window capabilities (along the z axis) (Chernuschevich et al. 2001, and Douglas 2009). 
 
The mass range limits of the quadrupole can be calculated using the Mathieu 
Parameter equations (see Collings & Douglas 1997).  These equations ascertain that to 
extend the mass range of the quadrupole for high mass studies, an individual has to either 
extend the maximum DC and RF (Radio frequency) voltages, or decrease the field radius 
(r0) and/or frequency of the RF (Chernuschevich et al. 2001, and Collings & Douglas 
1997). 
 The quadrupole can be further combined in line with a collision cell, and a second 
mass analyser such as another quadrupole (e.g. triple quadrupole, see section 1.3.2.1), or 
ToF (section 1.3.3), for tandem mass spectrometry (MS/MS) in-space studies  
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(section 1.3.2.1).
6
  The key difference between quadrupoles used for normal mass analysis 
(narrow select window) and high mass filtering (i.e. acting as an ion guide) however, is that 
non mass analysis quadrupoles run in RF only mode.  The RF is then modified to allow a 
broader or narrower m/z range through the region (Chernuschevich et al. 2001). 
 
 
Figure 1.9. Trajectory Stabilisation of 
Ions Through a Linear Quadrupole  
a) Stability diagram (dark grey area with 
axis numerical values not stated) where 
the shaded area represent the AC/DC 
voltage combinations corresponding to 
stable ion trajectories in the x-z (b, ii and 
iii) and x-y (c, i and ii) planes. Trajectory 
of ions i-iii, (set mass/increasing charge, 
or decreasing mass/set charge) highlights 
the trajectory along the (b) x-z or, (c) y-z 
axis.  Ions therefore are only able to 
traverse the z axis, when the ion is stable 
in both x and y axis (Baum 2006, and 
Miller & Denton 1986).  In practice the 
AC (V) and DC (U) voltages can be 
modified to shift the stability area, i.e. the 
quadrupole transmission window that 
allows i and iii to pass stably through both 
the x and y axis (lighter grey areas) 
(Chernuschevich et al. 2001). 
 
1.3.2.1. Collision Induced Dissociation of Isolated Species 
 
Development of collision induced dissociation (CID) of gas phase species by McLafferty & 
Bryce (1967), and Jennings (1968), had a major impact on mass spectrometry by extending 
the range of studies that could be performed (Hayes & Gross 1990).  Using CID an 
                                                 
6
 MS/MS-in-time studies decomposition of ions as a series of sequential events, requiring the use of an ion 
storage device such as an Ion Trap (Johnson & Yost 1991). 
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investigator is able to induce the unimolecular decay of an analyte ion through collisions 
with inert neutral gases, such as helium and argon.   Energy transfer between the neutral 
backing gas and analyte ion is generally influenced by several factors, including: collisional 
gas pressure, the molecular weight of the neutral gas (larger masses deposit more energy), 
collisional cross section of the analyte ion, in addition to their charge, injection energy and 
the loss of this energy as they traverse the collisional cell (Daniel et al. 2002, and Pittenauer 
& Allmaier 2009).   
The development of the MIKES (Mass-analysed Ion Kinetic Energy Spectrometry), 
instrumentation by Beynon and co-workers (1973) allowed the mass selection of precursor 
ions using magnetic sector instrumentation and a variable width aperture.  Subsequently the 
decomposition of mass selected ions was induced using a collision cell, prior to analysis of 
the fragmentation patterns using a second magnetic sector mass analyser (Beynon et al. 
1973, and Kruger et al. 1976).  This instrumentation found early applications in ion 
chemistry kinetics studies, such as those presented by Cooks and co-workers in the 
structural analysis of benzene and bromobenzene ions (Cooks, Beynon & Litton 1975). 
Subsequent work presented by Kruger and co-workers (1976) applied the mass 
selection capabilities of the MIKES instrumentation for the analysis of a complex mixture 
of dialkyl ketones.  Using the mass selection capabilities available, combined with analyte 
fragmentation induced by electron impact and chemical ionization, the dissociation patterns 
of the precursor ions could be studied to determine the component dialkyl ketones from the 
original sample (Kruger et al. 1976).  This work represents the first implementation of the 
MS/MS technique, whereby the instrumentation has been applied for sample analysis in 
lieu of the fundamental studies of ions and molecules previously commonplace.   
Instrumental developments by Yost & Enke (1978) would later lead to the 
development of the triple quadrupole mass spectrometer for MS/MS applications.  This 
instrumentation incorporated three sequential in-space quadrupoles.  The first and last 
operated in mass filter modes, permitting the selection and analysis of ions.  In contrast the 
central quadrupole, operating in the RF only mode, was used to fragment ions for CID 
studies (Yost & Enke 1978).  The application of quadrupoles for CID studies has since 
become commonplace, with many commercial and in-house built instruments incorporating 
at least one to mass filter ions for MS/MS studies. 
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Differences in MS/MS can be performed as a function of the energy levels (high or 
low) used to induce fragmentation.  High energy (keV range) CID utilise a unimolecular 
beam, directed toward an outlet pump, perpendicular to a focal point of an accelerated ion 
beam.  Interaction between the ion and unimolecular beam corresponding to gains in 
electronic energy, that induces decomposition of the analyte ion into fragment ions 
resultant from subtle differences in structural composition (e.g. peptide side chains) 
(Biemann 1990, and Pittenauer & Allmaier 2009).   
Comparatively, dissociation of ions studied using low energy (< 100 eV, Pittenauer 
& Allmaier 2009) studies occurs under the influence of an unfocussed higher pressure 
backing gas.  Interactions between the backing gas and analyte permit transmissions of 
energy from the backing gas to analyte that correspond to gains in vibrational energy.  
Although these energy transmissions are lower relative to the high energy, the unfocussed 
nature of the backing gas allows multiple collisions to occur (de Hoffmann 1996, and 
Jennings 2000). 
Applied to structural biology analysis, using low-energy MS/MS methods an 
investigator is able to quadrupole mass select the ion of interest allowing studies of the 
structural organisation of macromolecular assemblies.  Under increasing collision energies 
the outer, more weakly bound substrates will unfold and dissociate from the complex more 
rapidly.  This provides an indication of the structural organisation and stability, with 
examples readily within the literature (Benesch et al. 2006, and Hernandez et al. 2006).   
CID of large multimeric complexes typically results in a non-uniform redistribution 
of the ion charge.  An early example of this non-uniform redistribution was presented by 
Sobott & Robinson (2004) using the isolated +65 ion of the 14 subunit E. coli GroEL 
oligomer.  Fragmentation of ions, over an increasing collision voltage (4 to 200 V), 
highlighted the dissociation of a single GroEL subunit that carried ~50 % (z = 25-38) of the 
total charge of the isolated species.  The remaining charge was distributed amongst the 
intact 13 subunit oligomer (z = 26-39). 
Subsequent work performed by Benesch and co-workers (2006) would refine the 
explanation for this asymmetry.  The misconception is that each subunit carries a level of 
charge proportionate to its mass.  One would therefore expect an ion distribution functional 
to the ratio of the mass of the individual subunit, divided by the multimeric oligomer.  In 
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actuality, the charge distribution occurs as a function of the surface area, typically confined 
to subunits with an increased solvent accessible area.  This work supported the theory that 
removal of sequential subunits requires lower dissociation energies, resulting from 
coulombically favourable forces occurring due to changes in surface area and reduced 
charge density (Benesch et al. 2006). 
 
1.3.3. The Time-of-Flight Mass Analyser 
 
In terms of mass analysis, the ToF mass analyser is quickly becoming the default tool of 
choice, especially within native structural biology studies that rely on its superior high mass 
range.  Combined with a high level of adaptability, compatibility with an extensive range 
soft ionisation sources (e.g. nESI, and MALDI), and other components (e.g. quadrupole, 
and ion mobility separator), the ToF mass analyser has been applied to an expanding 
number of native structural biology based studies. 
 The original concept for ToF analysis was proposed by Stephens (1946), and later 
demonstrated by Cameron & Eggers (1948).  ToF analysers measure the physical properties 
of an analyte using velocity as a function of mass, timed over a set distance.  As velocity 
and mass correlate negatively at a constant charge, two equally charged ions (e.g. R and B) 
pulsed into the ToF component at the same time, with B of greater mass than R, will dictate 
that R reaches the detector first.   
Measurement of the m/z value can then be calculated from the time required for ions 
to traverse from the source, through the field free region of the ToF, to the ion detector 
(section 1.3.3.1).  To calculate the m/z of an ion, using the linear free flight tube, the 
following equations (Eq. 1.5 to Eq. 1.10) are used. 
Prior to entering the free-flight region, ions of specific mass (m) and total charge  
(q = ze) are accelerated by a potential (VS).  Its electric potential energy (Eel) is converted 
into kinetic energy (Ek), using equation 1.5: 
elSSk EzeVqV
mv
E 
2
2
  (Eq. 1.5) 
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Rearrangement of this equation can be used to calculate the velocity (v, in ms
-1
) of an ion 
through a simple free-flight tube using equation 1.6 below: 
2/1
2







m
zeV
v S
  (Eq. 1.6) 
Post acceleration, an ion travelling in a straight line at the velocity defined above, the time 
(tf, in s) required to cover the distance of the free flight tube (L, in m) is given by  
equation 1.7: 
v
L
t f    (Eq. 1.7) 
Replacing v by its value in equation 1.6 gives equation 1.8: 







S
f
eV
L
z
m
t
2
2
2
  (Eq. 1.8) 
e, represents the electronic charge in coulombs. 
Equation 1.8 can therefore be rearranged to determine m/z from the tf producing  
equation 1.9: 
  f
s
t
L
eV
zm









2
/
2/1
  (Eq. 1.9) 
In practice, as L and VS represent fixed values, applying the known m/z values of at 
least two suitably spaced calibration points (represented by A and B), equation 1.9 can be 
simplified to equation 1.10: 
  BAtzm f 
2/1
/   (Eq. 1.10) 
(Eq. 1.5 to 1.10 are taken from Guilhaus 1995, and de Hoffmann & Stroobant 2007) 
To calculate m we require the need to calculate the charge value (z) of the ion.  In 
the case of smaller ions that remain singly charged, i.e. z equals + or -1, using ESI 
protonation/deprotonation (M+H
+
/M-H
+
) methods, the mass gain/loss of the single added 
charge can be simply taken into account.  Larger proteins/peptides (generally in excess of 
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1200 Da), are increasingly likely to undergo multiple protonation/deprotonation events 
during ESI, producing a Gaussian-type distribution.  Assuming that two neighbouring 
charge peaks in a mass spectrum are part of the same Gaussian CSD the higher m/z value 
ion will carry the charge zn, and the lower m/z zn+1 (n = number of charges).  Determination 
of the zn can be calculated using equation 1.11 below (Mann, Meng & Fenn 1989): 
1
1 1





zz
z
n
MM
M
z
  (Eq. 1.11) 
M represents the m/z value of the parent ion at z and z+1 respectively. 
Equation 1.11 allows us to calculate the charge number of zn, and therefore given 
the mass of the added/lost H
+
 ion using equation 1.12, we can calculate the mass in Da 
using the ion m/z at zn: 
)()(  HzzMDa nnz   (Eq. 1.12) 
H
+
 represents the mass of a proton using the C
12
 rule.  Please note that the equation here represents mass 
calculation using the protonation model.  With the deprotonation model, subtraction of the added mass is 
replaced with addition of the lost mass. 
As the ToF mass resolving limitations are a function of the length of the free flight 
region, theoretically a mass spectrometer with a near-infinite length could hypothetically 
have a near limitless mass resolving power.
7
  The key limitation of the linear ToF analyser 
however, is the failure to account for differences in ion kinetics that can modulate the peak 
broadness of mass spectra proportional to the length of the free flight tube (Fig. 1.10a part i 
and ii).  As a result of this phenomenon, Mamyrin and co-workers (1973) combined the 
ToF with an electrostatic mirror (commonly known as a reflectron, Fig. 1.10b part i) to 
lessen the influence of kinetic differences, that modulate spectrum resolution  
(Fig. 1.10b part ii).  Advantageously this instrumental set up effectively doubled the length 
of the free flight tube, within the same area of the linear tube (Mamyrin et al. 1973). 
 
                                                 
7
 Typically ToF cells are also coupled to quadrupoles (section 1.3.2.), and/or other ion guides, which in 
practice tend to limit the mass range of acquired spectra more than the length of the free flight tube. 
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Figure 1.10. Linear and Reflectron Time of Flight Mass Analysers  
Both red (R) and blue (B) components represent the same theoretical m/z, with B exhibiting a lower kinetic 
energy value. a) i) Differences in the kinetic energy promote difference in the arrival times of R and B 
reaching the detector.  ii) These differences sequentially modulate the spectrum peak width and mass 
accuracy accordingly.  b) i) Addition of an electrostatic mirror (reflectron) counteracts the influence of 
kinetic differences between R and B. ii)  In addition to doubling the length of the free flight tube, compared 
to a linear ToF of comparable size, this electrostatic mirror reduces peak broadening.   
 
1.3.3.1. Detecting Ions at the End of the Free Flight Tube 
 
The earliest method to record ions, by Aston and Thomson, were photographic plates that 
allowed them to calculate the m/z or z/m values as a function of the deflection exhibited 
under the influence of a magnetic field.  In contrast, ion detection at the end point of the 
ToF free flight tube is typically performed using a microchannel plate (MCP).  These are a 
flat conversion surface with micro channels orientated 82 degrees from the parallel 
(Chernuschevich et al. 2001, and Wiza 1979).  Ion strike events at the MCP produce 
electrostatic pulse ~1-2 ns in length positively correlated with the momentum of the analyte 
(Chernuschevich et al. 2001, and Jungmann et al. 2013).  This pulse is amplified, and used 
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to the record tf. Variations in MCP instrumentation exist, including the transient recorder, 
and time-to-digital recorder (Chernuschevich et al. 2001).   
Application of these MCPs is dependent on the typical ionisation source at the front 
end of the mass spectrometer (Chernuschevich et al. 2001).  The transient recorder is an 
analogue system, typically used for MALDI-ToF instruments due its wide dynamic range, 
and digitises output ion current from the MCP.  Typically these are of limited use for single 
ion or MS/MS analysis due to the background noise associated with analogue systems.  The 
limitation of the transient recorder is that the width of the ion pulse window, translates 
directly to the resultant mass spectrum to determine the tf.   
The time-to-digital converter MCP is commonly found on nESI/ESI source 
instruments due to lower the intensity ion signal magnitudes that reach the detector.  
Despite the lower dynamic range compared to the transient recorder, this variation is 
typically of greater use in MS/MS experiments that requires the detection of individual ion 
events to improve the signal to noise ratio (Chernuschevich et al. 2001).  In further contrast 
to the transient recorder, the time-to-digital converter uses only the leading edge of the ion 
pulse to record the tf (Chernuschevich et al. 2001). 
The general limitation of the MCP overall is that it can record only one ion pulse 
window at any incidence time.  This includes the dead time following ion impact, where the 
MCP is unable to register another ion.  If further ions strike during this dead time MCP 
saturation can occur (Chernuschevich et al. 2001).  Accounting for all ions in the ToF 
exhibiting kinetic energy values equivalent to their mass, high mass ions will impinge the 
detector at a lower momentum than low mass ions.  As ion detection and recording events 
are dependent on secondary ion generation, which is positively correlated to ion 
momentum, the MCP can suffer from ‘high-mass roll-off’ reducing high mass analyte 
detection (Jungmann et al. 2013). 
 
1.4. Ion Mobility: The Next Dimension 
 
The theoretical basis for the calculation of the mobility of ions through the gaseous phase is 
was originally proposed by Langevin (1903).  This theory ultimately resulted in the 
development of the ion-mobility (IM) method, with the first mobility measurements 
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presented by Bradbury (1931) (Uetrecht et al. 2010).  The principle of the IM method, 
using the basic drift tube/drift cell mobility separator (Fig. 1.11), is that a pulsed packet of 
heterogeneous gas phase ions can be separated on the basis of their velocity through a low 
pressurised drift cell superimposed with an electric field (section 1.4.1) (Uetrecht et al. 
2010). 
The earliest example of a combined IM-MS instrument was first cited within the 
literature in the early nineteen sixties (McDaniel, Martin & Barnes 1962).  Combining the 
classical drift cell with a Nier type 60° magnetic sector mass analyser, the instrument was 
used to study the kinetics of ion-molecule reactions.  Later modifications of the IM-MS 
instrumental method would replace the magnetic sector with both ToF (McAfee, Sipler & 
Edelson 1967, and Edelson et al. 1967), and quadrupole mass analysers (Albritton et al. 
1968).  The focus of the instrumental method over the course of the next two decades 
however, remained on using the mass spectrometer component of the instrument to identify 
IM analysed components (Kanu et al. 2008).   
 
 
Figure 1.11. The Ion Mobility Drift Cell  
The fundamental operating procedure of the drift cell is that packets of ions are pulsed into the mobility 
separator at time 0, controlled through the action of a voltage/ion gate, at a constant pressure (1-15 mBar) of 
a neutral backing gas (e.g. He or N2) (Dugourd et al. 1997, and Uetrecht et al. 2010).  Ions traverse the drift 
cell under the influence of a uniform weak electric field (10 V cm
-1
) originating from metal  
(e.g. copper beryllium) drift guard rings (grey), typically interspersed with ceramic spacers (yellow) 
(Dugourd et al. 1997).  Once ions have migrated across the mobility separator, these pass into subsequent 
mechanical components allowing the instrument to record drift time and mass.  Weakly charged ions traverse 
the region less quickly than those of a higher charge state (if we maintain consistent mass and diameter), due 
to reduced influence of the static field.  Additionally ions of increased size and shape (linear or radial) 
traverse the drift cell more slowly due to increased interactions with the backing gas  
(Thalassinos & Scrivens 2009, and Uetrecht et al. 2010).   
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Work presented by Kuk and co-workers (1989), as well as Kemper &  
Bowers (1990), combined an IM drift cell with a mass spectrometer to obtain shape 
information for a series of analyte ions, presenting information on the structure of silicon 
clusters and cobalt respectively.  Despite the early nature of this work, it provided the 
cornerstone for work on far larger complexes, including: peptides, proteins, and protein 
complexes (section 1.4.3). 
 
1.4.1. Calculating Velocity and Size in the Drift Cell 
 
The velocity of an ion through a mobility region such as the drift cell (Fig. 1.11) is 
dependent on several factors, including: ion mass, charge, shape and density. This is in 
addition to drift cell conditions including the elevated pressure neutral backing gas used 
and the electric field.  Components of smaller and/or more compact shape, at a constant ion 
charge state interact with the backing gas less.  Subsequently these traverse the drift cell 
faster than ions exhibiting larger less compact shapes of equal charge (Ruotolo et al. 2008, 
and Uetrecht et al. 2010).  The IM (K, cm
2
 V
-1
 sec
-1
) of an analyte ion is defined in its 
simplest form using equation 1.13 outlined below (Kemper & Bowers 1990): 
E
V
K d
  (Eq. 1.13) 
Vd, represents the velocity, and E, the electric field strength (V/cm) 
In practice it is customary to work with the reduced mobility (K0) which expresses 
the mobility at standard temperature (T0) in Kelvin, and pressure (P0) in Torr (Eq. 1.14): 
0
0
0
TP
PT
KK 
  (Eq. 1.14) 
P and T represent effective pressure (Torr) and temperature (Kelvin) respectively 
Substituting T0 and P0 for their defined values, 273.15 Kelvin and 760 Torr respectively 
gives equation 1.15: 
760*
15.273*
0
T
P
KK 
  (Eq. 1.15) 
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The K0 of a species can then be related to the collision cross section (CCS), by applying 
equation 1.16: 
TkN
ze
K
B
21
16
3
0
0


  (Eq. 1.16) 
z, is the charge number, e, the electronic charge, N0 the buffer gas number density at T0 and P0, μ, the reduced 
mass of the buffer gas and ion (Da), kB, the Boltzmann constant, and Ω, the CCS (Ǻ
2
) 
(Eq. 1.13 to 1.16 are taken from Thalassinos & Scrivens 2009) 
Coupling the drift cell to a mass spectrometer subsequently enabled direct 
determination of the mass and charge values of an ion, required for equation 1.12.  Using 
these values the average Ω (Ωavg) can then be calculated, by relating it to the drift time (tD), 
in ms, through the following equation (Eq. 1.17) (Thalassinos et al. 2004): 
 
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  (Eq. 1.17) 
m, is the mass of the ion in Da, mB, the mass of the backing gas (Da) with its density represented by ρ, L the 
length of the cell (cm), and E, the electric field strength (V/cm).  
 
1.4.2. The Travelling Wave Mobility Separator  
 
The development of the travelling wave (T-wave) ion guide (Fig. 1.12) by the Waters 
Corporation (Manchester, UK) and outlined by Giles and co-workers (2004), allowed new 
IM techniques to be developed.  The basic principle was to use a sequential RF phase 
stacked ring ion guide (SRIG) (Fig. 1.12a) to confine analyte ions.  The charged analyte is 
then propelled through the central aperture of the ion guide using a DC potential 
superimposed on the RF of a single ring electrode.  This potential sequentially migrates to 
the next ring electrode and all subsequent ring electrodes in the cell, at a user defined 
velocity (Giles et al. 2004).   
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Figure 1.12. The Travelling Wave Ion Guide 
The T-wave mobility separator differs from the drift cell by using a non-uniform voltage distribution across 
the length of the cell, in addition to a RF confining field, to separate ions.  a) The non-uniform nature of the 
field results from a DC voltage applied to individual electrodes of the alternating RF phase SRIG.  b) This 
voltage is applied to sequential electrodes producing a ‘travelling wave’ that propels ions through the 
mobility separator.  As ions ride the crest of the DC wave, larger, more extended analytes (linear or radial), 
undergo increased interactions with the backing gas and are resultantly more likely to pass over this crest 
exiting the T-wave later (Thalassinos & Scrivens 2009, and Utrecht et al. 2010). 
 
Although the idea of the RF confined T-wave ion guide to propel and separate ions 
was not new, having previously been applied by Lampel et al. (1998) and Wangler (1998), 
this was the first time that the SRIG setup was applied to this function (Giles et al. 2004). 
Experimentally the T-wave SRIG is a diverse experimental set up in comparison to the drift 
cell, and is able to act as a collision cell required for MS/MS in addition to IM separation 
(Giles et al. 2004).   
Following on from the development of the T-wave, in mid-2006, the Waters 
corporation (Manchester UK), announced the Synapt High Definition Mass Spectrometer 
(HDMS, Fig. 1.13).  This instrument combined the T-wave IM separator with the widely 
used Q-ToF Premier (Waters, Manchester, UK), producing the world’s first commercially 
available mass analysis equipment capable of IM measurements for CCS analysis  
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(Waters Corporation 2006, and Pringle et al. 2007).  Functionally, the Synapt combined 
three neighbouring T-wave cells, marketed as the ‘TriWave.’  The first and last functioned 
as collision cells (termed the Trap, and Transfer respectively), whilst the central under the 
influence of increased operating pressures provided functional T-wave IM separation 
(Pringle et al. 2007, and Thalassinos & Scrivens 2009).
8
 
 
 
Figure 1.13. The Waters Synapt HDMS  
The above schematic represents the mechanical component layout of the first generation Waters Synapt 
HDMS.  IM tD measurements occur as a sum of the time between the release of a packet of ions via the 
voltage gate (labelled ‘GATE’ above) and arrival at the detector within the ToF (Giles et al. 2004, and 
Pringle et al. 2007).  For each packet of ions released by the voltage gate the orthogonal acceleration pusher 
(labelled ‘PUSHER’) ‘pushes’ 200 times, totalling one mass spectrum acquisition.  Arrival of an ion is 
recorded at the detector, and its tD expressed as the pusher number (also known as ‘scan’) that the ion is 
recorded, multiplied by the pusher period (time between pushes in ms).  It should be noted however, that due 
to multiple packets of ions traversing the T-wave at any incidence in time, any ion(s) taking longer than the 
total pushes x pusher period, effectively ‘roll over’ to the next spectrum (Pringle et al. 2007).   
Figure reproduced from Pringle et al. 2007 
 
 
                                                 
8
 Please note that since the development of the second generation Synapt HDMS, the TriWave has been 
modified to include a helium filled entry cell at the entrance to the mobility separator permitting increased 
operating pressures, suitable for improved drift time resolution. 
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Figure 1.14. Example of the Multi-Layered Data Acquired Using the Waters Synapt HDMS  
Data obtained using IM-MS methods, such as that from the Synapt HDMS, is inherently three dimensional 
comprising; (a) mass, (b) relative size in terms of the tD function (converted from scan number), and intensity 
as a function of the dynamic range (shown as a function of relative height to the most intense peak). c) Heat 
map data (white = highest intensity, black = lowest) output from Driftscope (Waters, Manchester, UK), is 
superimposed with lines that indicate the relationship between tD, and the oligomeric/structural state.  Data 
depicted shows a single IM-MS spectrum of the multimeric nature of the truncated S. cerevisiae protein Sgt1 
(amino acids 1-150) (Chapter 4). Each colour (a, b) represents the extracted tD of the nearest native state 
(lowest charged ion of oligomer) of each oligomer present: yellow = monomer, blue = dimer, red = trimer. 
 
The design of the Synapt
9
 provides a number of advantages over prior drift cell 
systems.  The TriWave is more versatile and easier to use, and the availability of a 
commercialised product derived from a popular and widely used instrument, is a clear 
improvement over the in-house developed instrumentation which had previously been the 
norm.  This commercial instrumentation was further aided by an updated version of the 
                                                 
9
 For an in depth description of the Waters Synapt HDMS please see Pringle et al. (2007) 
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industry standard mass analysis software, MassLynx, combined with the newer IM analysis 
program Driftscope.  Combined, these programmes enabled easy analysis of the 
multilayered data obtained using the Synapt instrumentation (Fig. 1.14).  This is in addition 
to improvements in sensitivity along with, a high level of tD reproducibility over the 
previous method (Thalassinos & Scrivens 2009). 
In the reverse comparison, drift cells have a comparatively better tD resolution, due 
to their typically higher operating pressures when compared to the T-wave.  Arguably, the 
largest advantage of the drift cell compared to the T-wave is the ability to directly 
determine the CCS of analysed components (Bush et al. 2010, and Thalassinos & Scrivens 
2009).  Therefore as the T-wave is unable to directly correlate the arrival time of an ion to 
determine the CCS, analyte tD requires calibration against standards of experimentally 
derived known cross sections.   
Known standard CCS values, required for T-wave calibration, are calculated using 
drift cell IM-MS and the equations previously highlighted in section 1.4.1.  These drift cell 
CCS values are presented in a range of literature, including (but not limited to):  
Bush et al. (2010), Campuzano et al. (2012), and Valentine et al. (1997).  Publications of 
these types typically feature a range of different native and non-native proteins and 
peptides, over a series of ionic charge states, along with variations in mobility gas used 
(N2(g) and He(g)) (Bush et al. 2010).  Additionally these values are typically collated and 
featured in a number of open access CCS databases, including those hosted by the Bush,
10
 
Clemmer
11
, and McLean
12
 (MALDI generated ions only) research groups.   
Calibration of T-wave derived experimental ion tD to calculate the CCS requires, as 
with any scientific investigation, equipment parameters consistent with the analyte.  This 
factor is essential in terms of the mobility T-wave wave height and velocity parameters, as 
modification of either will drastically influence the validity of the calibration plot for 
determining CCS from the unknown.  Various methods to plot calibration curves from 
                                                 
10
 http://depts.washington.edu/bushlab/ccsdatabase/ (correct as of 7
th
 August 2013) 
11
 http://www.indiana.edu/~clemmer/Research/Cross%20Section%20Database/cs_database.php (correct as of 
7
th
 August 2013) 
12
 http://www.vanderbilt.edu/AnS/Chemistry/groups/mcleanlab/ccs.html (correct as of 7
th
 August 2013) 
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standard derived tD values are outlined by publications, including: Ruotolo et al. (2008), 
Thalassinos et al. (2009), and Williams & Scrivens (2008).
13
   
Work presented by Leary and co-workers (2009) has shown that these calibrations 
can provide comparable CCS values between two individual and independently located 
instruments operating under similar conditions (Leary et al. 2009).  Current estimates of 
propagated errors for calculated average CCS, using careful T-wave calibration strategies, 
are estimated to be less than 5 % (Bush et al. 2010).   
Additional sources of CCS error have been considered and include the collisional 
heating of analyte ions under the influence of increasing T-wave velocities required for 
mobility separation.  Data presented by Morsa and co-workers (2011) indicated however 
that the He(g) and N(g) commonly used for mobility separation are unable to promote 
significant levels of ion heating that typically correspond to gains in CCS (see collision 
induced unfolding, section 1.4.3) (Morsa et al. 2011). 
Due to their relevance in work presented throughout subsequent chapters, the 
calibration methods for calculating the CCS of multiply charged proteins from T-wave tD 
values will be examined here.  Taking the drift cell derived calibrant CCS (Ω) in Å2, these 
are corrected for both the charge state and reduced mass (μ, Eq. 1.18), to generate corrected 
CCS (Ω’) values using equation 1.19 (Ruotolo et al. 2008, and Williams & Scrivens 2008): 
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This corrected CCS is then plotted against the t”D (m/z dependent corrected tD), 
which is calculated using equation 1.21.  In order to resolve this value however, calculation 
                                                 
13
 Facilities exist on the internet to allow rapid calibration curve plotting and CCS determination of analyte 
ions, including those hosted by the Scrivens, and Thalassinos research group websites: 
http://www2.warwick.ac.uk/fac/sci/lifesci/research/jscrivens/synapt_calibration/ and 
http://www.homepages.ucl.ac.uk/~ucbtkth/resources.html respectively (correct as of 1
st
 November 2013, 
Thalassinos et al. 2009) 
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of the m/z independent tD (t’D) is required, and outlined by equation 1.20 below 
(Thalassinos & Scrivens 2009): 
 tmDD tttt 3161'    (Eq. 1.20)  
tD, is the experimental drift time extracted from the FHWM of the ion of interest in ms. tm and tt, are the time 
(ms) spent in the mobility and transfer regions respectively, calculated as the time between pairs of ring 
electrodes in each region (61 and 31 respectively in the Synapt HDMS).  These are a function of the 
experimental wave velocity parameter and T-wave electrode spacing (3 mm in the Synapt HDMS).  
085.0*
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zm
tt DD   (Eq. 1.21) 
0.085, is the sum of the ToF flight time (44 μs), and transit time (41 μs) in ms at m/z 1000. 
The resultant plot of Ω’ against t”D is subsequently used to calculate the CCS of the 
unknown analyte ion applying a suitable trend line (Fig. 1.15).  Choice of trend line 
function is typically based on research presented by Shvartsburg & Smith (2008) with 
multiply charged calibrant protein ions (relevant here) plotted using a non-linear or power 
fit trend line.  In contrast singly or doubly charged peptide calibrants are plotted using a 
linear fit trend line.  This plot can be additionally applied to calculate the difference 
between the CCS derived from the fitted trend line against the published standard value, 
allowing for improved calibration accuracy by removing outlying points (Thalassinos et al. 
2009). 
Further experimental refinements require that the selection of calibrant(s) closely 
bracket the resultant analyte tD acquired using the T-wave, as well apparatus conditions 
maximising the coefficient of determination (R
2
) fitting of the calibration curve, to provide 
relevant, high accuracy CCS values (Salbo et al. 2012).  Failure to adapt to either of these 
pre-requisites may result in large calibration errors.  This is especially true if extrapolating 
curve fitting from calibrants that bracket tD values well below that of the experimental 
analyte, impairing the experimental validity (Bush et al. 2010, Shvartsburg & Smith 2008, 
and Thalassinos & Scrivens 2009). 
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Figure 1.15. Example Calibration Curve Required for T-wave CCS Analysis 
Example calibration curve drawn using denatured equine myoglobin (red), in combination with native bovine 
serum albumin (green), and S. cerevisiae alcohol dehydrogenase (blue) (all calibrants purchased from Sigma-
Aldrich Ltd, Dorset UK).  These are calibrated using CCS values derived from Bush et al. (2010), at a 
constant wave height of 9 V, travelling at 300 m/s.  R
2
 represents the agreement between the calibration curve 
and all of the calibrant points contributing to its gradient value (y). 
 
1.4.3. Applying the “Next Dimension” 
 
To date, IM-MS has been applied in a broad range of experimental methods including 
studies of conformation stability and gas phase separation.  Proteomic and metabolomic 
studies have applied the mobility separator to decongest spectra peaks.  Peptide ions 
between 500 to 2500 Da typically produce linear mass/ion mobility plots at a constant 
charge state, H
+
 or H2
+
 (Shvartsburg & Smith 2008, Valentine et al. 1999).  Therefore  
IM-MS allows separation of ions that share the same m/z, but exhibit different structural 
conformations, including other molecular classes that may be present such as lipids or 
MALDI matrices, due to differences in linear mass/mobility plots.  This method allows 
multidimensional separations of complex analyte mixtures, including in situ tissue analysis 
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using mass spectrometry imaging methods (Chughtai & Heeren 2010, and Jackson et al. 
2007).   
In addition to separating ions of the same m/z, but different structural 
conformations, instrumental set-ups such as the TriWave promoted the development of new 
experimental methods that allowed direct analysis of protein folding and stability dynamics.  
One commonly applied method is that of collision induced unfolding (CIU), first used to 
study structural folding intermediates by Ruotolo and co-workers (2007).  Combining  
T-wave IM-MS with increasing injection energies, this early CIU investigation was used to 
study the folding stability and conformations along the unfolding pathway of human 
transthyretin (TTR).   
Subsequent refinements to the CIU method applied the quadrupole to isolate a 
precursor ion, prior to collisional activation using the TriWave Trap region (Fig. 1.13) to 
induce unfolding.  Analysis of the structural state is subsequently performed using the 
mobility separator, to determine changes in CCS (Fig. 1.16) (Hopper & Oldham 2009).  
The advantage of this method is that an investigator can rapidly target and analyse the 
desired ion (typically the highest charged ion in the native CSD), studying its gas phase 
stability and conformational states with direct relationship to the collision energies  
(Han et al. 2011).  Applications of the method within the literature include the structural 
modulation, and conformational influences of binding small ligands (Hopper & Oldham 
2009), and anions (Han et al. 2011). 
What is undoubtedly the largest advantage provided by IM-MS analysis, is the 
ability to use the calculated CCS values, to aid de novo structural determination of an 
analyte using computational methods (see chapter 5).  This is as well as providing 
corroboratory evidence for X-ray crystallography (see chapter 4) and nuclear magnetic 
resonance (NMR, see chapter 3) results, without the imposed limitations of these respective 
methods.   
To allow comparison of IM calculated cross section data with protein database 
(PDB)
14
 structures, derived using X-ray and NMR based techniques, software such as 
MobCal (Mesleh et al. 1996, and Shvartsburg & Jarrold 1996) is required to convert these 
structures into compatible CCS values.  To produce these values MobCal applies a variety 
                                                 
14
 http://www.rcsb.org/pdb/home/home.do (correct as of 30
th
 May 2013) 
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of models to calculate structure derived CCS, including: exact hard sphere scattering, 
(EHSS, section 1.4.3.3), projection approximation (PA, section 1.4.3.1), and the trajectory 
method (TM, section 1.4.3.2).  Each of these methods, that have their own strengths and 
weaknesses, are explored in brief below along with the newly developed projection 
superposition approximation (PSA) model. 
 
 
Figure 1.16. Example of Collision Induced 
Unfolding to Study Protein Stability 
Study of the structural conformation of the 
monomeric +8 ion of a truncated S. cerevisiae 
protein (Sgt1, amino acids 1-178), using CIU and 
increasing collision energies (18, 27, and 36 V).  
Image indicates a shift in tD indicative of protein 
unfolding, with at least two stable, partially 
unfolded, conformations. A cartoon representation 
of the protein structure is depicted in red, to 
represent the unfolding that contributes to these 
increases in tD.  Please note that these cartoons are 
not representative of the structural nature of the 
Sgt1 protein, and are for illustrative purposes only. 
 
1.4.3.1. Calculating Collision Cross Sections Using the Projection Approximation 
Model 
 
The simplest method to calculate CCS from PDB files is the PA (Fig. 1.17) (Mesleh et al. 
1996).  This model provides an average cross section based on the sum of all ‘shadows’ or 
‘projections’ created by a protein orientated about the x and y axis (Scarff et al. 2008, and 
Scarff et al. 2009).  Typically Monte Carlo scoring is applied to allow determination of the 
projected area in any given x/y orientation (Bleiholder et al. 2011). 
Limitations of the PA occur at the equation level as it does not account for the long 
range electrostatic interactions, convex surface features and scattering of the backing gas.  
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Consequently the PA underestimates the CCS of larger analytes with complex collision 
geometries (Mesleh et al. 1996, Scarff et al. 2008, and Thalassinos & Scrivens 2009).  
Observations, performed by Scarff et al. (2008), on experimental T-wave derived data 
compared against theoretical CCS calculations obtained using PDB structures support these 
conclusions. 
 
 
Figure 1.17. Representation of the 
Projection Approximation Model 
for CCS Calculation Using PDB 
Data 
The PA calculates CCS values from 
NMR and X-ray derived PDB data.   
a) The three dimensional PDB 
structure is rotated about the x and y 
axis.  b) At each change in x and y, a 
new Monte Carlo hit test is performed 
producing an effective shadow of the 
structure that is equal to the sum of 
radii between the backing gas and 
analyte structure.  c) All resultant hit 
test scores are summed to produce an 
overall CCS shadow. 
 
1.4.3.2. Calculating Collision Cross Sections Using the Trajectory Method Model 
 
The TM (Fig. 1.18), has been shown to produce the most accurate PDB derived CCS 
estimates, especially for larger analytes (Scarff et al. 2008).  This model, first outlined by 
Mesleh et al. (1996), takes into account all interactions between the analyte and backing 
gas (He(g)) across the orientationally-averaged CCS (Campuzano et al. 2012).  These 
analyte-backing gas interactions include: collision geometries (i.e. angle of deflection), and 
the effect of convex features, on calculated CCS values (Fig. 1.18a).  Additionally the TM 
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calculates the influence of long range electrostatic interactions, which do not result in direct 
‘hits’ under the orientationally averaged CCS Monte Carlo method (Fig. 1.18b)  
(Hopper & Oldham 2009, Mesleh et al. 1996, and Campuzano et al. 2012).  Calculating the 
contributions of these long range interactions limits the application of the TM for CCS 
studies due to the computational demands required to perform them.   
  
 
Figure 1.18. Representation of the Trajectory Method for CCS Calculation Using PDB Data 
a) Applying the hard sphere collision model, the TM calculates for the angle of deflection (θ˚) resultant from 
direct backing gas (blue sphere) interactions with the analyte (red sphere) superimposed with a ‘hard sphere 
collision limit’ (pale red). b) The computational drain of the TM occurs as a result of calculating long range 
electrostatic interactions between the analyte charge cloud on both the analyte and backing gas (pink).  The 
EHSS enhances computational efficiency by removing this step from calculations, whilst providing accurate 
CCS measurements within a few percent of the TM (Scarff et al. 2008).  
 
1.4.3.3. Calculating Collision Cross Sections Using the Exact Hard Sphere Scattering 
Model 
 
Representing a compromise between the accuracy of the TM, and the speed of the PA 
models, the EHSS (Shvartsburg & Jarrold 1996) ignores the long range electrostatic 
interaction calculations of the TM (highlighted in Fig. 1.18b).
15
  Comparatively, the 
removal of these calculations from the model reduces accuracy only a few percent when 
compared to the TM (Jarrold 1999, and Scarff et al. 2008).  
                                                 
15
 These interactions are quoted to contribute “less than 10 %,” to the sum of all interactions of the fullerenes 
studied by Mesleh et al. (1996) when outlining the development of the TM.   
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The EHSS model superimposes a ‘hard sphere collision limit,’ equal to the 
combined radii of the analyte and backing gas (Fig. 1.18a) on the structure.  When this limit 
is surpassed by the buffer gas it is treated as a contact moment, with measurements of the 
scattering/deflection angle (Fig. 1.18a), counting towards the CCS value calculated by 
MobCal (Jarrold 1999).  Furthermore, this model accounts for structural features such as 
convex geometries which increase drag and reduce gas phase mobility (Bleiholder, 
Wyttenbach & Bowers 2011). 
 
1.4.3.4. Calculating Collision Cross Sections Using the Projection Superposition 
Approximation Model 
 
The recently developed PSA (Bleiholder, Wyttenbach & Bowers 2011, Bleiholder et al. 
2013, and Anderson et al. 2012), acts as a modified version of the PA highlighted 
previously.  Compared to the PA the PSA additionally accounts for the collective shape and 
size effects of analyte and backing gas, whilst remaining computationally efficient 
(Bleiholder, Wyttenbach & Bowers 2011).  In contrast to the other models previously 
highlighted, the PSA is only available in the modelling program Sigma (von Helden et al. 
1993, Wyttenbach et al. 1997, and Wyttenbach, Witt & Bowers 2000). 
Unlike the models above, the PSA replaces the idea of a hard sphere shell with a 
collision probability value, dependent on distance as well as the size of both the analyte and 
selected collision gas (Fig. 1.19).  Combined with calculations of shape modulation 
influences on the tD (also accounted for in the TM and EHSS), the PSA provides a greater 
accuracy compared to the PA from which it is derived (Bleiholder, Wyttenbach & Bowers 
2011).  
In-house analysis of the model, by the Bowers research group (Anderson et al. 
2012), has found that application of the PSA to study small supramolecular assemblies with 
complex shape factors was in high agreement with experimental CCS values.  Compared to 
PA and TM, the PSA has been shown to provide improved agreement between the 
theoretical and experimentally calculated CCS values.  This is in addition to being almost a 
“factor of 10 faster” than the TM (Anderson et al. 2012).   
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Follow up work by Wyttenbach, Bleiholder & Bowers (2013), applied the PSA to 
study a range of ions of greater mass (130 Da to 800 kDa) and size.  Research concluded 
with several observations outlined, at both the level of the PSA itself and buffer gas 
interactions.  With regards to the latter, data agreed with previous observations by  
von Helden and co-workers (1991) that relative contributions of buffer gas to the obtained 
tD decrease with ions of increasing size (nearly negated by 1x10
6
 Da), and is of importance 
when studying small peptides (Wyttenbach, Bleiholder & Bowers 2013).   
 
 
Figure 1.19. Representation of the Projection Superposition 
Approximation Model for CCS Calculation Using PDB 
Data 
Image represents a visualised depiction of the collision 
probability (Pj) for a chosen random point on the analyte, 
perpendicular to the plane of interception. Increasing 
temperatures (T), and distances (X) decrease the probability of 
interaction between the backing gas (blue) and the analyte  
(red, with hard sphere collision limit).  This probability 
decreases exponentially with distance, as long range 
electrostatic interactions (pink) are gradually negated and the 
influence of the backing gas lessens.  Below a certain distance 
however (X < 0) the hard sphere collision limit is surpassed 
and results in direct interactions that count directly toward to 
the projection cross section (σ). 
 
Of significant importance in future IM-MS studies are the observations that 
Wyttenbach, Bleiholder & Bowers (2013) highlight between the He acquired tD values, 
compared to those obtained using N2.  These are of concern due to an increased interaction 
between the analyte and N2(g) occurring due to its increased diameter compared to He(g)  
(~4x increase in interaction effects).  Therefore ions of larger size, exhibiting increased 
levels of surface concaveness, cannot be accurately predicted based on their formula whilst 
using N2 to correct for the experimental CCS (Wyttenbach, Bleiholder & Bowers 2013).  
1. Of Mountains and Molehills: the Development of Mass Spectrometry and Ion Mobility 
for the Study of Noncovalent Complexes 
 
63 
The wider applications of results presented using this model in the overall field of IM 
analysis, are however too early to dictate until further observations are published.  
 
1.5. Confirming the Biological Relevance of Gas Phase Structures 
 
Prior to the inception of the soft ionisation sources (section 1.2) publications of native-like 
mass spectra from biological materials were rare occurrences, these resulted due the non-
favourable conditions required for ionisation.  Upon the development of the MALDI and 
ESI soft ionisation sources, large multimeric complexes could be successfully transferred 
intact into the gas phase for mass analysis.  The combination of mass spectrometers with 
IM instrumentation for structural analysis subsequently meant that the validation of gas 
phase biological species took a massive step forward.  Before the turn of the 21
st
 century 
however the viability of native mass spectrometry and IM-MS to produce biologically 
relevant results had been questioned. Some individuals doubted or remained undecided on 
the ability of mass spectrometry to render the appropriate conditions required for gas-phase 
analysis (Loo 1997).   
Work performed by Pace and co-workers (2004), supported by earlier non-mass 
spectrometric based observations performed by Wolynes (1995), indicated that in a vacuum 
intermolecular interactions such as electrostatics were sufficient to stabilise the fold of the 
small globular protein, RNase Sa (S. aureofaciens).  In the absence of water however, 
hydrogen bonds and van der Waals interactions are weakened, with the structure primarily 
stabilised through electrostatic interactions.  Net protein charge is therefore a factor in gas 
phase stability, and exceeding a threshold value stabilising electrostatic interactions are 
compromised and protein unfolding occurs (Pace et al. 2004).   
Later work by other individuals would expand upon these observations and support 
them at the level of the multimeric protein assemblies.  Ruotolo and co-workers (2005), 
provided evidence to support the existence of native macromolecular structures in the gas 
phase.  Studying the trp RNA binding protein, TRAP (large multimeric ring structure), 
using drift cell IM analysis, experimenters were able to indicate that the lowest charged ion 
in the CSD produced a CCS in strong agreement with previous X-ray derived structural 
data.  Increases in charge state showed a transition state between native macromolecular 
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states, to a non-native collapsed state (Ruotolo et al. 2005), and supports the observations 
by Pace and co-workers (2004) above.   
As these higher charge states are increasingly likely to provide biologically 
irrelevant CCS values, the work supports the use of the ‘nearest native’ charge state for IM 
tD analysis, i.e. lowest charged analyte ion in the CSD of interest.  This is further supported 
by extended work performed by Scarff and co-workers (2009) who presented a positive 
correlation between the proteins charge state and increasing, less native, CCS.  These 
changes in CCS are concluded to occur as an influence of increasing Coulomb repulsion at 
the higher charge states (Scarff et al. 2009). 
 
 
Figure 1.20. Stepwise Gas Phase Evolution: Desolvation to Gas Phase Stabilization 
Post ESI globular proteins undergo a series of structural evolution events dependent on desolvation and 
intramolecular binding loss/gain events. A) The ionised sample enters the gas phase within a solvent shell.  
B) This ionised sample desolvates over the ns timescale until only exterior ionic functional groups remain 
encapsulated within the solvent.  C) Further desolvation leads to an effectively dry sample allowing the 
functional ionic groups’ to collapse over the picosecond timescale.  D) This results in a ‘near-native’ state 
that over an extended ms timescale suffers a loss of (E) hydrophobic and (F) electrostatic bonding, producing 
a transient unfolded state.  G) Over an extended period of time, not typically of IM-MS analysis in 
instrumentation such as the Synapt HDMS, these transient, unfolded states may refold to produce stable gas 
phase structures (Brueker & McLafferty 2008). ‘T’ represents temperature. 
Figure reproduced from Brueker & McLafferty 2008 
 
Using questions highlighted by Loo (1997), with regards to the stability and 
relevance of biological materials in the gas phase, Breuker & McLafferty (2008) proceeded 
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to ask; “for how long, under what conditions, and to what extent can solution structure be 
retained without solvent?” Combination of experimental and computational analysis 
allowed the authors to produce a time frame evolution of sample desolvation and gas phase 
stability modifications (Fig. 1.20).  The work performed concluded that with regards to the 
original question, asked above, solution structure is eventually lost on the post ms time 
scale.  This therefore confirms the biological validity of IM derived CCS values which 
occur on the sub ms time scale. 
Additional considerations with regards to the stability of gas phase ions and their 
native-like nature are further outlined by Tahallah and co-workers (2001) on their studies of 
oligomeric species using increasing source pressures.  Increasing source pressures showed a 
direct correlation with the detection of higher m/z ions.  This is accounted as a feature of 
differential collisional cooling effects on ions of increasing mass, in tandem with reduced 
desolvation represented by decreasing peak resolution.  This decreased desolvation would 
hypothetically stabilise hydrophilic interactions within the gas phase for an extended period 
of time.  Additionally their observations further outline the use of suitable ionisation 
conditions to prevent excessive source dissociation, stabilising the biologically relevant 
state (Tahallah et al. 2001). 
Subsequently, with the above inferring biological validity of results obtained under 
suitable conditions, studies of gas phase protein complexes using mass spectrometry and 
IM-MS are becoming increasingly commonplace in the field of structural biology.  These 
studies apply the combined speed, mass sensitivity, and structural resolution, of a single 
instrumental method. Work presented in the following chapters has applied a range of both 
gas and solution phase methods, to probe the oligomeric and structural conformations of 
three proteins required within their respective organisms, to ensure viability. 
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2. Instrumentation and Analysis 
-------------------------------------------------------------------------------------------------------------- 
 
Overarching instrumentation and analysis methods are outlined here. For investigation 
relevant materials and methods please see the appropriate chapter.  
 
2.1. Mass Spectrometry: Instrumentation 
 
All data sets were acquired using a first generation Synapt HDMS (Waters, Manchester, 
UK), hybrid quadrupole orthogonal accelerator mass spectrometer with TriWave IM 
capabilities (Schematic previously depicted in Fig. 1.13).  This instrument has been 
modified for high mass by installing a reduced RF frequency quadrupole generator enabling 
the study of ions up to m/z 32 000.  For all studies presented here, instrumentation was 
combined with a nESI source using in-house prepared, gold coated ‘bee-stinger’ type 
nanospray capillaries.  Instrumental condition control and data acquisition were performed 
using MassLynx v4.1 (SCN728) (Waters, Manchester, UK).   
ToF calibration was performed using an aqueous solution of 24 mg/ml caesium 
iodide diluted with 30 % isopropanol, producing a suitable calibration range exceeding  
m/z 16 000 (Sterling et al. 2010).  N2(g) was used for IM separation, with Ar(g) used within 
the Trap and Transfer TriWave components (see schematic in Fig. 1.13) for collision 
studies.  When required, sample cone cleaning was performed using a solution of 45 % 
methanol, 45 % ddH2O and 10 % formic acid, and sonicated at 37 kHz for no more than  
15 minutes, prior to ToF calibration and analysis.   
‘Bee-stinger’ type nanospray capillaries were produced in-house using,  
1 mm outside / 0.5 mm inside diameter, borosilicate glass capillaries (Sutter Instruments, 
Novato, CA, USA) and calibrated using a P-97 flaming/brown type micropipette puller 
(Sutter Instruments, CA, USA).  Calibrated capillaries were coated with a fine layer of gold 
using a SC7620 ‘Mini’ sputter coater (Quorum Technologies, West Sussex, UK).  
Nanospray capillaries were loaded with 2.5 μL of solvent-diluted analyte combined with an 
estimated sample flow rate less than 10 nL/min enabling nESI durations exceeding  
30 minutes, suitable for native mass spectrometric analysis. 
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2.2. Mass Spectrometry: Data Analysis 
 
Mass spectra and tD analysis were performed using MassLynx v4.1 (SCN712) (Waters, 
Manchester, UK), combined with Driftscope v2.1 (Waters, Manchester, UK) for extended 
IM spectra analysis.  All spectra herein are shown with minimal smoothing and no baseline 
subtraction. 
 IM tD values were converted to CCS using power fit curves in accordance with the 
methods outlined in Hilton et al. (2010), and Thalassinos et al. (2009).  Calibration was 
performed using experimental He(g) drift cell CCS values presented by Bush et al. (2010), 
and corrected for the N2(g) mobility gas used in the IM separator.  Calibration curves were 
fitted against experimental tD values, obtained from the FWHM of the ion peak, to calculate 
CCS using Microsoft Office Excel 2003 (Microsoft, WA, USA).  Calibrants exhibiting 
estimated cross sections deviating more than 5 % from the published cross sections were 
removed from calibration curves to optimise fitting, whilst retaining a suitable tD spread. 
Conversion of PDB data to CCS values for comparison against IM experimental 
values was performed using MobCal to apply the PA and EHSS models, averaged over  
30 returned simulations (Mesleh et al. 1996, and Shvartsburg & Jarrold 1996).  Due to its 
computationally demanding nature, the TM model was not used.  This is supported by 
observations by Scarff and co-workers (2008) reporting comparable accuracy between the 
TM and EHSS methods for proteins similar in size to those studied here. 
 
2.3. Sample Analysis: Buffer Preparation and Exchange Methods 
 
Native-mass spectrometry analysis buffers were produced using crystalline analytical 
reagent grade AmAc (> 99.9 % PURITY, Fisher Scientific Ltd, Loughborough, UK), 
diluted to concentration using ddH2O.  Buffer pH was measured using a SevenMulti pH 
probe (Mettler-Toledo Ltd, Leicester, UK), and modified to the required value using glacial 
acetic acid (> 99.9 % purity, Fisher Scientific Ltd, Loughborough, UK) and 33 % ammonia 
solution  (Sigma-Aldrich Ltd, Dorset, UK).   
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Two interchangeable methods for buffer exchanging samples were applied either 
individually or, as sequential complementary methods.  Initial sample buffer exchange 
applied Micro Bio-Spin 6 columns (BioRad, Hertfordshire, UK).  Columns were typically 
prepared using four 1000 mM AmAc (pH dependent on the protein sample) washes, 
followed by three at the experimental concentration and pH.  Two or more Bio-Spin 
column washes were not used, as observations indicated a sample concentration loss of  
~20 % for each Bio-Spin 6 column used (data not shown). 
Amicon 1.5 ml 10 kDa MWCO centrifugal concentrator columns (Millipore, 
Dundee, UK) were typically used as a final buffer exchange, and sample concentration step.  
Amicon columns were prepared using two washes at 1000 mM AmAc (pH dependent on 
the protein sample), with the excess solvent removed via centrifugation.  This step was 
followed by a single wash at the required experimental AmAc buffer concentration and pH.  
Sample buffer exchange was performed using a single column with two to three wash 
cycles.  Minimum sample recovery volume was 50 μL, with no notable loss in 
concentration (< 10 % compared to theoretical). 
Samples of native Bovine serum albumin (BSA) and S. cerevisiae alcohol 
dehydrogenase (ADH, Sigma-Aldrich Ltd, Dorset, UK) IM-MS calibrants were produced 
by resuspending the lyophilised protein to 20 μM in 200 mM AmAc (pH 7).  These 
samples were then buffer exchanged into the required experimental AmAc buffer 
concentration and pH using a single Bio-Spin 6 column prior to analysis.  
Samples of non-native Equine myoglobin (Sigma-Aldrich Ltd, Dorset, UK) IM-MS 
calibrant were produced by resuspending the lyophilised protein to 20 μM in denaturing 
buffer: 49.5 % ddH2O, 49.5 % acetonitrile, 1 % formic acid.  For denatured protein mass 
analysis a single wash using the above Amicon MWCO centrifugal concentrators were 
applied to buffer exchange samples into denaturing buffer.  Denatured control analysis, of 
all proteins studied here in, has been used to accurately calculate experimental masses and 
applied to improve the accuracy of molarity calculations. 
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2.4. Additional Software 
 
Extended tD and mass analysis, including graph and table production, was performed using 
Microsoft Office Excel 2003, and 2010 (Microsoft, WA, USA).  Images and other figures, 
not referenced to outside sources, were produced using Illustrator CS3 (Adobe, CA, USA). 
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Chapter 3: Probing Conformational Intermediates of an  
α1-Antitrypsin Variant 
-------------------------------------------------------------------------------------------------------------- 
 
Exhibiting a native metastable fold, mutations of α1-Antitrypsin can promote misfolding 
events increasing the susceptibility to aggregation events at sites of synthesis through toxic 
gain of function.  Formation of these α1-Antitrypsin misfolding intermediates are known to 
propagate under biologically relevant conditions.  Using IM-MS we have characterised the 
structure and stability of the slow polymerisation mutant K154N.  The results obtained 
have shown that this mutant populates an intermediate of increased structural stability upon 
incubation at biologically relevant temperatures. 
 
3.1.1. The Serine Protease Inhibitor Super-Family 
 
The serine proteinase inhibitor (serpin) superfamily, are a family of proteins originally 
termed for their identification in mammalian plasma (Carrell & Travis 1985).  To date 
however, over 1500 serpin-like proteins have been characterised in all taxonomic kingdoms 
(Huntington 2011, Janciauskiene et al. 2011, and Silverman et al. 2001).   
Ranging between 350 and 500 amino acids in length, serpins inhibit the 
chymotrypsin serine family of proteases.  Inhibition of proteinases by serpins progresses by 
a suicide substrate mechanism, promoting a rearrangement of the typical serpin metastable 
fold that binds the serpin and proteinase irreversibly.  These irreversibly bound serpin-
proteinase complexes are then targeted for destruction (Silverman et al. 2001).   
Of the 1500 identified species, the 36 of human origin are required for tightly 
regulated functions that include blood coagulation, fibrinolysis and inflammation 
(Huntington 2011).  Additionally these human serpins are recognised to be required in 
cross-class inhibition, hormone transport, and blood pressure regulation (Huntington 2011, 
and Silverman et al. 2001).   
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3.1.1.1. α1-Antitrypsin: Structure and Function 
 
The human glycoprotein α1-Antitrypsin (AAT) (UniProt ID; P01009, 46 kDa,  
418 amino acids) is the most abundant human serpin and is predominantly secreted into the 
blood serum by the liver, which accounts for 70 to 80 % of all expressions (Janciauskiene 
et al. 2011, and Massi & Chiarelli 1994).   Additional, low level sites of expression and 
secretion include the alveolar macrophages and intestinal wall epithelial cells (Massi & 
Chiarelli 1994).   
Like all serpins, AAT can be structurally characterised by a metastable fold of nine 
α-helices (A-I), and three β-pleated sheets (A-C) (Fig. 3.1) (Patschull et al. 2011).   
β-sheet A is the primary scaffold that the overall metastable tertiary structure forms around, 
and is heavily associated with overall protein function (Dafforn et al. 1999).   
 
 
Figure 3.1. Crystal Structure of α1-Antitrypsin 
α-helices labelled ‘hx’ and β-pleated sheets labelled 
‘syx’ (‘x’ represents the helix or sheet, and ‘y’ the 
strand number).  Relevant to work presented here is 
the K154N mutation (orange circle) which is located 
within α-helix F (purple).  PDB ID: 3NE4 
Figure reproduced and adapted from Nyon et al. 2012 
 
AAT primarily functions to inhibit neutrophil elastase (section 3.1.1.2), binding 
with a high affinity (Ka 10
7 
M
-1
s
-1
, Taggart et al. 2000) in a 1:1 ratio (Fig. 3.2), to prevent 
elastolytic destruction of tissues (Gooptu & Lomas 2009).  Neutrophil elastase binding to 
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AAT occurs at the protruding reactive centre loop, mediated by the amino acids Met358 
and Ser359 (Massi & Chiarelli 1994, and Taggart et al. 2000).  Upon formation of the 
native 1:1 oligomer, the complex is quickly targeted for phagocytosis by macrophages 
(Massi & Chiarelli 1994).   
 
 
Figure 3.2. Neutrophil Elastase Inhibition by α1-Antitrypsin 
Native AAT adopts a metastable fold with a protruding reactive centre loop (red, shown here as a β-sheet) 
that acts as a pseudo substrate for the target neutrophil elastase (black).  This forms an initial Michaelis 
complex that promotes the protease function of neutrophil elastase, cleaving the AAT reactive centre loop.  
Upon cleavage of the reactive centre loop, AAT undergoes structural rearrangement, inserting the reactive 
centre loop within the β-sheet A (blue), to form the fourth (of six) strand.  This structural rearrangement 
promotes the translocation of the neutrophil elastase from pole to pole, in an irreversibly bound state that 
causes inactivation. 
Figure reproduced and adapted from Gooptu & Lomas 2009 
 
Additionally AAT is required in both immunological resistance and 
immunoregulation.  As an immunoregulator, investigations into fibroblast proliferation 
have shown that AAT is able to act as a mitogen, promoting tissue repair in a range of 
tissues (Dabbagh et al. 2001).  Studies of immunological resistance to pathogens presented 
by Knappstein and co-workers (2004) showed that AAT could bind, and inhibit E. coli 
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EspB.  EspB induces pore formation in host cell membranes, allowing effector protein 
injection and correlates positively with blood cell lysis.  Therefore, AAT inhibition of EspB 
is able to prevent haemolysis of blood cells (Knappstein et al. 2004).   
Work performed by Griese and co-workers (2007) explored the pharmaceutical 
applications of ATT.  Their work showed that inhalation of an aerosolised form of AAT, by 
cystic fibrosis patients suffering from pathogenic bronchial infection, reduced lung 
inflammation.  In addition to these expected reduced levels of inflammation, typical of  
in situ AAT activity, inhalation reduced the observed levels of the pathogen P. aeruginosa 
(Griese et al. 2007) in line with its previously identified immunological function. 
 
3.1.1.2. Neutrophil Elastase 
 
Neutrophil elastase (UniProt ID; P08246, 28.5 kDa, 267 amino acids) is a serine protease 
that is recruited to the lungs at sites of inflammation and infection, acting as a front line 
defence against gram-negative bacteria, spirochaetes, and fungal attack (Chua & Laurent 
2006).  Recruitment of neutrophil elastase occurs through the innate immune systems 
neutrophil cells that secrete azurophilic granules containing an estimated 67 000 activated 
elastase proteins (Kelly, Greene & McElvaney 2008).   
Upon secretion, neutrophil elastase degrades the majority of the pulmonary 
extracellular matrix components elastin, laminin and proteoglycan fibronectin.  These 
degradation events are promoted through nucleophilic attack connected with the neutrophil 
elastases catalytic region (His
41
-Asp
99
-Ser
173) serine γ-oxygen.  Additionally neutrophil 
elastase is able to induce epithelial cell apoptosis through surface receptor activation 
(Kelly, Greene & McElvaney 2008, and Lungarella et al. 2008).  Therefore, unregulated 
neutrophil elastase activity, through the loss of AAT activity, can be highly detrimental to 
an individual’s health. 
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3.1.2. Pathology and Mechanisms of α1-Antitrypsin Genetic Disorders 
 
AAT was originally identified by Jacobson (1955) as the primary inhibitor of blood serum, 
exhibiting the highest serum circulation level of any protease (Heimburg & Haupt 1965).  
Subsequent work by Laurell & Eriksson (1963) connected AAT deficiency with 
emphysema.  This deficiency additionally promotes the development of serpinopathies, 
such as liver cirrhosis, which occur due to the toxic gain of function.  These toxic gain of 
function disorders occur as a feature of the ordered polymerisation of serpins at the site of 
synthesis (Ekeowa et al. 2010). 
Deficiency and aggregation disorders of AAT affect 1 in 2000 Caucasian 
individuals of north European ancestry (Blanco et al. 2001, Knaupp & Bottomley 2009).  
Therefore, AAT has become subject to intense study within the scientific community.  
These studies have subsequently identified in excess of 100 allelic variants of AAT 
(Belorgey et al. 2007).  These allelic variants are classified according to an isoelectric point 
and electrophoretic pattern based phenotypic identification (Pi) system, measuring the 
phenotypic expression level, and mobility pattern on a polyacrylamide gel  
(McElvaney et al. 1997, and Massi & Chiarelli 1994).   
The Pi system classifies alleles in two ways.  The first of these is polyacrylamide 
gel mobility pattern separation, which groups alleles into one of four alphabetic 
classifications dependent on their conformationally extensive nature: F = fast, M = medium, 
S = slow, and Z = very slow.  F alleles represent compact structural conformations, in 
contrast to the more extended, slow moving, S and Z classifications.  Therefore, these 
classifications indicate the propensity of an allelic variant to aggregate in contrast to the 
wild type (wt) protein.  Individuals are thereby classified by their autosomal-codominant 
status e.g. ZZ, SZ, etc, with heterozygous phenotypes exhibiting a combination of both 
allelic variants using the polyacrylamide gel analysis methods (Blanco et al. 2001, and 
Hutchinson et al. 1983).   
The Pi system additionally classifies alleles by their expression levels, again into 
one of four categories, dependent on blood serum levels: normal (1.5-3.5 mg/ml),  
deficient (0.15-2 mg/ml), null (no expression due to introduction of premature stop codon), 
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and dysfunctional (normal serum levels, functionally ineffective) (Gooptu & Lomas 2009, 
Massi & Chiarelli 1994, and McElvaney et al. 1997).  
Clinically the general population exhibits a mixture of the predominant MM Pi 
phenotype (86 % population), and MS Pi phenotypes (9 % population). Both the MM and 
MS exhibit normal blood serum levels (Kelly et al. 2010, and Sandford et al. 1999).  
Comparatively the third most common phenotype is the MZ Pi phenotype (3 % population) 
which exhibits a deficient level of AAT (57 % of normal) (Sandford et al. 1999).   
Common allele mutations causing AAT deficiency levels are the S-type E264V, and 
Z-type E342K (Fra et al. 2012, and Kelly et al. 2010).  Phenotypes with commonly 
associated clinical effects are the SS homozygous, and SZ and ZZ heterozygous, 
phenotypes.  The SS phenotype results in mild deficient AAT levels, with an increased risk 
to developing emphysema (Fra et al. 2012, and Sandford et al. 1999).  In contrast, the SZ 
and ZZ phenotypes exhibit more severe serum level reductions, 25 % and 15 % of normal 
respectively, and account for the majority of clinically diagnosed deficiency disorders  
(Fra et al. 2012).   
The common Z mutation, E342K, causes a conformational change in β-sheet A that 
distorts its relationship with the reactive centre loop, allowing polymerisation  
(Ekeowa et al. 2010, and Gooptu & Lomas 2009).  Consequently, Z phenotypes have been 
shown to promote the development of a range of liver diseases (neonatal hepatitis, juvenile 
cirrhosis, and hepatocellular carcinoma), glomerular renal damage, chronic obstructive 
pulmonary disease.  This is in addition to a predisposition to early onset emphysema 
resulting from the reduced serum neutrophil elastase inhibitory activity (Dafforn et al. 
1999, Gooptu & Lomas 2008, and Larsson 1978).   
As well as a predisposition to emphysema, AAT deficiency has been connected to 
the appearance of other disorders such as panniculitis, which affects an estimated 1 in 1000 
deficient patients (Rajpara, Erickson & Driscoll 2010).  The clinical manifestation of AAT 
associated panniculitis is linked to a range of deficiency alleles and typically characterised 
by painful, weepy cutaneous nodules at sites of trauma, with areas of fat necrosis 
(diagnosed by deep skin biopsies) (Stoller & Aboussouan 2005).  Pathogenesis of 
panniculitis has been demonstrated, in the skin of one individual, as a co-localization of 
neutrophils with Z allele AAT polymers.  This suggests that these polymers aid the process 
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of panniculitis development (Gross et al. 2009).  Due to the rarity of this disorder the 
current hypothesis is that panniculitis is a most likely a multi-factorial based disease, 
combining AAT disorders with other factors and genetic predispositions, with work still 
ongoing (Rajpara, Erickson & Driscoll 2010, and Stoller & Aboussouan 2005). 
 
3.1.3. α1-Antitrypsin Polymerisation Pathways 
 
The native folding pathway of AAT requires that it must bypass a global free energy 
minimum to favour the active metastable state required to bind neutrophil elastase. 
Typically, folding intermediates in this pathway tend to be short-lived preventing 
polymerisation.  AAT point mutations however, can modify folding intermediate activity, 
formation, and lifetime.  These modifications are subsequently able to promote AAT 
misfolding, enabling polymerisation (Yamasaki et al. 2011). 
Formation of AAT mutant intermediates, within the first step of the polymerisation 
pathway, has been shown in vitro to populate under several conditions.  These conditions 
include: chaotropic agents (Kim & Yu 1996, and Tew & Bottomley 2001), low pH  
(Devlin et al. 2002), and high temperature (Egelund et al. 2001, and Ekeowa et al. 2010).  
Ekeowa and co-workers (2010) concluded that these conditions induce different solution 
based structural intermediates that support a number of polymerisation models (outlined 
below).  Polymerisation sequentially progresses in a concentration, and temperature 
dependent manner (Lomas et al. 1992, and Lomas et al. 1993).  
To date three models of AAT polymerisation have been proposed: the 
intermolecular reactive centre loop insertion (section 3.1.3.1.), β-hairpin insertion  
(section 3.1.3.2.), and C-terminal domain swapping models (section 3.1.3.3.).  All three of 
these polymerisation models progress via a two-step process, which requires AAT to form a 
polymerogenic intermediate that promotes the formation of polymers (Nyon et al. 2012, 
and Yamasaki et al. 2008).  These polymers exhibit a ‘beads on a string’ morphology that 
is able to permit self-termination by circularising (Huntington et al. 1999, Lomas et al. 
1992, and Lomas et al. 1993).   
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3.1.3.1. Intermolecular Reactive centre loop Insertion Model 
 
The earliest, or ‘classical,’ model of AAT polymerisation is the intermolecular reactive 
centre loop insertion model (Fig. 3.3).  Destabilisation of β-sheet A, promoted by the  
Z-mutant E342K, enables the reactive centre loop to exhibit a more open intermediate 
conformation (Lomas et al. 1992).  This destabilised open reactive centre loop extends and 
inserts within the β-pleated sheet A of a second monomer.  Repetition of these unfolding 
and binding events promotes AAT polymerisation (Dafforn et al. 1999, Gooptu et al. 2000, 
and James & Bottomley 1998).   
 
 
Figure 3.3. Intermolecular Reactive centre loop Insertion Model of α1-Antitrypsin Polymerisation 
The Z mutation (E342K, red circle) destabilises β-sheet A (blue) forming an activated intermediate species. 
Intermolecular linkage then occurs through donation of the reactive centre loop (red) from one molecule, to 
the open lower portion of the central β-sheet A channel of a second molecule.  
Figure reproduced and adapted from Ekeowa et al. 2010 
 
3.1.3.2. β-Hairpin Insertion Model 
 
The β-hairpin insertion model (Fig. 3.4) supports a relatively extensive level of domain 
swapping in comparison to the other models presented. This polymerisation pathway model 
is strongly dependent on the classical Z mutation, E342K, located within the head of  
β-sheet A, strand 5 (red circle, Fig. 3.3) (Yamasaki et al. 2008).  Formation of the 
intermediate progresses through an unfolding of α-helix I, which promotes the formation of 
a β-hairpin intermediate (consisting β-sheet A5, and the reactive centre loop).  This 
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promotes the formation of an open region within β-sheet A that enables β-hairpin 
intermediate binding by a second monomer (Krishnan & Gierasch 2011, and  
Yamasaki et al. 2008). 
 
 
Figure 3.4. β-Hairpin Insertion Model of α1-Antitrypsin Polymerisation 
β-hairpin insertion model first requires that α-helix I is unfolded (green arrow), allowing the extension of  
β-sheet A5 (purple).  This extension provides an intermediate state with a generated binding interface 
comprising the reactive centre loop (red) and β-sheet A5 (purple).  This enables insertion of the hairpin into 
the open β-sheet A region of a second monomer. 
Figure reproduced and adapted from Ekeowa et al. 2010 
 
3.1.3.3. C-Terminal Domain Swapping Model 
 
The C-terminal domain swapping model,
16
 recently reported by Yamasaki and co-workers 
(2011), has shown that AAT polymerisation can be promoted by the formation of a  
β-hairpin comprising β-sheet 4B and 5B.  Formation of this β-hairpin additionally promotes 
dissociation of β-sheet 1C (Fig. 3.5).  This model has shown that the unassimilated  
β-sheet 4B and 5B are able to assimilate into the incomplete β-sheet of a second monomer, 
completing the native like fold.  Data additionally supports that this unassimilated  
                                                 
16
 Alternative known as the ‘triple strand model’ 
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β-sheet B loop is able to re-assimilate into the native fold, of the same protomer, promoting 
self-termination (Yamasaki et al. 2011). 
  
 
Figure 3.5. C-terminal Domain 
Swapping Model of  
α1-Antitrypsin Polymerisation 
a) Crystal structure of the 
polymerogenic intermediate 
required for polymerisation by the 
C-terminal domain swapping 
model.  The fold exhibits a 
dissociated β-sheet 4B, 5B and 1C.  
The unassimilated β-sheet 4B and 
5B form a β-hairpin that is able to 
embed within the β-sheet B of the 
second monomer completing the 
native metastable fold.  b) This 
assimilation promotes the head to 
tail morphology of the polymer.   
The open C-terminal domain of the 
red monomer subunit can be 
subsequently self donate enabling 
self-termination of polymerisation. 
Figure reproduced and adapted from 
Yamasaki et al. 2011 
 
3.2. Experimental Aims and Objectives 
 
All three models of AAT polymerisation exhibit common conclusions: dissociated β-sheets, 
and ‘beads on a string’ polymer morphology (Nyon et al. 2012, and Yamasaki et al. 2008).  
Despite these common conclusions, research has yet to provide a conclusive answer 
regarding the mode of AAT polymerisation.  Consequently, recent investigations have 
progressed to study the polymerisation pathway using rarer mutations that stabilise the 
intermediate step, slowing the polymerisation pathway.  Stabilisation of this intermediate 
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step should help to confer support for either, or all three, of the above models dependent on 
the conditions and methods used. 
The work presented here has been published, in part, in Nyon et al. (2012) 
(Appendix I), targeting the study of the recently reported AAT mutation, K154N (orange 
circle, Fig. 3.1).  This mutation is located within α-helix F (purple, Fig. 3.1), promoting 
deficient serum levels (0.6 mg/ml) and a phenotype between the ZZ homozygote, and the 
MZ heterozygote.  The K154N substitution causes a 36 % loss in functional activity 
(apparent association rate studies), resulting from perturbed electrostatic interactions caused 
by the loss of H-bonding between K154 and the positively charged K174 (hF to s3A 
linker).  Additionally this substitution reduces salt bridging interactions with E151 (hF) that 
are required to negatively regulate AAT polymerogenic intermediate formation (Nyon et al. 
2012). 
Using IM-MS we have studied the conformational stability of the AAT mutant 
K154N, upon incubation at physiological temperatures.  Any observed changes in 
conformation, upon incubation, should support previous observations that AAT mutations 
can promote polymerisation under biologically relevant temperatures (Ekeowa et al. 2010).  
In addition to these incubation studies, CIU has been applied to study the stability of 
K154N unfolding intermediates.  Increases in stability would support that the K154N 
substitution is able to promote stable, long lived, conformational intermediates that can 
promote AAT polymerisation.  
This work has been used to expand upon observations made using NMR 
spectroscopy techniques to report the structural differences between wt AAT and K154N.  
Compared to all other instrumental methods applied in Nyon et al. (2012) for studies of the 
AAT K154N mutation, the major advantage of IM-MS is the ability to derive accurate 
changes in CCS, and separation of co-existing structural conformations.   
 
3.3. Materials and Methods 
3.3.1. Molecular Biology: Preparation and Purification of α1-Antitrypsin  
 
All AAT samples were purified by the Gooptu research group, prior to buffer exchange and 
mass spectrometric analysis protocols, using the methods outlined below. 
3. Probing Conformational Intermediates of an α1-Antitrypsin Variant 
 
92 
Mutations were introduced into AAT complementary DNA (cDNA), and inserted 
into pQE31, and the pcDNA3.1 plasmids by polymerase chain reaction mutagenesis, using 
the methods outlined in Zhou, Carrell & Huntington (2001).  Plasmids containing cDNA 
encoding His-tagged (purification tag comprising 6 sequential C-terminal histidine amino 
acids required for nickel column separation) recombinant AAT were then transfected into  
XL1 Blue E. coli (Stratagene, CA, USA).  
Wt and K154N proteins were expressed and purified from the soluble fraction of the 
E. coli lysate using HiTrap nickel chelating column and glutathione-sepharose  
(GE Healthcare Life Sciences, Bucks, UK) column chromatography.  Samples were 
dialysed into 50 mM Tris, 50 mM KCl at pH 7.5, with purity confirmed using 12 % weight 
to volume SDS-PAGE (Parfrey et al. 2003).   
 
3.3.2. Mass Spectrometric Analysis of α1-Antitrypsin 
 
Prior to mass spectrometric analysis, samples were buffer exchanged using a single Micro 
Bio-Spin 6 column (BioRad, Hertfordshire, UK) equilibrated to 100 mM AmAc pH 7.  
Sample concentrations were measured using serial dilution Nanodrop 1000  
(Thermo Scientific, DE, USA) analysis. Extinction coefficients were applied to correct 
Nanodrop 1000 mg/ml values (table 3.1).  Using the corrected mg/ml values, sample 
molarity was calculated using the experimentally calculated mass (from denatured protein 
mass analysis) (table 3.1).  Upon measurement of concentration, samples were diluted to  
20 μM for analysis, using 100 mM AmAc pH 7.   
Calibrations of experimental AAT tD values, to calculate CCS, were performed 
using the method outlined in section 2.2.  All data were acquired at a constant wave 
velocity of 300 m/s, with a wave amplitude of 10 V.  Denatured Equine myoglobin  
(Sigma-Aldrich Ltd, Dorset, UK) was used as the CCS calibrant.  CCS data are the mean of 
three repeats, plus/minus (
+
/-) mean standard deviation (MSD). 
Incubations of AAT, for structural stability studies at increasing temperatures, were 
performed using a BTD dry block heating system (Grant, Cambridge, UK) set at  
20, 34 or, 39 ˚C for 120 minutes.  Control spectra were recorded at time zero.  Mobility 
data were extracted from the FWHM of the wt and K154N lowest observed charge  
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+12 ion (m/z 3798.5 and 3797.4 respectively).  These studies were performed using static 
Trap and Transfer (see schematic in Fig. 1.13) voltages of 6 and 4 V, respectively, to 
minimise unfolding prior to mobility analysis. 
Quadrupole mass isolation was used to select the m/z corresponding to the +12 ion 
of both the wt and K154N (m/z above), prior to collisional unfolding and mobility studies.  
The TriWave Trap voltage was ramped from 6 to 72 V, in increments of 6 V, refined to 3 V 
between 36 and 54 V.  The TriWave Transfer voltage was kept constant at 4 V.  
Additional instrumental values not previously stated: Capillary voltage;  
0.9 to 1.2 kV, Nanoflow pressure; 0.08 to 0.15 Bar, Sampling cone; 20 V, Extraction cone; 
1.0 V, Source temperature; 40 ˚C, Trap DC bias; 22 V, Trap Gas; 5 ml/min, IM separator 
gas flow; 20 ml/min (0.5 mBar).  All other Trap values: release time; 100 μs,  
amplitude; 10 V, and extract amplitude; 5 V.  Instrumental pressures: source  
backing; 5.75 mBar, Trap; 0.04 mBar, mobility separator; 0.55 mBar, ToF; 2.5x10
-6
 mBar. 
Mass spectra were acquired over an m/z range of 500 to 8 000, for two minutes using two 
second scans. 
 
3.4. Results 
3.4.1. MobCal Analysis of the α1-Antitrypsin Native Structural Conformation 
 
To confirm the biological relevance of our IM-MS studies, MobCal analysis was used to 
compare CCS data between the native AAT X-ray crystallography structure 3NE4
17
 
(Patschull et al. 2011).  Triplicate analysis of the quadrupole isolated lowest observed AAT 
charge state, +12 (m/z 3798.5), indicates a CCS equal to 3310.21 (
+
/- 38.35) Å
2
.  MobCal 
calculated CCS from the PDB structure over thirty simulations provided an average of 
2661.22 (
+
/- 27.68) Å
2
 for the PA, and 3441.596 (
+
/- 42.98) Å
2
 for the EHSS.  PA and EHSS 
calculated values exhibit an excellent agreement with the lowest observed charge wt CCS 
conformation.  The closest agreement between the gas phase and MobCal calculated CCS 
data, is the EHSS.  Experimentally this model produces the most accurate results, when 
compared to the PA (Scarff et al. 2008).  These data confirm that the conditions used here 
                                                 
17
 Amino acids 1-418 (full length wt), with a resolution of 2.0 Å
2
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are able to maintain the native-like structure of AAT, and are therefore capable of 
producing biologically valid results.   
 
3.4.2. Thermal Stability Studies of α1-Antitrypsin Wild Type and K154N  
 
Work by Ekeowa and co-workers (2010) showed that incubation of the common AAT  
Z-mutant, E342K, at a temperature of 37 ˚C for four hours promoted AAT polymerisation 
(Ekeowa et al. 2010).  Compared to common AAT mutants such as the above, K154N 
represents a slow polymerisation mutant with a hypothesised stable polymerogenic 
structural intermediate.  Therefore, K154N represent a unique opportunity to study the 
conformational state of an AAT structural intermediate required for polymerisation.  Both 
wt AAT and K154N were incubated at increasing temperatures (20, 34 and 39 ˚C) to 
compare the stability of the protein metastable state at physiological and near-physiological 
temperatures using IM-MS.   
 
Table 3.1. Theoretical and Experimentally Calculated Masses of α1-Antitrypsin 
Proteins  
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wt His-tag  25565 45550.89 45570.26 2 +19.37 
K154N His-tag 25565 45536.82 45557.26 1.1 +20.44 
 
Prior to initiation of all incubations control mass analysis was performed on both 
the wt AAT and K154N variant (Fig. 3.6).  These data indicate no marked differences in 
the oligomeric state or CSD between either of the proteins.  These spectra are consistent 
with the oligomer and CSDs of AAT after incubation at all experimental temperatures used 
below.  This work supports observations made by other individuals using native PAGE 
(polyacrylamide gel electrophoresis) showing that within the experimental time range used, 
no polymerisation events are observed (Fig. 3.7) (Nyon et al. 2012).   
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Figure 3.6. Control Mass 
Spectra of Wild Type  
α1-Antitrypsin and K154N  
Control mass spectra 
analysis of (a) wt and  
(b) K154N at time zero.  
The K154N substitution 
promotes no difference in 
oligomerisation behaviour 
or CSD (monomer = blue) 
with similar levels of 
unexpected higher-order 
oligomers (green = dimer, 
yellow = trimer).  The 
monomer CSD, between  
m/z 1750 to 2600, represents 
a population of extended 
conformation AAT ions 
indicative of increased 
solvent accessible basic 
amino acids. 
 
 
Figure 3.7. Native PAGE Gel Analysis of Wild Type α1-Antitrypsin and K154N  
7.5 % native PAGE polymerisation study of wt and K154N AAT (0.5 mg/ml) studied over twelve days at  
37 ˚C and 42 ˚C.  Time points indicate polymerisation levels at 0, 1, 2, 6 and 12 days.  Polymerisation is 
indicated by the loss of the monomeric band lower down, shifting to bands higher up the gel. 
Figure reproduced and adapted from Nyon et al. 2012 
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Comparisons of CCS after the 120 minute incubation period indicate no observable 
differences between both the wt and K154N at 20 and 34 ˚C (Fig. 3.8 and 3.9, a and b).  At 
39 ˚C, compared to the native wt conformation under the same conditions, the K154N 
mutation promotes a CCS increase from 2991.07 (
+
/- 0) to 3239.71 (
+
/- 49.39) Å
2
  
(Fig. 3.8c and 3.9c).  This represents a CCS gain of 8.3 % compared to the wt, and an 8.2 % 
increase over the K154N prior to incubation (2994.66 
+
/- 87 Å
2).  Using the Student’s 
paired t-test, the 8.3 % increase between the wt and K154N and 39 ˚C represents a 
significant change in collision cross section with a calculated p-value of 0.0065.   
 
 
Figure 3.8. Drift Time Analysis of Incubated Wild Type α1-Antitrypsin and K154N  
tD analysis of incubated K154N (red) and wt (black) AAT after 120 minute incubation at (a) 20 ˚C,  
(b) 34 ˚C, and (c) 39 ˚C.  Observations indicate no difference between wt and K154N structural conformation 
at 20 and 34˚C.  In contrast, at 39 ˚C the K154N exhibits an increased tD when compared with the wt, under 
the same conditions, indicative of an extended structural conformation.  These observations are expanded in 
figure 3.9.  Data represents tD values extracted from the FWHM of the lowest observed charge +12 ion  
(m/z 3798.5 and 3797.4, wt and K154N respectively). 
 
These data show that the K154N substitution destabilises the AAT metastable fold, 
promoting the formation of an extended conformational state at biologically relevant 
temperatures.  Additionally these observations are supported by thermal denaturation 
circular dichromism (CD) experiments performed by other individuals, which indicate that 
at increasing temperatures K154N unfolds more readily consistent with a reduced stability 
fold (Fig. 3.10) (Nyon et al. 2012).   
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Figure 3.9. CCS Difference Analysis of Wild Type α1-Antitrypsin and K154N   
Despite the lowest observed charge AAT +12 ion (m/z 3798.5 and 3797.4, wt and K154N respectively) 
exhibiting no conformational change within MSD at 20 ˚C and 34 ˚C, at 39 ˚C a CCS increase of 8.3 % is 
observed for the K154N (red) against the wt (blue).   
 
 
Figure 3.10. Thermal Denaturation Circular Dichromism of Wild Type α1-Antitrypsin and K154N  
Thermal dissociation CD spectra (mean ellipticity at 222 nm, n=10) for wt (blue) and K154N (red)  
(Nyon et al. 2012).  Data supports IM data, indicating that the K154N substitution reduces the stability of the 
AAT metastable fold.  
Figure reproduced and adapted from Nyon et al. 2012 
 
In addition to the above, observations of K154N at 39 ˚C indicated aggregation 
events concluded from increased sample turbidity.  These observations are supported by 
difficulties in sample ionisation due to increased sample viscosity.  Mass spectra however 
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failed to provide evidence of these higher order oligomers in the gas phase, and therefore 
this line of questioning was taken no further. 
 
3.4.3. Collision Induced Unfolding of α1-Antitrypsin Wild Type and K154N  
 
The folding pathway of the AAT metastable intermediate for neutrophil elastase binding 
activity requires passage of a global free-energy minimum.  AAT mutations can increase 
the stability of folding intermediates, enabling long-lived conformations that can promote 
AAT polymerisation (Yamasaki et al. 2008, and Gooptu & Lomas 2009).  CIU (previously 
described in section 1.4.3) has been applied to compare the conformation stability and 
number of structured unfolding intermediates of wt AAT and the K154N substitution.  
Advantageously this method provides a level of accuracy not currently reproducible using 
other instrumental techniques, enabling the study of stable structural unfolding 
intermediates and their relative contributions within the acquired arrival time distribution. 
 
 
Figure 3.11. Collision Induced Unfolding Analysis of α1-Antitrypsin Conformational Populations 
a) CIU of the AAT lowest observed charge +12 ion (m/z 3798.5 and 3797.4, wt and K154N respectively) 
indicates that as the collision voltage of the TriWave Trap region is increased, AAT undergoes structural 
rearrangement from the native conformation (A) leading to five extended stable conformations (B to F).   
b) These conformations represent significant increases in CCS.  
 
Collisional unfolding of the quadrupole isolated lowest observed charge  
+12 (m/z 3798.5 and 3797.4, wt and K154N respectively) monomer ion, was performed 
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using a TriWave Trap voltage ramp (6 to 72 V), prior to mobility separation.  This 
conformational analysis (Fig. 3.11) has resolved five significantly extended conformational 
states (B-F) for both the K154N and wt.  No unique, wt or K154N, structural conformations 
were observed. 
 
 
Figure 3.12. Comparative Stability Studies of  
Wild Type α1-Antitrypsin and K154N 
Conformations 
Comparison of conformational stability between 
K154N (red), and wt (black) ATT.  Stability is 
measured as a function of the normalised intensity 
of each conformation, relative to other structural 
intermediates at each dissociation condition.  Data 
indicates that relative to the wt significant increases 
in conformational stability of K154N are observed 
for conformational species C (3731 Å
2
), and  
D (3882 Å
2
). 
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The conformational stability of the wt and K154N AAT variants have been 
compared as a function of the average normalised intensity (%) of their unfolding 
intermediate conformations across the applied collision voltage ramp (Fig 3.12).  Neither 
the native conformation (A, 3310 Ǻ2) nor the initial unfolding intermediate (B, 3524 Ǻ2) 
exhibit any differences in stability between the wt and K154N, when accounting for MSD.  
In contrast the second (C, 3731 Ǻ2) and third (D, 3882 Ǻ2) unfolding intermediates indicate 
an increased level of K154N structural stability relative to the wt between 50 to 60 V  
(Fig. 3.12).  These results therefore support that the K154N substitution is able to promote 
the existence of extended non-native structures of increased structural stability, in line with 
observations using other AAT mutations.   
 
 3.5. Discussion 
  
In all three models of AAT polymerisation, extended structural intermediates are required 
to promote the ‘beads on string’ polymer morphology (Dolmer & Gettins 2012, Krishnan & 
Gierasch 2011, Lomas et al. 1992, and Yamasaki et al. 2008).  Our data has shown that 
under biologically permissible temperatures (39 ˚C) the K154N mutant exhibits an 
extended conformational state, proposed to be the polymerogenic intermediate required for 
AAT polymer formation (section 3.4.1).  This temperature stabilised conformation exhibits 
a CCS 8.3 % greater than the native AAT metastable state.   
Previous work has shown that AAT mutations within the reactive centre loop can 
increase the stability of folding intermediates, promoting long-lived conformations that 
enable AAT polymerisation (Yamasaki et al. 2008).  Although the initial unfolding and 
native conformations, B and A respectively, exhibit no significant difference in stability 
between the wt and K154N (accounting for MSD), studies of the extended conformations 
have been used to apply support to our observations.  At collision voltages of 50 to 60 V, 
the extended K154N conformations C and D exhibit increased structural stability, 
accounting for MSD, compared to the wt.  These data therefore support that mutations 
encoded within AAT structural motifs, other than the reactive centre loop (K154 encoded 
within hF, Fig. 3.1), are able to promote stable structural intermediates.  It should be noted 
however, that neither C nor D have been identified as being biologically relevant 
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polymerogenic intermediates, and are solely evidence of increased structural stability along 
the unfolding pathway of the K154N mutant. 
If the CIU intermediate B represents the polymerogenic, or a polymerogenic-like 
intermediate, required for AAT polymerisation our data indicates that this conformation is 
exhibited by both the wt and K154N, at similar collision voltages (45 V, Fig. 3.12).  These 
data therefore indicate that collisional activation may be able to promote structural 
conformations similar to the AAT polymerogenic intermediate previously observed 
(section 3.4.1) in both the wt and K154N AAT variants.  Conferring support from the CIU 
structured unfolding intermediates C and D, the K154N substitution may promote an 
energetically unfavourable refolding landscape upon formation of the polymerogenic 
intermediate.  This folding landscape would therefore promote a long-lived intermediate 
required for AAT polymerisation.  In contrast, the wt sequence would exhibit an energy 
landscape that favoured refolding to the metastable state. 
The use of quadrupole isolation for CIU analysis prevents comparisons with the 
incubation study, due to differences in the experimental methods.  Therefore, we are unable 
to confirm that the CIU structural intermediate B is the temperature stabilised polymeric 
intermediate observed in the incubation studies due to these experimental differences 
promoting variations in the CCS.   
 
3.6. Summary and Future Directions 
 
Work here has shown that the polymerogenic intermediate required for AAT K154N 
polymerisation is propagated under biologically permissive temperatures, representing a 
significant increase in CCS equal to 8.3 %.  This substitution additionally stabilises the 
unfolding intermediates, required for polymerisation activity.  Other data presented within 
Nyon et al. (2012), including CD and native-PAGE, have supported our observations. 
These data are unable however to confirm or refute either three of the proposed 
models of AAT polymerisation (section 3.1.3), supporting only common observations: 
extended, increased stability structural conformations, propagated under biological 
conditions.  Studies to confirm these models therefore remain a direction for future 
analysis. 
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4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast 
Kinetochore Assembly 
-------------------------------------------------------------------------------------------------------------- 
 
Saccharomyces cerevisiae Sgt1 dimers mediate binding between Hsp90 and Skp1, to 
initiate chromosome separation.  Mutations of the Sgt1 dimerization domain are known to 
inhibit Sgt1: Skp1 binding, arresting the cell cycle at the G2/M interface.  Work here has 
shown that this dimer is stabilised by an Ascomycota specific structural loop within the 
dimerisation domain, with potential contributions from other domains.  Using MS/MS, we 
have shown that this dimer does not represent the structural minimum for Skp1 binding.   
 
4.1.1. The Kinetochore  
 
The Saccharomyces cerevisiae kinetochore (Fig. 4.1) is a complex that comprises more 
than 70 different proteins, organised into a variety of sub-complexes.
18
 Additionally these 
sub-complexes can be divided into three different layers: the inner DNA anchoring layer, a 
dynamic central bridging/linker layer, and the outer layer that functions as the microtubule 
binding interface (Westermann, Drubin & Barnes 2007).  Overall, this complex mediates 
the interactions between chromosomes and spindle microtubules required for cell division 
(Bansal et al. 2009a, Cho et al. 2011, and Westermann, Drubin & Barnes 2007).   
 
4.1.2. The Inner Kinetochore Sub-Complex CBF3 
 
The inner kinetochore contains two multimeric sub-complexes, the centromeric nucleosome 
and the CBF3 (centromere binding factor 3) (Westermann, Drubin and Barnes 2007).  Of 
interest here is the CBF3, an essential component of kinetochore initiation and formation, 
required for passage of the G2/M spindle checkpoint assembly interface (Bansal et al. 
2009a, and Makhnevych & Houry 2012).   
 
                                                 
18
 For a larger overarching review on the topic of kinetochore sub-complexes the author directs the reader to 
the review by Westermann, Drubin & Barnes (2007) 
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Figure 4.1. Three Domain Architecture of the Kinetochore 
The S. cerevisiae kinetochore exhibits a three-domain architecture, which anchors spindle fibres to DNA.  
The inner domain binds to the centromere DNA (CEN) and is required to establish kinetochore formation 
and activity.  The kinetochore attaches to the spindle components required for chromosome separation at the 
S phase through the outer kinetochore components.  The inner and outer kinetochore domains are connected 
through a central bridging/linker layer. Together, the overall structure combined with required checkpoint 
proteins allows passage of the G2/M interface and the sequential separation of sister chromatids 
(Westermann, Drubin & Barnes 2007). 
 
 
Figure 4.2. Structure of the Inner Kinetochore: The CBF3 Complex at the DNA Binding Interface 
Skp1 and Ctf13 form the CBF3 initiation complex, allowing binding of the Cep3 dimer (Kaplan, Hyman & 
Sorger 1997).  Dimerisation of Cep3 creates a cleft in the quaternary structure required for Cep3-DNA 
binding at CDEIII and CDEII (Rodrigo-Brenni et al. 2004).  The model proposed by Purvis & Singleton 
(2008), suggests that Ctf13 binds within the Cep3 cleft between the two CDE components, opposite the 
homodimerisation domains, stabilising DNA binding.  Ndc10 associates with the CBF3 by binding to Ctf13.  
Complex stability promotes further Ndc10 interactions outside of the CBF3 complex (Cho et al. 2011).  
Skp1 feedback interactions with Bub1 additionally act as a checkpoint of kinetochore assembly as a measure 
of complex stability (Kitagawa et al. 2003).  Image not to scale, DNA PDB ID; 3BSE. 
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The CBF3 is a heteromeric complex that comprises four essential proteins  
(Fig. 4.2): Skp1 (section 4.1.2.4), Ctf13 (section 4.1.2.1), Cep3 (section 4.1.2.2), and 
Ndc10 (section 4.1.2.3).  This complex is anchored to the DNA at the 25 bp long CDEIII 
(centromere determining element 3) motif of the centromere (Ortiz et al. 1999, Kitagawa & 
Hieter 2001, and Makhnevych & Houry 2012). 
 
4.1.2.1. Ctf13 Within the CBF3 
 
Ctf13 (Uniprot ID; P52286, 22.3 kDa, 194 amino acids) and Skp1 (section 4.1.2.4) form 
the initiation complex of the CBF3 complex.  Structurally, Ctf13 mediates the interactions 
between Skp1 and the other components of the CBF3 complex.  The Ctf13 internal binding 
domain (amino acids 139-336) binds Cep3 towards its C-terminal end, with Skp1 and 
Ndc10 binding to the N-terminus of this sequence (Russell, Grancell & Sorger 1999).  
Regulation of Ctf13 and Ndc10 binding events are currently proposed to occur through one 
of two methods, post-translational phosphorylation of Ctf13 by Skp1 (Kaplan, Hyman & 
Sorger 1997), or the involvement of Hsp90 chaperones (Stemmann et al. 2002). 
As Ctf13 is structurally unstable within the cytosol (Russell, Grancell & Sorger 
1999), it currently represents the in vitro limiting step for characterising both the individual 
protein and CBF3 complex.   
 
4.1.2.2. Cep3 Within the CBF3 
 
Cep3 (Uniprot ID; P40969, 71.4 kDa, 608 amino acids) dimers regulate the DNA binding 
activity of the CBF3.  Cep3 binds DNA at the CDEIII domain of the centromere (Fig. 4.3).  
Although Cep3 is able to interact with the CDEIII regardless of further interactions with 
Skp1 or Ctf13, stable binding requires formation of the Skp1: Ctf13: Cep32 complex 
(Russell, Grancell & Sorger 1999). 
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Figure 4.3. DNA Binding Model of Cep3 
DNA binds within a groove formed on the underside of the Cep3 dimerisation interface. DNA binding is 
promoted through the Cep3 N-terminal Zn2Cys6 class zinc finger domain, to a conserved CCG site within the 
CDEIII domain (Espelin, Kaplan & Sorger 1997) with additional interactions with a TGT motif 3’ of the 
CDEII motif (Espelin, Kaplan & Sorger 1997, and Jehn et al. 1991).  The linker between the  
zinc-finger and C-terminal domains confers the necessary flexibility of the N-terminus to bind DNA in this 
manner.  These binding events sequentially stabilise interactions on the opposite side of the DNA binding 
groove (Purvis & Singleton 2008). PDB ID: 2VEQ. 
Figure reproduced and adapted, with permission, from Willhöft 2013 
 
4.1.2.3. Ndc10 Within the CBF3 
 
Ndc10 (Uniprot ID; P32504, 112 kDa, 956 amino acid) within the CBF3 is dimeric and has 
been identified as the final component to associate.  Structurally Ndc10 is a tri-domain 
protein, that contains, an N-terminal DNA binding domain, central dimerisation domain 
(Cho et al. 2011), and C-terminal regulatory domain (Peng et al. 2011).  Ndc10 binds to 
DNA non-specifically, orientating at the CDEIII when complexed with the CBF3  
(Cho et al. 2011, and Perriches & Singleton 2012).   
Ndc10 performs a scaffolding role within the CBF3, connecting this complex to 
other components of the kinetochore (Cho et al. 2011, and Perriches & Singleton 2012).  
Ndc10 recruits the histone chaperone Scm3 to form bridging interactions with the Cse4 
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component of the centromeric nucleosome.  Although it may be suggested that the Ndc10 
functions to initiate further layers of the kinetochore to form, it cannot be concluded to 
proceed within this role as a checkpoint protein (Camahort et al. 2007, and Mizuguchi et al. 
2007). 
The activity and localisation of Ndc10 is regulated by Ipl1 and CK2 mediated 
phosphorylation of the C-terminus.  Ndc10 phosphorylation by Ipl1 protein inhibits Ndc10 
interactions with Bir1, preventing targeting of the protein to the anaphase spindles.  In 
contrast, phosphorylation by the highly conserved phosphorylation protein CK2 prevents 
the localisation and incorporation of Ndc10 within the CBF3 kinetochore complex  
(Peng et al. 2011).   
 
4.1.2.4 Skp1 Within the CBF3 
 
The S. cerevisiae protein Skp1 (Suppressor of kinetochore protein 1, Uniprot ID; P52286, 
22.3 kDa, 194 amino acids) (Fig. 4.4) is required for initiation of the CBF3 complex 
through Hsp90 mediated interactions with Ctf13.  This Hs90: Skp1 interaction is promoted 
by interactions mediated by Sgt1 (Lingelbach & Kaplan 2004), and is essential for passage 
of the G2/M cell cycle transitions (Zhang et al. 2008).  Initiation of the CBF3 complex by 
Hsp90 will be discussed in increased detail in section 4.1.4. 
Further to its requirement at the G2/M as part of the CBF3 complex, Skp1 is 
additionally required at the G1/S transition as a component of the SCF functional E3 
ubiquitinase (Yoshida, Murakami & Tanaka 2011).   
 
4.1.3. Hsp90 Structure and Function 
 
The S. cerevisiae protein, Hsp90 (Heat shock protein 90 kDa, Uniprot ID; P02829,  
82.4 kDa, 709 amino acids)
 19
 is a dimeric, ATP dependent molecular chaperone that 
comprises 1-2 % of the S. cerevisiae soluble cell fraction (Borkovich et al. 1989, and 
Neckers & Workman 2012). The Hsp90 class of proteins is highly conserved in nature, 
                                                 
19
 Synonym; Hsp82. The Sgt1 S. cerevisiae homologue provides an exception to the rule of Hsp# proteins 
classified in terms of their molecular weight. Hsp90 is typically used for naming due to the functional cross 
specie homologues. 
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present in eukaryotes and prokaryotes (Makhnevych & Houry 2012),
20
 and therefore 
represents an essential component of organism survival (Johnson 2012).  In addition to the 
inducible form of Hsp90 outlined here, the S. cerevisiae genome additionally encodes the 
constitutively expressed, Hsc82 (Uniprot ID; P15108). 
 
 
Figure 4.4. Domains and Crystal 
Structure of S. cerevisiae Skp1 
a) Skp1 contains a single structured 
domain, comprising the BTB/POZ 
(amino acids 1-159), and a C-terminal  
F-box interaction domain (magenta, 
amino acids 162-185).  The BTB/POZ 
domain is the binding site for Sgt1.  The 
F-box domain allows binding of Ctf13 
required promoting formation of the 
CBF3, along with chaperone activity in 
the SCF complex (Willhöft 2013, and 
Zhang et al. 2008). b) The intact crystal 
structure of this domain has been 
resolved to 2.6 Å, highlighting both 
domains (PDB ID; 3MKS).   
 
 
Figure 4.5. Domains of S. cerevisiae Hsp90 
Hsp90 comprises, an N-terminal ATPase domain (red, amino acids 1-220) which further acts as a drug 
binding domain, a central (blue, amino acids 255-540) client binding domain, and a C-terminal (green, amino 
acids 541-709) homo-dimerisation domain (Pearl & Prodromou 2006).   There is currently no complete PDB 
crystal structure of the S. cerevisiae Hsp90, with the largest available structure comprising amino acids 1-677 
(PDB ID; 2CG9, resolved to 3.1Å). 
 
S. cerevisiae isoform of Hsp90 comprises a three domain architecture: an  
N-terminal ATPase domain, central co-chaperone binding domain, and a C-terminal 
                                                 
20
 There are no known members in archaea (Pearl & Prodromou 2006). 
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dimerisation domain (Fig. 4.5).  Hsp90 dimerisation at the C-terminus occurs at a Kd of  
60 nM, and is therefore observed as a constitutive dimer (Richter et al. 2001). 
 
 
Figure 4.6. N-terminal ATPase Domain of Hsp90 
a) The Hsp90 ATPase domain in its ATP bound state exhibits closed lid segment conformation  
(PDB ID; 2CG9, S. cerevisiae, resolved to; 3.1 Å).  b) ATP hydrolysis, producing ADP, promotes 
conformational rearrangement of the lid segment to an open conformation (PDB ID; 2IOR, E. coli - HtpG, 
resolved to; 1.65 Å).  The 90˚ structural rotation highlights the nucleotide-binding pocket. Despite the species 
difference, the highly conserved nature of the protein, and its N-terminal ATPase domain, allows direct 
comparison between homologues (Makhnevych & Houry 2012). 
 
The conformational state of the Hsp90 N-terminal ATPase domain regulates its  
co-chaperone binding activity. Binding of ATP, includes conformational changes in the  
N-terminus and middle segment catalytic loop (Fig. 4.6).  These changes aid positioning of 
the ATP hydrolysis apparatus (Ali et al. 2006), which represents the rate limiting step of 
the hydrolysis mechanism (Cunningham, Krukenberg & Agard 2008).  Dimerisation of the 
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N-terminus has been additionally shown as a requirement for ATP hydrolysis  
(Vaughan et al. 2009).  Through changes in the monomeric/dimeric state of the Hsp90  
N-terminal domain and ATP/ADP conformational states, co-chaperone and client binding 
activity can be regulated.  The current model of the ATP dependent conformational cycle is 
outlined in figure 4.7. 
 
 
Figure 4.7. ATP Dependent Conformational Hydrolysis Cycle of Hsp90 
Structural rearrangement of the Hsp90 dimer occurs in an ATP dependent manner. (1) From an open dimeric 
conformation, (3) binding of ATP induces conformational rearrangement to a closed state  
(2) through a proposed intermediate step identified using the crystal structure of Grp94 (Humans, 
endoplasmic reticulum Hsp90 homologue, Dollins et al. 2007). This structure (2) however, may further 
represent a non-catalytic ATP/ADP unbound, conformation (Krukenburg et al. 2011). (4) Hydrolysis of 
bound ATP causes further compaction of the protein, releasing ADP, and allowing the cycle to restart.  
Despite the cross species nature of these conformational states, a high level of sequence similarity across 
Hsp90 homologues supports the relevance of the model to S. cerevisiae (Vaughan et al. 2009). 
Figure reproduced from Krukenberg et al. 2011 
 
4.1.3.1. Hsp90 Co-chaperone Activity 
 
Hsp90 interacts with a range of co-chaperones, including kinases and transcription factors, 
which are typically termed ‘clients’ (Hartl, Bracher & Hayer-Hartl 2011, and  
Verghese et al. 2012).  Many of these clients are at the epicentre of genetic cascades, and 
therefore Hsp90 is closely connected with a number of oncogenes (genes with the potential 
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to cause cancer).  Subsequently, Hsp90 and its binding partners are an area actively studied 
in terms of drug design to inhibit cancer-related pathways (Neckers et al. 2012). 
Currently, no specific sequence or structure has been identified to promote targeting 
of Hsp90 to client proteins for folding support.  Co-chaperones that mediate the activity 
between Hsp90 and these clients have been shown to contribute to this recognition process 
(Taipale et al. 2012, Vaughan et al. 2006, and Willhöft et al. In Preparation).  These 
include the protein Sgt1 (described below) which acts as an Hsp90 client adaptor protein to 
promote Skp1 binding (Catlett & Kaplan 2006).   
 
4.1.4. Sgt1 
 
The S. cerevisiae protein, Sgt1 (Uniprot ID; Q08446, 44.9 kDa, 395 amino acids), was 
originally identified as a dosage suppressor of G two allele of skp1 mutants (Kitagawa et al. 
1999).  Sgt1 homologues have been identified in other species, including humans where 
two splice variants are known to exist (Niikura & Kitagawa 2003).   
 
 
Figure 4.8. Domains of Wild Type Sgt1 and the TPRκ Mutant  
a) Sgt1 contains three domains (TPR in red, CS in blue and SGS in green), connected by flexible linker 
regions (Bansal et al. 2009a and Bansal et al. 2009b).  b) Relevant to work performed here, the Sgt1 TPRκ 
truncate has been used to study the influence of the CS and SGS domains on the oligomeric state.  This 
protein is defined as the TPR domain plus capping helix (κ). 
 
Structurally, Sgt1 (Fig 4.8a) comprises a three structured domain architecture: an  
N-terminal TPR (Tetratricopeptide repeat) domain (section 4.1.1.1), central CS (CHORD 
protein- and Sgt1- specific) domain, and a C-terminal SGS (Sgt1 specific sequence) domain 
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(section 4.1.1.2).  Flexible linkers connect all three domains (Bansal, Abdulle, & Kitagawa 
2004, and Bansal et al. 2009a).   
The tertiary structure is highly conserved between Sgt1 homologues.  In contrast, 
the number of Sgt1 protomers bound at the quaternary level varies between species.  In  
S. cerevisiae Sgt1 exists in vivo as a dimer (Bansal et al. 2009a) whilst the human 
homologue is monomeric.  Oligomers of the A. thaliana and H. vulgare Sgt1 homologues 
are concentration dependent (Nyarko et al. 2007). 
 
4.1.4.1. The Sgt1 TPR Domain 
 
 
Figure 4.9. Crystal Structure of 
the TPR Domain 
a) Crystal structure of the Sgt1 
dimerisation domain resolved to 4.3 
Å.  The structure has been solved 
using the dimerisation domain only 
TPRκ mutant (amino acids 137-150 
remain unresolved in the final 
structure), in an unexpected trimer 
(α, β and γ).  Additions of 
sequential Sgt1 monomers occur 
with a 90˚ rotation about the 
binding interface.  b) The curved 
binding interface of the 
dimerisation domain is promoted by 
the organised stacking of TPR 
repeats against the capping helix 
(Willhöft 2013, and Willhöft et al. 
In Preparation).  Structure currently 
unpublished in the PDB. 
 
TPR motifs, jointly identified in 1990 (Hirano et al. 1990, and Sikorski et al. 1990), are a 
widespread structural motif in nature (> 5 000 identified containing proteins) (Zeytuni & 
Zarivach 2012).  These motifs are defined by their 34 amino acid, anti-parallel  
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helix-turn-helix topology (Main, Jackson & Regan 2003, and Main et al. 2003), and are 
involved in a range of protein-protein interactions.   
TPR mediated interactions are dependent on peptide sequence and variations in the 
number of repeats contributing to the larger super secondary and tertiary structure (Zeytuni 
& Zarivach 2012).  In S. cerevisiae TPR containing proteins are involved in a broad range 
of functions and interactions. Ssn6 contains ten consecutive N-terminal TPR motifs which 
enable Opi1 and Sin3 binding.  This interaction is subsequently able to inhibit phospholipid 
biosynthesis (Jäschke et al. 2011).  In contrast, Sti1 contains nine TPR repeats spread 
across three domains (TPR1, TPR2A and TPR2B).  Of these three TPR domains, TPR1 and 
TPR2A function as binding domains required to modulate the activity of Hsp70 and Hsp90 
respectively (Flom et al. 2006). 
 
 
Figure 4.10. Topology Comparison of 
the Consensus and Sgt1 Sequence 
TPR Domains 
TPR topology of the (a) consensus 
sequence (CTPR, Main, Jackson & 
Regan 2003) and (b) S. cerevisiae Sgt1 
dimerisation domain.  Despite amino 
acid sequence differences, the core alpha 
helical fold is conserved.  Variations in 
the primary structure of the two proteins, 
resulting from sequence substitution and 
insertions, promote differences in helix 
length, along with an inserted sequence 
between TPR2 helix A, and B.  Please 
note A and B highlight the N- and  
C-terminal helices within each TPR 
repeat respectively. 
Figure reproduced and adapted, with permission, 
from Willhöft 2013 
 
The Sgt1 TPR domain (S. cerevisiae crystal structure Fig. 4.9b, and topology model 
Fig. 4.10b) contains three sequentially encoded TPR repeats (1, 2 and 3), and promotes 
protein-protein interactions.  In S. cerevisiae this domain acts as the Sgt1: Sgt1 dimerisation 
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domain (Bansal et al. 2009a).  Sgt1 dimerisation occurs through a perpendicular 
arrangement of monomers (Fig. 4.9a), modulated by a concave face arrangement of one 
monomer stacking against the convex face of a second.  Crystal structure analysis has 
shown that this ordered arrangement of stacked Sgt1 monomers is stabilised by an 
Ascomycota
21
 specific structured insert between TPR2A and B (amino acids 54-59)  
(Fig. 4.10b), critical for S. cerevisiae dimerisation.  This interaction is stabilised by a pi 
stacking interaction between the W58 of one monomer, to the H59 of a second (Fig. 4.11a).  
These amino acids are orientated within the convex and concave faces respectively 
(Willhöft et al. In Preparation). 
 
 
Figure 4.11. Sgt1 Stacking Interactions 
a) S. cerevisiae Sgt1 dimerisation is stabilised by a pi stacking interaction between W58 and H59, of the 
convex (yellow, with grey text) and concave (blue, with red text) faces of adjacent TPR domains respectively.  
Both amino acids are encoded within the Ascomycota specific structured insert between TPR2A and B.   
b) This interaction is additionally stabilised by interactions between the convex face D57, S60, D61 amino 
acids, to their respective partners H59, N100, R130 in the concave face.  Additionally, the D57-H59 
interaction is proposed to stabilise the orientation of the latter within the binding face (Willhöft 2013). 
Structure currently unpublished in the PDB. 
 
Stabilisation of S. cerevisiae Sgt1 dimerisation is additionally promoted by 
hydrogen bonding interactions between neighbouring monomers.  These are formed 
between the convex face amino acids: D57, S60 and D61 (all located within the extended 
                                                 
21
 Taxonomic phylum within the kingdom Fungi. 
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
118 
loop region), and their binding partners within the concave face: H59, N100 and R130  
(Fig. 4.11b) (Willhöft et al. In Preparation).
22
   
The H. vulgare Sgt1 homologue contains three cysteine amino acids within the 
homo-oligomerisation domain.  Two of these cysteines, C84 and C117, promote 
dimerisation through disulphide linkages.  Formation of this bond has been suggested to 
function as an oxidative stress sensor during pathogenic attack (Nyarko et al. 2007).  
Concerning the S. cerevisiae homologue studied here, sequence analysis by Oliver Willhöft 
indicated the presence of a single cysteine residue (C47) orientated within the dimerisation 
domain (TPR2A).  SV-AUC (sedimentation velocity, analytical ultracentrifugation), with 
and without DTT, has shown that this residue is not involved in dimerisation  
(Willhöft 2013). 
 
4.1.4.2. The Sgt1 SGS and CS Domains 
 
Sgt1 dimerisation is a regulated event, and inhibition of this interaction arrests the  
S. cerevisiae cell cycle at the G2/M interface by preventing kinetochore assembly.  
Observations by Bansal and co-workers (2009b) showed that the S. cerevisiae Sgt1 S361, a 
residue within the SGS domain, acts as a phosphorylation site for CK2.  Phosphorylation of 
this residue has been proposed to modify the structure of the SGS domain, and the CS to 
SGS linker (amino acids 270-312).  This phosphorylation subsequently inhibits Sgt1 
dimerisation, arresting the cell cycle by abolishing the Skp1 interactions mediated by this 
oligomeric state (Bansal et al. 2009b).  Therefore, this represents a dual role of CK2 
regulated kinetochore formation, in addition to the previously outlined inhibition of Ndc10 
function (section 4.1.1.2) (Peng et al. 2011).  Furthermore this domain has been shown to 
interact with leucine rich repeat domains, such as that of the Hsp90 client protein Ctf13 
(section 4.1.1.1), an early component of the CBF3 complex mediated by Sgt1: Skp1 
interactions (Austin et al. 2002). 
  The CS domain is a highly conserved structural cross-species homologue, required 
to promote Sgt1: Hsp90 binding in both S. cerevisiae and Humans (Bansal, Abdulle & 
Kitagawa 2004, and Zhang et al. 2008).   
                                                 
22
 N100 and R130 are located within TPR3B and capping helices respectively. 
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4.1.5. Initiation of the CBF3 Complex 
 
Formation of the CBF3 initiation complex occurs in a step wise manner.  This step-wise 
interaction allows Hsp90 to promote Skp1: Ctf13 binding, through additional interactions 
with Sgt1 (Fig. 4.12) (Catlett & Kaplan 2006, Stemmann et al. 2002).  This interaction is 
proposed to induce Skp1 mediated Ctf13 phosphorylation (Kaplan, Hyman & Sorger 1997) 
that subsequently promotes stable CBF3 formation (Fig. 4.2) (Russell, Grancell & Sorger 
1999, and Yoshida, Murakami & Tanaka 2011).   
 
 
Figure 4.12. Sequential Interactions 
Mediating the Activation of Ctf13 by 
Hsp90 
a) Sgt1 binds to Hsp90 in its ADP bound 
compact dimeric state (Zhang et al. 
2008).  b) This interaction promotes 
Sgt1: Skp1 binding (Bansal, Abdulle & 
Kitagawa 2004).  c) Interactions 
between Sgt1 and Skp1 subsequently 
allows stable Skp1: Ctf13 binding 
through the latter’s weakly conserved  
F-box domain (Russell, Grancell & 
Sorger 1999).  This interaction allows 
Skp1 mediated Ctf13 phosphorylation, 
required for CBF3 complex formation 
(Kaplan, Hyman & Sorger 1997).  
 
Hsp90 in its ADP bound form binds, to the CS domain of Sgt1, through its ATPase 
domain supporting a 1:1 interaction (Fig. 4.13) (Zhang et al. 2008, and Zhang et al. 2010).  
Formation of the Hsp90: Sgt1 complex promotes Skp1 binding supporting a binding 
promoter role for Sgt1 (Bansal, Abdulle & Kitagawa 2004, and Lingelbach & Kaplan 
2004).  Observations have shown however that Sgt1: Skp1 binding can occur in the absence 
of Hsp90, with a Kd of 6 μM (Willhöft et al. In Preparation).   
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Figure 4.13. Crystal structure of the Hsp90 ATPase 
domain complexed with the Sgt1 CS domain 
Crystal structure of the Hsp90 ATPase domain (red, lid-
segment highlighted in black), ADP bound form, 
interacting with the CS domain of Sgt1 (blue)  
(PDB ID; 2JKI, resolved to 3.3 Å) (Zhang et al. 2008). 
 
 
Figure 4.14. Crystal Structure of Sgt1 TPRκ3Skp1 ΔBTB/POZ 
The crystal structure of the Sgt1: Skp1 binding interface has been recently solved using Skp1ΔC and Sgt1 
TPRκ (α, β and γ).  Despite a Sgt1: Skp1 incubation ratio of 2:1, the resolved crystal produced an unexpected 
3:1 oligomer (resolution 2.8 Å).  Skp1 binds within the concave face of Sgt1 TPRκ α.  β and γ stack 
sequential on top of α (Willhöft 2013, and Willhöft et al. In Preparation). The structure of Skp1 remains 
unresolved between amino acids 101-177, consistent with other crystal structures including 3KMS (Fig. 4.4b) 
(Willhöft et al. In Preparation).  Structure currently unpublished in the PDB. 
 
In S. cerevisiae the Hsp90: Skp1 interactions are Sgt1 dimer dependent.  In contrast, 
human homologues require Sgt1 monomers to promote these interactions (Bansal et al. 
2009a, and Zhang et al. 2008).  The structure of the S. cerevisiae Sgt1: Skp1 binding 
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interface has recently been solved, using an Sgt1 N-terminal TPR domain only mutant 
(TPRκ, amino acids 1-150) and Skp1ΔC (Fig. 4.14).  Sgt1: Skp1 binding progresses 
through the burial of the Skp1 N-terminus within the concave face of the Sgt1 TPR domain 
(Willhöft 2013, and Willhöft et al. In Preparation).  This interaction is stabilised by the 
strongly conserved region of acidic amino acids within the Skp1 sequence  
(amino acids 65-73), and a region of basic amino acids orientated within the concave face 
of the Sgt1 TPR domain (Willhöft et al. In Preparation). 
Formation of the Hsp90: Sgt1: Skp1 interaction promotes a 3.2x increase in  
Skp1: Ctf13 binding (Bansal, Abdulle & Kitagawa 2004).  This interaction is stabilised by 
a weakly conserved F-box domain within the Ctf13 (N-terminal 58 amino acids), and the 
Skp1 C-terminus F-box interacting domain.  This interaction confers an E3 ubiquitin ligase 
like interaction similar to Skp1’s activity within the SCF complex (Russell, Grancell & 
Sorger 1999).   
 
4.2. Experimental Aims and Objectives 
 
The X-ray crystal structure of the Ascomycota specific loop (amino acids 54-59) within the 
S. cerevisiae Sgt1 dimerisation domain supports sequential H59-W58 pi-stacking 
interactions between adjacent Sgt1 monomers (Fig. 4.11a).  In the absence of the  
C-terminus a deletion mutant encoding only the dimerisation domain, TPRκ  
(amino acids 1-150, TPR plus capping helix; κ), has been shown to enable Sgt1 
trimerization (Fig. 4.9).  This is in contrast to the native Sgt1 dimer required for in vivo 
activity.  Modifying the protein concentration we have studied the ability of the 
Ascomycota specific loop to support higher order oligomers, both in the presence (wt) and 
absence (TPRκ) of the C-terminal domains. 
 Analysis of the X-ray crystallography structure has shown that dimerisation is 
stabilised by H-bonding interactions outside of the Ascomycota specific loop (Fig. 4.11b).  
These interactions are thought to be salt sensitive, modifying the oligomeric state at higher 
ionic strengths.  Therefore, we have studied the influence of increasing ionic strengths to 
modify the oligomeric state of wt Sgt1 and the deletion mutant TPRκ. 
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Amino acid substitutions have been applied to further study the requirement of 
Ascomycota specific loop, and additional H-bonding interactions, to promote stable 
dimerisation behaviour.  These studies have been performed using H59A, and D61R 
substitutions.  The H59A substitution has been designed to study the role of the ascomycete 
specific loop in dimerisation, inhibiting its interaction with W58 (Fig. 4.11a).  The D61R 
substitution has been designed to inhibit its interactions with R130 (Fig. 4.11b), allowing 
studies of the extended H-bonding interactions that are proposed to stabilise the 
dimerisation interface.  
In S. cerevisiae Sgt1 dimers mediate Hsp90: Skp1 binding.  Analysis of the crystal 
structure of the TPRκ3Skp1 (Fig. 4.14) however, has shown that the interaction between the 
Sgt1 dimer and Skp1 is stabilised by a 1:1 interaction.  MS/MS has been applied to study 
the organisation and stability of the Sgt1: Skp1 binding interface under dissociative 
conditions.   
 
4.3. Materials and Methods 
4.3.1. Molecular Biology, Preparation, and Purification of Proteins Studied 
 
All Sgt1 and Skp1 samples were purified by the Vaughan research group. Sample 
preparation was performed using transformed E. coli (BL21) for all proteins, except TPRκ 
that utilised T7 Express LysY/IQ.  Vector systems for transfection of genetic material 
encoding the required proteins are outlined in table 4.1.   
Protein samples were purified using three to four chromatography steps (table 4.1). 
Samples were supplied in the following, final elution buffer: 25 mM HEPES, 150 mM 
NaCl, 2 mM DTT, and 1 mM EDTA at pH 7.0. 
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4.3.2. Mass Spectrometric Analysis of Sgt1 
 
Prior to mass spectrometric analysis, samples were buffer exchanged using a single Micro 
Bio-Spin column (BioRad, Hertfordshire, UK), and three sequential washes using a single 
Amicon 1.5 ml 10 kDa MWCO centrifugal concentrator column (Millipore, Dundee, UK).  
All columns were prepared using the required experimental concentration of AmAc (pH 7). 
 
Table 4.1. Biological Purification Methods for Sgt1 and Skp1 Proteins 
IEX; Ion Exchange Chromatography.  All columns purchased from GE Healthcare Life Sciences, 
Buckinghamshire, UK. 
Adapted, with permission, from Willhöft 2013 
 
Two methods were applied to measure sample concentrations. The low mass 
proteins (native oligomer less than 69 kDa) Skp1 and TPRκ, were measured using a  
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Qubit 2.0 fluorometer (Invitrogen, Paisley, UK), and a 1 in 100 dilution of sample: running 
buffer. The high mass proteins (native oligomer greater than 69 kDa) wt Sgt1, H59A, and 
D61R (including incubated wt: Skp1 samples post purification), were measured using serial 
dilution Nanodrop 1000 (Thermo Scientific, DE USA) analysis.  Extinction coefficients 
were applied to correct Nanodrop 1000 mg/ml values (table 4.2).  Using the corrected 
mg/ml values, sample molarity was calculated using the experimentally calculated mass 
(from denatured protein mass analysis) (table 4.2). 
These differences in concentration analysis occur due to identified accuracy 
limitations of the Qubit method to measure proteins with masses greater than the bovine 
serum albumin (BSA) standard used for calibration (Jones, Haugland & Singer 2003).
23
  In 
all cases the recovered sample was diluted to the experimental concentration using the 
required ionic strength of AmAc buffer (pH 7). 
 
4.3.2.1. Mass Spectrometric Analysis of Sgt1: Area Under Curve Analysis 
 
The following conditions are relevant to the work performed in sections 4.4.2 and 4.4.3.  
Analysis of oligomer contributions to each spectrum were performed using the recently 
developed Amphitrite software (Sivalingam et al. 2013).  This software deconvolutes 
individual mass spectra using Gaussian curve fitting to calculate component contributions 
to mass spectra as a normalised percentage.  This software is therefore able to calculate the 
area under curve (AUC) contributions of oligomeric species normalised to the observed 
dominant ion peak.   
Amphitrite deconvolution of experimental spectra was performed on individually-
imported files with a grain value of 500,
24
 reducing the computational demands of the 
analysis. Additional light smoothing of mass spectra was applied within Amphitrite to 
improve the automatic peak detection.  Manual selection of CSD peaks was performed to 
minimise calculated mass errors.  Individual spectra were sequentially simulated with a 
variety of ‘single peak FWHM’ values to maximise deconvolution of all charge peaks 
                                                 
23
 These observations confirmed using Nanodrop 1000 vs. Qubit sample concentration measurements, on the 
TPRκ and FL proteins. Data not shown.   
24
 Grain represents spacing between imported values, 1 = 0.0116 m/z. Grain of 500 therefore samples spectra 
points every 5.8 m/z. 
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within the distribution.  After successful simulation of oligomer CSD’s, the respective 
AUC values were copied from the graphical user interface for analysis using Microsoft 
Office Excel 2003 (Microsoft, WA, USA). 
Prior to mass spectrometric analysis, all homogenous samples of wt Sgt1, TPRκ, 
H59A and D61R were incubated at 4 ˚C for 60 minutes.  Prior to incubation, all samples 
were diluted to a 20 µL final volume at the required experimental protein concentration and 
ionic strength, acquiring control spectra at time zero.  All spectra and results presented here 
represent data acquired post incubation. 
Wt and TPRκ samples were studied over a range of ionic strength and protein 
concentrations. Samples were incubated in the following AmAc concentrations, at pH 7: 
150, 500, and 1000 mM.  At each ionic strength the following protein concentrations were 
analysed: 4.5, 11.2, and 22.3 μM.  At 150 mM AmAc, wt Sgt1 was additionally analysed at 
the following protein concentrations: 7.9, 14.9, and 18.6 μM.  H59A and D61R were 
analysed at a concentration of 11.2 μM, incubated in 150 mM AmAc (pH 7).  All data sets 
are the mean of five repeats, 
+
/- MSD.   
Instrumental values for mass spectrometric analysis were: capillary voltage; 0.9 to 
1.5 kV, Nanoflow pressure; 0.00 to 0.15 Bar, Sampling cone; 80 V, Extraction cone; 1 V, 
Source temperature; 40 ˚C, Trap collision; 5 V, Transfer collision; 10 V,  
Trap DC bias; 8 V, Trap Gas; 4 ml/min.  Spectra were typically acquired over two minutes 
using two second scans, unless longer was required to improve the signal to noise value 
(between 5 to 10 minutes).  Instrumental pressures: Trap; 0.02 mBar, mobility  
separator; 0.002 mBar, ToF; 1.5x10
-6
 mBar.  Wt, H59A and D61R mass spectra were 
acquired over an m/z range of 1 000 to 16 000 with a source backing pressure of 5 mBar.  
TPRκ mass spectra were acquired over an m/z range of 500 to 8 000 with a source backing 
pressure of 4.5 mBar. 
 
4.3.2.2. Mass Spectrometric Analysis of Sgt1: Ion Mobility  
 
The following conditions are relevant to the work performed in section 4.4.1.1.  Ion 
mobility data have been acquired for the lowest observed charge of the TPRκ trimer ion 
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(+13, m/z 4000.65) at a concentration of 11.2 μM.  Analysis was performed using an AmAc 
buffer concentration of 150 mM, pH 7. 
Calibration of the experimental tD values, to produce relevant CCS values, was 
performed using the method outlined in section 2.2.  Denatured Equine myoglobin  
(Sigma-Aldrich Ltd, Dorset, UK) was used as the CCS calibrant.  All data sets are the mean 
of five repeats, 
+
/- MSD, acquired at a range of mobility separation conditions: 250 m/s 7 V,  
275 m/s 7.5 V, and 300 m/s 8 V.   
Due to the requirement of increased operating pressures for IM separation, the 
following values were used: Trap DC bias; 20 V, Trap Gas; 5 ml/min, IM separator gas 
flow; 20 ml/min.  Instrumental pressures: Trap; 0.04 mBar, mobility separator; 0.52 mBar, 
ToF; 2x10
-6
 mBar.  All other instrumental parameters are consistent with those detailed in 
section 4.3.2.1. 
 
4.3.2.3. Mass Spectrometric Analysis of Sgt1: Tandem Mass Spectrometry Analysis of 
Skp1 Binding 
 
The following conditions are relevant to the work performed in section 4.4.4.  Unless stated 
samples of wt Sgt1 or TPRκ were mixed with Skp1 in 2:1.  Samples were mixed to produce 
a theoretical final Sgt12Skp1, or TPRκ2Skp1, concentration of 30 μM, calculated using the 
minimum Amicon 1.5 ml 10 kDa MWCO centrifugal concentrator column (Millipore, 
Dundee, UK) recovery volume of 50 µL.  Sample concentration measurements were 
performed according to the methods previously outlined above (section 4.3.2). 
Samples of Sgt1: Skp1 were suspended in 400 µL incubation buffer  
(25 mM HEPES, 150 mM NaCl, 2 mM DTT, 1 mM EDTA, pH 7.0) and sequentially 
inverted using a SRT6 roller mixer (Stuart, Staffordshire, UK), at a machine defined  
33 rpm, for 60 minutes at 4 ˚C.  Prior to buffer exchange samples were concentrated to the 
minimum recovery volume of the Amicon centrifugal concentrator columns, removing the 
excess incubation buffer.
25
  Prior to recovery, samples were buffer exchanged was 
                                                 
25
 Micro Bio-Spin 6 columns (BioRad, Hertfordshire. UK) were not used for buffer exchange protocols due to 
sample volumes exceeding the recommended load volume greater than six fold.   
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performed by three sequential washes into 150 mM AmAc (pH 7) using a single Amicon 
1.5 ml 10 kDa MWCO centrifugal concentrator columns (Millipore, Dundee, UK). 
Quadrupole mass isolation was used to select the m/z corresponding to the 
Sgt12Skp1 +23 ion (m/z 4856) prior to CID.  The TriWave Trap (see schematic in  
Fig. 1.13) voltage was ramped from 10 to 120 V, in increments of 10 V.  Analysis of the 
TPRκ2Skp1 complex was performed by isolating the m/z value corresponding to the  
+15 ion (m/z 3791).  The TriWave Trap voltage was ramped from 10 to 80 V, in increments 
of 5 V.  Analysis of both complexes was performed with a static TriWave Transfer voltage 
of 10 V.  
Protein independent instrumental settings for mass spectrometric analysis 
inconsistent with the previously stated values in section 4.3.2.1 were: Trap DC bias; 20 V, 
Trap Gas; 2 ml/min. Spectra were typically acquired over two minutes, unless longer was 
required to improve signal to noise, using two second scans.  Instrumental pressures:  
Trap; 0.015 mBar, mobility separator; 0.002 mBar, ToF; 1.5x10
-6
 mBar.  The m/z range for 
analysis was 1 000 to 25 000. 
Protein variable values, excluding collision voltages, are as follows, wt2Skp1: LM 
and HM values; 4 and 15 respectively, source backing; 5 mBar. TPRκ2Skp1: LM and HM 
values; 4 and 19 respectively, source backing; 4.5 mBar. 
 
4.4. Results 
4.4.1. Control Mass Analysis of the Sgt1 and Skp1 Proteins Studied 
 
As a prerequisite for mass analysis of all Sgt1 and Skp1 proteins studied here, denatured 
protein mass analysis was performed to calculate accurate experimental mass values using 
the buffer exchange method outlined in section 2.3.  Experimentally calculated masses, 
along with mass difference comparisons with the theoretical are described in table 4.2.   
The observed Sgt1 and Skp1 mass differences are proposed to occur because of  
N-terminal methionine clipping (M1), explaining an average loss of ~130 Da.  This is 
supported by denatured protein mass analysis of selenomethionine labelled TPRκ, required 
for crystallography phase determination (Fig. 4.15b).
26
  Analysis of selenomethionine 
                                                 
26
 Crystallography work performed by Oliver Willhöft. 
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labelled TPRκ showed two successful methionine to selenomethionine substitutions, in lieu 
of the expected three encoded by the amino acid sequence.  In contrast, if C-terminal 
clipping were occurring we would expect a mass difference of 101 Da (Threonine) for 
TPRκ, 156 Da (Arginine) for Skp1, and 137 Da (Histidine from His-tag) for the wt, H59A, 
and D61R proteins. 
 
Table 4.2. Theoretical and Experimentally Calculated Masses of Sgt1 and Skp1 
Proteins 
 
Denatured mass analysis of H59A and D61R indicated a large number of additional 
masses.  Analysis of the H59A (Fig. 4.16b) denatured spectra indicates species with and 
without N-terminus methionine clipping.  In contrast, D61R (Fig. 4.16c) denatured spectra 
indicates a variety of mass values, including those with and without methionine clipping 
and masses corresponding to increases over theoretical values.  The causes of these 
additional higher mass distributions currently remain unidentified, and have been observed 
in a number of different sample expression and purification runs obtained from our 
collaborators. 
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Sgt1 
wt 
His-
tag 
64 860 47 023 46 895.88 6.23 -127.12 
H59A 59 360 46 957 46 832.41 4.92 -124.59 
D61R 59 360 47 064 46 931.63 6.51 -132.37 
TPRκ None 22 920 17 462 17 331.83 3.23 -130.17 
Skp1 wt None 20 970 22 330 22 200.25 4.04 -129.75 
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Figure 4.15. Denatured Mass 
Spectra of TPRκ and 
Methionine to 
Selenomethionine Substituted 
TPRκ 
a) Denatured protein mass 
analysis of TPRκ prior to 
Methionine to Selenomethionine 
substitutions, indicated a mass 
difference of 130.17 (
+
/- 3.23) Da 
compared to the theoretical (red).  
This mass loss was proposed to 
occur due to N-terminal 
methionine clipping. 
b) Denatured protein mass 
analysis to calculate the number 
of Methionine to 
Selenomethionine substitutions.  
Analysis was performed to aid the 
calculation of the  crystallography 
phase for the TPRκ oligomer 
structure solved by Oliver 
Willhöft (Fig. 4.9a). Of the three 
methionines encoded by the TPRκ (M1, M64 and M76), mass analysis shows up to two observed 
substitutions (red = 0, yellow =1, blue =2) are successful, with no evidence of a third. This therefore supports 
that the observed average mass loss of 132 Da, occurs due to non-specific cleavage of M1 during the 
expression and purification.  Mass difference between methionine and selenomethionine is 46.9 Da.  
 
Accounting for N-terminal methionine clipping occurring in samples studied the 
theoretical mass was updated to reflect these observations.  Comparison between the 
theoretical masses lacking methionine and the experimental are presented in table 4.3, and 
represent good agreement between the two values. 
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Figure 4.16. Denatured Mass 
Spectra of the Sgt1 Wild Type, 
H59A & D61R Proteins 
a) Denatured protein mass 
analysis of wt Sgt1 indicates 
methionine (M1) clipping (Red).  
This clipping is additionally 
observed in (b) H59A and  
(c) D61R, with masses 
corresponding to the theoretical 
native (blue).  Of concern are the 
observed masses in the D61R 
spectra that correspond to gains 
in mass.  These represent masses 
of 130 (orange), 1929 (green) 
and 3686 (purple) Da greater 
than the D61R theoretical.   
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Table 4.3. Comparison of Theoretical and Experimental Mass Differences of Sgt1 and 
Skp1 Proteins Accounting for Methionine Clipping  
P
ro
te
in
 
P
ro
te
in
 N
a
m
e
 
T
h
eo
re
ti
ca
l 
M
a
ss
 (
D
a
) 
 
A
cc
o
u
n
ti
n
g
 f
o
r 
M
et
h
io
n
in
e 
C
li
p
p
in
g
 
E
x
p
er
im
en
ta
l 
M
a
ss
 (
D
a
) 
M
a
ss
 E
rr
o
r
 
(+
/ -
 D
a
) 
M
a
ss
 D
if
fe
re
n
ce
  
(E
x
p
t.
 -
 T
h
eo
.)
 
Sgt1 
wt 46 891 46 895.88 6.23 +4.88 
H59A 46 825 46 832.41 4.92 +7.41 
D61R 46 932 46 931.63 6.51 -0.37 
TPRκ 17 330 17 331.83 3.23 +1.83 
Skp1 wt 22 198 22 200.25 4.04 +2.25 
Removal of N-terminal Methionine represents a subtraction of 132 Da from the theoretical mass. 
 
4.4.1.1. MobCal Analysis of the TPRκ Trimer Native Structural Conformation 
 
This investigation has drawn on a key advantage provided by the Synapt HDMS (Waters, 
Manchester, UK) over other commercial ToF mass spectrometers.  Using the inbuilt  
T-wave mobility separator, we are able to confirm or refute the biological relevance of the 
mass spectrometry data sets by comparing IM calibrated CCS, with MobCal analysis of 
available crystal structure data.  
IM-MS was used to calculate the CCS of TPRκ lowest observed charge +13 ion 
(m/z 4000.65).  The tD extracted from the FWHM of this ion exhibits two structural 
conformations (1 and 2, Fig. 4.17d).  The calibrated CCS of this ion equates to  
3635.6 (
+
/- 76.91) Å
2
 for the primary compact, and 3886.36 (
+
/- 84.81) Å
2
 for the low 
intensity secondary conformation.  This secondary conformation represents an increase of 
6.9 % over the primary compact. 
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Figure 4.17. Ion Mobility Extracted Drift Time Data of the TPR Oligomers 
a) Mass spectra recreated from the sum of the TPRκ mobility data acquired at a wave velocity of 300 m/s and 
an amplitude of 7 V.  Sample concentration 11.2 μM, in a 150 mM AmAc buffer (pH 7).  b) tD data recreated 
from the FWHM of the monomer +7 ion (m/z 2476.9, grey) shows a single compact structural conformation 
(1580.0 
+
/- 37.57 Å
2
).  c) Like the monomer, the dimer +11 ion (m/z 3152.2, blue) shows a single compact 
conformation (2619.2 
+
/- 79.98 Å
2
).  d) tD data recreated from the FWHM of the trimer +13 ion (m/z 4000.65, 
purple) indicates two conformations, an abundant compact (1) conformation  
(3635.6 
+
/- 76.91 Å
2
), and less abundant extended (2) conformation (3886.36 
+
/- 84.81 Å
2
).  Due to the strong 
overlap of TPRκ oligomer (monomer, dimer & trimer) CSDs studies of the lowest charged monomer  
(M/D; = +6 monomer, overlapping with +12 dimer) and dimer (D/T; +10 dimer, overlapping with +15 
trimer) ions could not be performed.  These ions therefore represent the lowest charged m/z value not shared 
with either other oligomeric species, ensuring no additional tD contributions used to calculate the CCS of the 
respective ions studied. 
 
MobCal was used to apply the PA and EHSS to calculate the CCS of for the TPRκ3 
crystal (Fig. 4.9a) across thirty simulations.  The PA calculated CCS equalled  
3057.45 (
+
/- 30.21) Å
2
, with the EHSS CCS equalling 3924.68 (
+
/- 44.48) Å
2
.  Comparison 
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of these MobCal data with the primary dominant conformation (3635.6 
+
/- 76.91 Å
2
), 
suggests good agreement between both the PA and EHSS.  The closest agreement between 
the gas phase and MobCal calculated CCS data, is the EHSS.  Experimentally this model 
produces the most accurate results, when compared to the PA (Scarff et al. 2008).  These 
data confirm that the conditions used are able to maintain the native-like structure of the 
TPRκ trimer, and are therefore capable of producing biologically valid results.   
The existence of a second conformation for the trimer is contrary to the monomer 
and dimer, which both exhibit only a single compact conformation (Fig. 4.17b and c, 
respectively). The less abundant secondary, more extended, conformation may however 
represent a further biologically relevant structure, the significance of which will be 
discussed later (section 4.5.1). 
 
4.4.2.1. Comparison of Sgt1 Wild Type and TPRκ Oligomerisation as a Function of 
Concentration 
 
The recently solved crystal structure of TPRκ (Fig. 4.9a) has shown that Sgt1 dimerisation 
is promoted by a W58-H59 stacking interaction between adjacent monomers (Fig. 4.4a).  In 
the absence of the C-terminal steric clashes, that inhibit higher order-order oligomerisation 
(e.g. trimer, tetramer), these amino acids are orientated to enable sequential stacking of 
Sgt1 monomers.  Therefore, we have applied mass spectrometry to study the effect of 
concentration on the oligomerisation behaviour of TPRκ to promote higher order 
oligomers, comparing these with wt analysis.   
Samples of wt and TPRκ were incubated in 150 mM AmAc (pH 7), to compare 
oligomerisation as a function of concentration at 4.5, 11.2 and 22.3 μM (Fig. 4.18).  Wt 
data was expanded to study oligomerisation at 7.9, 14.9, and 18.6 μM.  These conditions 
were incorporated after initial analysis, using the sum of oligomer normalised peak 
intensities, produced an inconclusive relationship between the concentration and oligomeric 
state. This peak intensity analysis predated the Amphitrite software.  Comparison of all 
concentration points using Amphitrite calculated AUC analysis is shown in figure 4.19.   
In the absence of the Sgt1 C-terminal 151-395 amino acids, analysis indicates that 
the TPRκ is able to undergo concentration dependent oligomerisation.  This is further 
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supported by the appearance of higher order Sgt1 oligomers (tetramer and pentamer), not 
previously observed.  These data therefore indicate that the orientations of W58 and H59 
allow higher order oligomerisation in the absence of C-terminal domain steric clashes. 
 
 
Figure 4.18. Comparison of Sgt1 Wild Type and TPRκ Oligomerisation as a Function of Concentration 
Amphitrite analysis of the simulated oligomer species to calculate AUC values for the wt (top row) and TPRκ 
(bottom row) oligomers as a function of the concentration.  Data is expanded in quantitative detail in figure 
4.19.  Spectra indicate the oligomerisation state of each protein at the represented concentrations, and 
highlight a positive correlation between concentration and higher order oligomers in the absence of the  
C-terminal amino acids 151-395.  
Experimentally acquired spectra; black, simulated spectra; red, monomer; grey, dimer; blue, trimer; purple, 
tetramer; green, pentamer; brown. Charge states: wt +13; ○, wt2 +20; ●, wt3 +24; ♦, TPRκ +8; □,  
TPRκ2 +11; ■, TPRκ3 +13; ø, TPRκ4 +15; †, TPRκ5 +17; ‡ 
 
Wt AUC decreases only fractionally outside of MSD across the low to high 
concentration range (Fig. 4.19b).  These decreases in wt dimer AUC, from low to high 
concentrations, suggests that the CS and SGS domain clashes may not be able to 
completely prevent concentration dependent oligomerisation.  This observation is supported 
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by an increase in trimer AUC between 4.5 and 18.6 μM.  At 22.3 μM, however, we observe 
a sudden unexplained change in oligomer contributions; an increase in monomer is 
observed with decreased levels of trimer inconsistent with trends in oligomerisation.  
Despite a small reduction in AUC, in both figures (Fig. 4.18 and 4.19), the wt Sgt1 
protein exhibits a consistent and relatively stable preference for the dimer, with an average 
AUC of 59.6 (
+
/- 7.5) % across all protein concentrations.  These results may therefore 
indicate that the CS and SGS domains act to promote oligomer stability. Excluding the SGS 
domain acting as a phosphorylation site for CK2, that negatively regulates dimerisation, 
contributions of the CS and SGS domains to promote oligomer stability have not been 
previously identified.   
 
 
Figure 4.19. Percentage Area Under Peak Comparison of Sgt1 Wild Type and TPRκ as a Function of 
Protein Concentration 
Comparison of average AUC Amphitrite calculated data, for the (a) wt and (b) TPRκ oligomers, as a function 
of protein concentration.  
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4.4.2.2. Comparison of Sgt1 Wild Type and TPRκ Oligomerisation as a Function of 
Ionic Strength  
 
 
Figure 4.20. Comparison of Sgt1 Wild Type and TPRκ Oligomerisation as a Function of Ionic Strength 
Amphitrite analysis of the simulated oligomer species, to derive AUC data for wt (top row) and TPRκ 
(bottom row) oligomers as a function of the ionic strength.  Data is expanded in quantitative detail in figure 
4.21. Protein concentration remains static in all spectra: 22.3 μM.  
Experimentally acquired spectra; black, simulated spectra; red, monomer; grey, dimer; blue, trimer; purple, 
tetramer; green, pentamer; brown. Charge states: wt +13; ○, wt2 +20; ●, wt3 +24; ♦, TPRκ +8; □,  
TPRκ2 +11; ■, TPRκ3 +13; ø, TPRκ4 +15; †, TPRκ5 +17; ‡ 
 
Analysis by Oliver Willhöft, using SV-AUC had shown that the extended electrostatic 
interactions between D57 and D61 (convex face) and their respective binding partners H59 
and R130 (concave face) required to stabilise the dimerisation interface, are perturbed at 
increasing ionic strengths.  The former of these, the D57-H59 interaction, is required to 
orientate the H59 within the concave face to bind the W58 of the neighbouring Sgt1 
monomer (Willhöft 2013).  Mass spectrometry has therefore been applied to accurately 
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resolve the effect of increasing ionic strengths on Sgt1 oligomerisation behaviour.  Studies 
were performed using AmAc, in lieu of the NaCl buffer used in previous SV-AUC 
experiments (Willhöft 2013), due to the non-volatile nature of the latter buffer.
27
  
Samples of wt and TPRκ were incubated at a protein concentration of 22.3 μM, in 
150, 500, and 1000 mM AmAc. Comparison of wt and TPRκ spectra across the ionic 
strength range studied is shown in figure 4.20.  These data are expanded using the 
Amphitrite calculated AUC analysis in figure 4.21.   
 
 
Figure 4.21. Percentage Area Under Peak Comparison of Sgt1 Wild Type and TPRκ as a Function of 
Ionic Strength 
Comparison of Amphitrite calculated average AUC data, for (a) wt and (b) TPRκ oligomers, as a function of 
ionic strength.   
 
The analysis presented here indicates that ionic strength is able to destabilise the 
binding interface of Sgt1. Reduced levels of higher order oligomers are observed for both 
wt and TPRκ as ionic strength increases, and is supported by a consistent increase in 
monomeric species.  The largest decrease in higher order oligomers, in both the wt and 
TPRκ, occurs between 150 and 500 mM.  Above these ionic strengths, marginal decreases 
in the higher order wt oligomers are observed.  In contrast, at the highest ionic strength 
studied (1000 mM AmAc) not all TPRκ higher order oligomers have been destabilised.  
                                                 
27
 PubChem (http://pubchem.ncbi.nlm.nih.gov/, access date 7
th
 August 2013) Property information;  
NaCl; CID 5234, 58.44277g/mol, H-Bond Donors 0, H-Bond Acceptors 1 (Net; +1 Acceptor) 
Ammonium Acetate; CID 517165, 77.08248g/mol, H-Bond Donors 1, H-Bond Acceptors 2  
(Net; +1 Acceptor) 
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This suggests that higher ionic strengths may be required to promote similar TPRκ 
oligomer levels when compared with the wt data.   
 
4.4.2.3. Comparison of Sgt1 Wild Type and TPRκ Oligomerisation as a Function of 
Concentration and Ionic Strength 
 
In order to expand on the studies above, oligomerisation as both a function of ionic 
strength, and protein concentration were compared (sections 4.4.2.1 and 4.4.2.2).  Wt and 
TPRκ were incubated in both 500 and 1000 mM AmAc, to compare oligomerisation at  
4.5, 11.2 and 22.3 μM (for 150 mM data please see Fig. 4.19). 
 
 
Figure 4.22. Extended Comparison: Percentage Area Under Peak Comparison of Sgt1 Wild Type and 
TPRκ 
Comparison of average AUC calculated using Amphitrite for the oligomerisation state of the (a) wt and  
(b) TPRκ, as a function of ionic strength and protein concentration. For simplicity, only common oligomeric 
species present at all ionic strengths are shown (monomer, dimer, and trimer).  Contributions from other 
TPRκ oligomers species represent a contribution of 2.9 % (Tetramer + Pentamer) at 22.3 μM, 500 mM 
AmAc.  Data here represents an extension of the data presented in figure 4.19. 
 
Compared with previous data (Fig. 4.21), results suggest that destabilisation of the 
salt sensitive binding interface interactions occur prior to the 500 mM AmAc concentration 
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(Fig. 4.22).  This is supported by a minimal changes in oligomer AUC within MSD 
between 500 and 1000 mM AmAc, observed using both the wt and TPRκ at all protein 
concentrations.  The remaining dimerisation interactions therefore appear to stabilise the 
oligomeric state, albeit at reduced levels, between both ionic strengths presented.  
 
4.4.3. Disrupting the Binding Interface Using H59A and D61R Substitutions 
 
Histidine 59 (H59) is a positively charged amino acid located within the extended loop 
region located between TPR2A and TPR2B (amino acids 54-59).  This forms a stacking 
interaction with Tryptophan 58 (W58) in the extended TPR loop region of a second Sgt1 
monomer (Fig. 4.11a) (Willhöft et al. In Preparation).  This interaction is thought to 
central to the homodimerisation interaction, and it is hypothesised that a histidine to alanine 
substitution (H59A) should significantly reduce oligomer stability. 
In addition to the W58-H59 stacking interface, further polar interactions aid 
stabilisation of the Sgt1 homodimerisation interface.  Of interest here is the negatively 
charged amino acid Aspartic acid 61 (D61) located within the TPR2B helix, which forms 
an electrostatic interaction with the positively charged Arginine 130 (R130) of its 
neighbouring monomer (Fig. 4.11b).  As this binding interface is supported by additional 
electrostatic interactions: D57 to S60, and H59 to N100 (convex to concave respectively), a 
D61R substitution will not completely disrupt oligomerisation, but hypothetically reduce its 
stability.  
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Figure 4.23. Analysis and Comparison of the Sgt1 Binding Interface Substitutions 
a) Deconvolution of (i) H59A, (ii) wt, and (ii) D61R oligomeric species using Amphitrite. Experimental 
acquired spectra; black, simulated spectra; red, monomer; grey, dimer; blue, trimer; purple. Charge states: 
monomer +14; ○, dimer +20; ●, trimer +24; ♦.  b) Comparison of H59A (red), and D61R (blue), oligomer 
AUC values (wt in yellow).   
The mass heterogeneity observed using denatured mass analysis (previously described section 4.4.1 and  
Fig. 4.16) is proposed to account for the poor D61R dimer peak separation within acquired mass spectra. 
 
Work presented here compares the two previously highlighted substitutions, against 
the wt protein, using the same solution and gas phase conditions (11.2 μM, 150 mM AmAc, 
pH 7).  Comparisons of protein oligomeric species are shown in figure 4.23.  
The H59A substitution inhibits higher order oligomerisation from 80 % in the wt 
(dimer + trimer) to almost a third of this value (28 %).  These results represent a good 
agreement with the above hypothesis, supporting a central role of the H59-W58 stacking 
interaction to stabilise Sgt1 dimerisation.   
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In contrast, compared to the wt the D61R substitution appears, within MSD, to 
increase dimerisation events (61 to 72 %) with both proteins exhibiting comparable levels 
of monomer.  Comparisons of trimerization oligomerisation events, however, indicate that 
this substitution destabilises further oligomerisation events, nearly negating the trimeric 
species within MSD (5.3 
+
/- 3.57 %).  This is in direct contrast to the wt trimer species, 
which comprises nearly a fifth of all oligomers.  This comparison therefore supports the 
above hypothesis that this D61R substitution should reduce the stability of the binding 
interface by inhibiting its interactions with R130. 
 
4.4.4.1. Analysis of the Sgt12Skp1 Binding Interface Using Tandem Mass 
Spectrometry 
 
The crystal structure of TPRκ3Skp1 has shown that Sgt1: Skp1 binding is mediated by a 1:1 
interaction (Fig. 4.14).  MS/MS is a common method used to probe the organisation of 
multimeric complexes, and has been applied here to study Sgt1: Skp1 binding interface.  
Dissociation of a single Sgt1 subunit from the wt Sgt12Skp1 complex would support the 1:1 
binding interface observed in the crystal, and indicate that the Sgt1 dimer is not required for 
stable Skp1 binding.  In contrast, if no Sgt11Skp1 oligomers were observed, this would 
suggest that the second Sgt1 monomer is required to stabilise the binding interface. 
Incubation of wt Sgt1: Skp1 using the method previously described  
(section 4.3.2.3), produced a heterogeneous mixture of Sgt1 and Skp1 complexes  
(Fig. 4.24c).  MS/MS analysis of the isolated Sgt12Skp1 +24 (m/z 4856) ion at a TriWave 
Trap collision voltage of 70 V produced a fragmentation pattern consistent with the 1:1 
binding interface, with dissociated Sgt11 and Sgt11Skp1 complexes (Fig. 4.24a).  Further 
increases in collision voltage (90 V) improved the relative intensity of Sgt1Skp1  
(Fig. 4.24b).  At higher collision voltages (> 90 V) the signal to noise ratio inhibited 
observations of all oligomeric species. 
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Figure 4.24. Tandem Mass Spectrometry Analysis of the Wild Type Sgt12Skp1 Complex 
a) MS/MS analysis of the wt Sgt12Skp1, using the isolated +24 (m/z 4856, grey sphere) ion at 70 V.  Data 
shows that a single subunit of wt Sgt1 can be dissociated (blue sphere), whilst retaining an intact Sgt11Skp1 
complex (yellow sphere) (red sphere, represents the co-isolated 2:1 +22 ion).  b) Increasing the collision 
voltage to 90 V, allows the 1:1 heterodimer to be more clearly resolved.  c) Control spectra Amphitrite 
analysis shows the presence of unbound Skp1 (grey, +8; ○), Skp12 (blue, +13; ●) and Sgt1Skp1  
(purple, +17; ♦), along with the required Sgt12Skp1 protein (green, +24; †).  Experimentally acquired spectra 
in black, simulated spectra in red. 
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4.4.4.2. Analysis of the TPRκ2Skp1 Binding Interface Using Tandem Mass 
Spectrometry 
 
Following from studies of the Sgt12Skp1 complex, analysis was performed on the 
TPRκ2Skp1 oligomer to support the wt data above.  This would allow progression of the 
study to analyse the TPRκ3Skp1 oligomer observed in the crystal structure (Fig. 4.14). 
Using the same incubation method as for the wt protein, mass analysis of incubated 
TPRκ: Skp1 produced a heterogeneous mixture of increased complexity oligomers  
(Fig. 4.25).  To identify the CSD of the TPRκ2Skp1 oligomer spectra deconvolution was 
required. As this analysis predated the development of the Amphitrite software, 
deconvolution of these spectra was performed by using the quadrupole to isolate each peak 
across the m/z range.  Ion decomposition was then collisionally induced to study the 
resultant fragmentation patterns.   
The CID fragmentation patterns were used to identify the CSD’s of TPRκxSkp1y 
oligomers (x and y = number of respective monomeric subunits).  These identifications 
were confirmed using at least one neighbouring charge state (z = 
+
/- 1) within the theoretical 
CSD.  These data were corroborated by summing the average charge totals of the 
fragmentation pattern to ensure close agreement with the theoretical value expected of the 
oligomer at the observed m/z value.   
Using the identified CSD of the required 2:1 heteromer, a suitable TPRκ2Skp1 ion 
peak (+15, m/z 3791) was isolated using the quadrupole (highlighted as ‘Q,’ in Fig. 4.25), 
and analysed using CID (Fig. 4.26).  Suitability of ions for quadrupole isolation was 
defined as an ion peak that did not overlap, within an appropriate m/z range (
+
/- m/z 50), any 
other heteromeric protein that may produce a contradictory fragmentation pattern. This is in 
addition to retaining a suitable relative intensity for ease of analysis.  MS/MS analysis has 
shown a fragmentation pattern consistent with a TPRκ monomer dissociated from 
TPRκ2Skp1, retaining an intact TPRκ1Skp1 heteromer.  This is in excellent agreement with 
the wt work above (section 4.4.4.1).   
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Figure 4.26. Tandem Mass Spectrometry Analysis of the TPRκ Sgt12Skp1 Complex 
The isolated TPRκ2Skp1 (grey) +15 (m/z 3791) ion was fragmented using a TriWave Trap collision voltage 
ramp (10-80 V).  Fragmentation pattern at 45 V indicates a TPRκ monomer (blue) can be dissociated to leave 
an intact TPRκSkp1 heterodimer (yellow) supporting the 1:1, Sgt1: Skp1, binding interface.  Also shown are 
the trace co-isolated +14 TPRκ2Skp1 (m/z 4045) ion (red), and +16 TPRκSkp12 (m/z 3851) ion (purple). 
 
4.4.4.3. Progressing to Study the Crystal Structure Relevant TPRκ3Skp1 Binding 
Interface 
  
Despite the biologically relevant oligomer that binds Hsp90 in vivo being Sgt12Skp1, the 
recently solved crystal structures of TPRκ, and TPRκ: Skp1 (Fig. 4.9 Willhöft 2013, and 
Fig. 4.14 Willhöft et al. In Preparation) have shown trimeric Sgt1 species incorporated 
within these oligomers.  Therefore, it was proposed that MS/MS could be applied to probe 
the organisation of TPRκ3Skp1 oligomer to allow a greater understanding of the binding 
interface. 
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Figure 4.27. Promoting Gas 
Phase TPRκ3Skp1: Sample 
Ratio Effects 
Data shows TPRκ: Skp1 
incubated at ratios of (a) 1:1,  
(b) 3:1 and (c) 5:1.  Method of 
peak identification is outlined in 
figure 4.25.  As above  
(Fig. 4.25) the green spheres 
represent an overlap of two 
potential proteins, supporting 
evidence for either a  
1:3 (79 kDa) or 2:2 (84 kDa)  
TPRκ: Skp1 oligomer.  
Data shows that as the 
concentration of TPRκ increases 
a reduction in higher order Skp1 
oligomers occur.  Spectra were 
unable to resolve the required 
TPRκ3Skp1. 
The purple sphere, observed in 
b, highlights a potential 
TPRκ3Skp1 +20 (‡, m/z 3710.8) 
ion, albeit at a reduced relative 
intensity to the other ions 
observed.  Within the theoretical 
CSD +19 and +21 charge states 
overlap too closely with other 
oligomeric species, to actively 
conclude the presence of the 
TPRκ3Skp1 oligomer at these 
conditions.  Mass spectrum in 
part b, represents the only datum 
that may indicate the presence of 
TPRκ3Skp1.  Sgt1: Skp1 oligomer charge states: 0:1 +8; ●, 0:2 +12; ■, 0:3 +16; ♦, 1:1 +12; ○, 1:2 +15; □,  
2:1 +14; ◊, 2:3 +21; ø, 1:3 +17 or 2:2 +16; †, 3:1 +20; ‡. 
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
147 
Accounting for the solvent accessible area of the species, using a projected CSD 
comparable to the charge increase between 1:1 and 2:1 and globular protein charge 
prediction equations,
28
 the TPRκ3Skp1 oligomer was expected to appear between  
+17 to +21 (m/z 3500 to 4400).
 29
  Unfortunately, the incubation method used to produce 
observed TPRκ2Skp1 heteromer studied above, failed to resolve a CSD corresponding to 
TPRκ3Skp1.   
To resolve the TPRκ3Skp1 CSD, incubations varying the solution conditions were 
performed.  Initial attempts modified the ratio of TPRκ to Skp1, studying incubation ratios 
of 3:1 and 5:1.  These ratios were studied due to the observation of TPRκ concentration 
dependent oligomerisation.  At 30 μM, the 3:1 ratio (Fig. 4.27b) would contain a Sgt1 
concentration equal to 21 μM, whilst the 5:1 (Fig. 4.27c) would contain 23.9 μM.  
Therefore, we expected comparable, or improved, levels of TPRκ trimer to those observed 
during the oligomerisation as a function of concentration work above (section 4.4.2.1).  For 
control methods, we additionally studied an incubation ratio of 1:1, TPRκ: Skp1  
(Fig. 4.27a).   
Spectra acquired at each of the incubation conditions are presented in figure 4.27, 
applying the previously described MS/MS fragmentation pattern method to identify 
TPRκxSkp1y oligomers.  Incubations of TPRκ: Skp1 at ratios of 3:1 and 5:1 promoted 
observable improvements in the intensities of the TPRκSkp1 and TPRκ2Skp1 heteromers 
relative to other oligomers.  Excluding a single non-overlapping ion peak (purple sphere 
Fig. 4.27) that exhibited, with good agreement, a m/z value in line with the theoretical  
+20 (m/z 3710.8) ion, the TPRκ3Skp1 CSD remained unobserved.
30
  Due to the low 
intensity of this peak, relative to the neighbour ions, MS/MS analysis could not be 
performed to confirm its oligomeric identity.  Replication of the conditions corresponding 
to the datum in figure 4.27b failed to reproduce observations of this ion peak. 
Subsequently, it was proposed that the key limiting factor to clearly resolve the 
TPRκ3Skp1 oligomer, was the over abundance of higher order Skp1 oligomers. This 
homomerisation occurs as a property of the Skp1 surface cysteine amino acids to form 
                                                 
28
  z = 0.078 x √m (Kebarle & Verkerk 2009) 
29
 Theoretical m/z series produced using the denatured spectra derived experimental masses of both the TPRκ 
and Skp1 proteins (section 4.4.1.). 
30
 TPRκ3Skp1 +20 theoretical m/z = 3710.77, experimental observed peak m/z = 3742.8 
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disulphide bonds between monomers.  Therefore, DTT was suspended to a final 
concentration of 3 mM within the AmAc (150 mM, pH 7) electrospray buffer, to reduce 
Skp1 disulphide-bridges.   
 
 
Figure 4.28. Promoting Gas Phase TPRκ3Skp1: Effect of DTT (Pt. I) 
The 2:1 ratio incubation of TPRκ: Skp1 readily shows the difference between electrospray buffer both,  
(b) with, and (a) without DTT (3 mM).  In the presence of DTT the previously unknown species suspected as 
being either the 2:2 or 1:3 oligomer (green sphere) are concluded to be the former (2:2).  This does not 
exclude the conclusion that the 1:3 oligomer may exist in the absence of DTT, and is supported by the 
presence of Skp13 oligomers.  Sgt1: Skp1 oligomer charge states: 0:1 +8; ●, 0:2 +12; ■, 0:3 +16; ♦,  
1:1 +12; ○, 1:2 +15; □, 2:1 +15; ◊, 2:2 +16; ‡, 2:3 +21; ø, 1:3 +17 or 2:2 +16; †. 
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Figure 4.29. Promoting Gas Phase TPRκ3Skp1: Effect of DTT (Pt. II) 
5:1 ratio incubation of TPRκ: Skp1 showing the difference between electrospray buffer both, (b) with, and (a) 
without DTT (3 mM).  In the presence of DTT the previously unknown species suspected as being either the 
2:2 or 1:3 oligomer (green sphere) are concluded to be the former (2:2).  This figure is a continuation of the 
2:1 incubation ratio data presented in figure 4.28.  Sgt1: Skp1 oligomer charge states: 0:1 +8; ●, 0:2 +12; ■, 
0:3 +16; ♦, 1:1 +12; ○, 1:2 +15; □, 2:1 +15; ◊, 2:2 +16; ‡, 2:3 +21; ø,  
1:3 +17 or 2:2 +16; †. 
 
Analysis using this modified method was performed using 2:1 and 5:1 concentration 
ratios of TPRκ: Skp1.  The 2:1 incubation ratio replicated the conditions used to produce 
the crystal required for X-ray crystallography (Fig. 4.14). The 5:1 incubation targeted 
solution conditions promoting the concentration dependent oligomerisation of TPRκ.   
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Figure 4.28 compares the observed oligomeric species for the 2:1 incubation of 
TPRκ: Skp1 in both the presence (b), and absence (a) of 3 mM DTT.  Incubations of  
TPRκ: Skp1 at 5:1 are compared in figure 4.29.  Extended analysis using the MS/MS 
fragmentation pattern method, previously described, again failed to indicate the presence of 
observable TPRκ3Skp1 oligomers despite an apparent reduction in higher order Skp1 
oligomers, complexed with and without TPRκ, relative to other species. 
Concluding that the 3:1 observed in figure 4.14 was likely an artefact of the 
crystallisation method, resulting from the high protein concentrations required, further 
attempts to study this complex were not made.  Additionally the MS/MS analysis of the 
biologically relevant Sgt12Skp1 oligomer, originally targeted by the investigation, had 
already been performed. 
 
4.5. Discussion 
 
Comparison of the mass spectrometric data presented here is produced in combination with 
other data presented by Willhöft (2013), and Willhöft et al. (In Preparation).  
 
4.5.1. Regulation of Sgt1 Dimerisation  
 
Analysis of wt Sgt1 protein, excluding 22.3 μM at 150 mM AmAc, shows stable oligomer 
AUC values across the protein concentration range studied (Fig. 4.20 and Fig. 4.23).  This 
is in comparison to the TPRκ protein, which exhibits a concentration dependent mode of 
oligomerisation.  These data suggest that the absence of the C-terminus removes the steric 
clashes that prevent further oligomerisation interactions, and allow additional W58-H59 
stacking interactions between adjacent monomers.   
SV-AUC analysis performed by Willhöft (2013) (Fig. 4.30) has shown that the 
TPRκ is able to form trimers in solution, and is supported by the gas phase analysis 
presented here.  In contrast the TPRκλ (TPRκ plus linker; λ) protein (amino acids 1-178) 
only forms dimers.  Therefore, the TPRκ (amino acids 1-150) likely represents what is 
close to the structural maximum that supports Sgt1 trimerization, with further additions to 
the protein sequence inhibiting these oligomerisation events occurring due to steric clashes.   
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Figure 4.30. Comparison of Sgt1 Proteins Using SV-AUC  
SV-AUC analysis of four Sgt1 proteins (molecular weight order), TPRκ (amino acids 1-150), TPRκλ  
(amino acids 1-178), ΔSGS (amino acids 1-279) and wt (full length). A positive correlation is observed in 
sedimentation coefficient and increasing monomeric mass (left).  In terms of the observed weight-average 
frictional ratio, (right) proteins encompassing regions of the 151 to 395 amino acid stretch show a similar 
increasing trend in the frictional ratio, due to the linear addition of structural features that restrict higher order 
oligomerisation. The TPRκ, which does not encompass these additional amino acids, is able support 
additional oligomerisation events (i.e. trimerization) accounting for a weight-average frictional ratio increase 
inconsistent with the higher mass proteins.  Data collected and analysed by Oliver Willhöft (Willhöft 2013). 
Figure reproduced, with permission, from Willhöft 2013 
  
These data are supported by analysis of the crystal structure analysis by  
Oliver Willhöft (2013).  This analysis has shown that the TPRκ is unlikely to support 
further oligomerisation events due to the increasing steric clashes between neighbouring 
Sgt1 monomers.  These observations contradict the mass spectrometric data presented here 
which has shown that the TPRκ protein is able to support increasing levels of tetramer and 
pentamer oligomers at concentrations exceeding 11.2 μM (Fig. 4.18 and Fig. 4.19).  These 
oligomerisation events are therefore likely to support a model of non-specific gas phase 
interactions that are known to occur as a function of increased concentration under the 
charged residue model of analyte desolvation (see Fig. 1.5a) (Sun et al. 2007).  In a 
contrasting explanation, these higher order oligomers may form due to a second mode of 
dimerisation. 
Consensus TPR (CTPR) analysis performed by Krachler & co-workers (2010) using 
CTPR3Y3, a triple mutant variation of CTPR3, indicated a potential second mode of 
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dimerisation.  Mutations within the capping helix destabilised hydrogen bonding that 
promoted displacement of this secondary structure element to enable a third CTPR3Y3 to 
bind to the existing dimer.  In contrast to the classical stacking interface, this displacement 
promoted an end-on mode of oligomerisation producing a quasi-continuous oligomer  
(Fig. 4.31) (Krachler, Sharma & Kleanthous 2010). 
 
 
Figure 4.31. Different Modes of TPR Self-Association 
The CTPR3Y3 presents two potential modes of self-association of TPR-containing proteins. Dimerisation 
can occur through the loop-mediated interactions (stacking) or by a hydrophobic end-on association 
(Krachler Sharma & Kleanthous 2010, PDB ID: 2WQH). 
Figure reproduced, with permission, from Willhöft 2013 
 
Within the studies performed here, the open C-terminal nature of the TPRκ may 
allow the capping helix to dissociate from the dimerisation domain forming a secondary, or 
end-on, binding interface.  Due to the reduced number of amino acids contributing to 
binding between monomers compared to the stacking interface, the stability of the end-on 
mode of oligomerisation will be weaker in contrast.  Subsequently due to these reduced 
binding stabilities, we would expect lower levels of these oligomers consistent with the 
observed tetrameric and pentameric species. 
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It may be argued that the use of the buffers (AmAc) required for native mass 
spectrometric analysis, when compared to those used for SV-AUC and SEC-MALS  
(Size Exclusion Chromatography-Coupled Multi-Angle Light Scattering) (NaCl), may 
contribute to these extended oligomerisation events.  Considering that anions and cations of 
AmAc and NaCl share similar positions within the Hofmeister series however, suggests 
that this is unlikely (Curtis & Lue 2006).  It is more likely that the SV-AUC and  
SEC-MALS analysis methods presented by Willhöft (2013), lack the dynamic range, 
sensitivity, and accuracy required to resolve these higher order oligomers, when compared 
to the mass spectrometric methods used here. 
Analysis of the TPRκ IM data acquired indicates single conformational species for 
both the monomer and dimer (Fig. 4.17, b and c).  In contrast the trimer exhibits a second, 
less abundant, conformation of 3886.36 (
+
/- 84.81) Å
2
 (Fig. 4.17d).  This represents a 
conformational increase of 6.8 % over the primary, more compact, conformation  
(3635.6 
+
/- 76.91 Å
2
).  Due to reduced structural compaction resulting from the displaced 
capping helix of the end-on mode of dimerisation (Krachler, Sharma & Kleanthous 2010), 
increases in  CCS are to be expected and may support that the TPRκ is able to oligomerize 
using this alternative mode of oligomerisation.  Unfortunately, due to the relative intensities 
of the tetramer and pentamer oligomers in the acquired IM mass spectra, mobility analysis 
cannot be readily performed to confirm these suggestions. 
Although the W58 and H59 amino acids that mediate dimerisation are orientated in 
a way to support trimerization, analysis performed by Willhöft (2013) has indicated that the 
C-terminal domains of the wt protein would cause steric clashes between the α and γ 
monomers preventing wt Sgt13 formation (Fig. 4.9a).  Data presented here however has 
shown that the wt is able to promote trimerization, in an interaction that is perturbed by the 
D61R substitution.  It may be concluded that these steric clashes reduce higher order 
binding stability, but are unable to completely inhibit these interactions explaining why we 
see only low levels of trimer across the 4.5 to 22.3 μM concentration range (Fig. 4.19a).  In 
addition to increasing steric clash events, the extended C-terminus should prevent binding 
by the end-on stacking interface, further explaining why we see no evidence of tetrameric 
or pentameric oligomers using the wt.   
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Comparing oligomerisation as a function of protein concentration (Fig 4.18 and 
4.19), the TPRκ supports concentration dependent oligomerisation: predominantly 
monomeric at 4.5 μM, dimeric at 11.2 μM, with a trend indicating preference for the trimer 
above 22.3 μM.  In contrast, the appearance of wt oligomers appear to be concentration 
independent, and exhibit a preference for the dimer across the range studied.  These 
observations therefore support the requirement for the C-terminal domains to stabilise the 
native dimeric oligomer.   
Despite indicating a requirement for C-terminal stabilised oligomers, what role 
these domains play to regulate these dimerisation events is non-resolvable, nor accurately 
suggests which domain is responsible.  The previously outlined SV-AUC and SEC-MALS 
data indicate that increasing the length of the TPRκ by 18 amino acids (TPRκλ) inhibits 
trimerization.  This is understood to occur because of C-terminal steric clashes, in addition 
to with the reduced sensitivity of the methods used for analysis compared to mass 
spectrometry.  Comparison with the literature however suggests that the SGS domain, 
which acts as a site for CK2 mediated phosphorylation inhibiting dimerisation  
(Bansal et al. 2009b), is therefore the most likely site for stabilization.  How this SGS 
domain contributes structurally to the dimer however remains currently unidentified.
31
   
Comparison of ionic strength against protein concentration (Fig. 4.22) indicates that 
increases in ionic strength between 150 mM and 500 mM may be sufficient to destabilise 
the electrostatic interactions that are required for stable Sgt1 dimerisation.  This is 
supported by similar AUC of each oligomer, within MSD, between 500 mM and 1000 mM 
AmAc across the protein concentration range.  Above 500 mM AmAc, it is expected that 
only the H59-W58 stacking interaction will support Sgt1 dimerisation.  This observation is 
in line with the previously outlined requirement of this interaction using the H59A 
substitution (section 4.4.3). 
 
4.5.2. Sgt1, Skp1 Interactions 
 
MS/MS data of both the wt and TPRκ supports that the binding interface for Sgt1: Skp1 
binding is a 1:1 interaction.  The requirement for the previously identified Sgt1 dimer that 
                                                 
31
 The structure of the SGS domain currently remains unresolved. 
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mediates in vivo interactions between Hsp90 and Skp1 in S. cerevisiae is yet to be 
concluded.  These observations are supported by pull down experiments using the 
monomeric H59A Sgt1 mutant, which is able to bind to Skp1 without prior  
homo-dimerisation (Willhöft 2013).  Combined these observations support the suggestion 
that Sgt1 dimerisation is not required to promote stable binding of Skp1. 
Data presented here expands on previous observations by supporting the 
requirement of increased collisional voltages to dissociate a single wt subunit from the 
Sgt12Skp1 when compared to the TPRκ2Skp1 oligomer.  These data further support that the 
requirement of the C-terminal domains that have been proposed here to stabilise Sgt1 
dimerisation.  These observations are more likely however, to occur due to the increased 
mass of the wt allowing additional energy transfers with the collision gas, prior to 
unfolding and dissociation.   
 
4.6. Future Directions 
4.6.1. Exploring the Dimerisation Interactions Further 
 
Of interest for future Sgt1 mass spectrometry based studies are the deletion mutants at 
sequence lengths between the wt and TPRκ, and their influence on oligomer stability.  
These include the deletion mutants TPRκλ (amino acids 1-178), and ΔSGS  
(amino acids 1-279, lacks CS-SGS linker domain) previously studied using SV-AUC and 
SEC-MALS (Fig. 4.30).  Using these Sgt1 deletion mutants to study oligomerisation as a 
function of protein concentration (see section 4.4.2.1) would allow us to support the 
requirement of either the CS, SGS or TPR to CS domain linker, to promote oligomer 
stability.   
It is hypothesised here that the shortest protein, in amino acid length, exhibiting 
concentration independent oligomerisation behaviour would indicate that the last domain or 
linker encoded at the C-terminus is required to regulate stable Sgt1 dimerisation.  
Therefore, if the TPRκλ exhibits concentration independent oligomerisation, this would 
indicate that the 18 amino acids directly C-terminus to the TPRκ are sufficient to regulate 
the Sgt1 dimerisation behaviour.  These observations would subsequently support a role for 
this linker region.  In contrast, if the TPRκλ exhibits concentration dependent oligomers, 
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this would indicate that a domain toward the C-terminus, not encoded by the sequence, is 
required to regulate stable Sgt1 dimerisation e.g. CS or SGS. 
Although CK2 inhibits Sgt1 dimerisation by phosphorylating the residue S361 
located within the SGS domain, it has been suggested that there may exist a further 
inhibitory domain between amino acids 270 to 312 (CS to SGS domain linker) (Bansal  
et al. 2009a and Bansal et al. 2009b).  Therefore, in addition to the above TPRκλ and ΔSGS 
Sgt1 mutants I suggest the production of a further Sgt1 deletion mutant that encodes  
amino acids 1-312, or a suitable nearby residue, for studies of concentration 
dependent/independent oligomerisation.  Although lacking the SGS, this mutant would 
additionally incorporate the CS to SGS linker domain not encoded by the ΔSGS.  
Additionally phosphorylated wt Sgt1 may represent a suitable control for analysis, allowing 
wt dimerisation negative analysis.  Combined, these investigations provide an interesting 
mass spectrometry led method to refine the regulation of Sgt1 dimerisation events. 
In addition to the regulation of the oligomeric state by the C-terminal domains, of 
further interest is the influence of ionic strength on the stability of the dimerisation domain.  
Data presented using wt Sgt1 has suggested that destabilisation of the extended electrostatic 
interactions at the binding interface occurs between 150 and 500 mM AmAc.  Therefore 
refining this range to study an extended number of ionic strengths, e.g. 80, 220, 290, 360, 
430, and 600 mM AmAc, may indicate the minimum salt concentration suitable to 
destabilise binding. 
Expanding these studies to incorporate the D61R substitution, which removes a 
single electrostatic interaction, may allow us to probe the effect of these conditions further.  
It is expected that initial losses of higher order oligomers would occur more rapidly than 
the wt, due to the reduced stability of the dimer interface.  At higher ionic strengths, above 
500 mM AmAc, oligomer AUC values are expected to plateau at similar values to the wt 
once all the electrostatic dimerisation interactions are negated.  If the wt and D61R plateau 
at the similar oligomer AUC contributions, we may conclude that only the  
W58-H59 interaction is stabilising the binding interface.  This would support the role of 
ascomycete specific loop for dimerisation. 
Data presented here has shown that at the highest ionic strength, 1000 mM AmAc, 
TPRκ oligomer contributions have yet to reach a plateau.  Therefore, it is proposed that 
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future studies incorporate AmAc concentrations above the 1000 mM limit studied here,  
e.g. 1250, 1500, 1750 and 2000 mM.  Given a suitable range, we would expect to observe a 
plateau similar to oligomer contributions observed with the wt Sgt1.  This hypothesis 
should only remain true if there are no added C-terminal contributions to oligomerisation. 
 
4.6.2. Studying the Sgt1 Mediated Hsp90: Skp1 Binding Interactions Further 
 
Hsp90: Sgt1 binding occurs in a 1:1 interaction between the Sgt1 CS, and Hsp90 ATPase 
binding domain (Fig. 4.13, Zhang et al. 2008).  Probing this interaction may indicate why 
in vivo S. cerevisiae Hsp90: Skp1 interactions are mediated by Sgt1 dimers, whilst the 
human homologue requires only monomeric Sgt1 (Zhang et al. 2008).   
It is still to be shown however if the stable Hsp902Sgt12 oligomer is mediated by 
one or two CS: ATPase domain binding pairs.  Therefore, studying Hsp902Sgt12 using 
MS/MS would permit studies of these interactions.  If a Sgt1 monomer can be successfully 
dissociated from the complex, with an observed Hsp902Sgt1 complex, these data would 
support that a single CS: ATPase pair mediates the Hsp90: Sgt1 interaction.  In contrast, if 
a Sgt1 dimer can be dissociated, with an observed Hsp902 oligomer, this would indicate 
that stable binding requires two CS: ATPase interactions. 
Although the H59A substitution inhibits dimerisation, pull down experiments have 
shown that this protein retains Skp1 binding activity (Willhöft 2013).  As this mutation 
only modifies the homo-dimerisation domain, the Hsp90: Sgt1 interaction should remain 
unaffected.  Therefore, H59A could be used to study if a monomer of Sgt1 is able to stably 
bind the Hsp90 dimer.  If no Hsp90: H59A interactions are observed this interaction would 
support a role of the Sgt1 dimer to promote formation of this Hsp902Sgt12 complex.  In 
contrast, if a single H59A monomer can bind Hsp90 this would allow progression of 
investigations to study the interactions that mediate Hsp90: Skp1 binding further.  If this 
Hsp902H59A complex is unable to allow Skp1 binding, these data may indicate that Sgt1 
dimerisation is a prerequisite to reduce steric clashes between Hsp90 and Skp1.  This 
suggestion is supported by an observed 90˚ rotation between TPRκ monomers upon 
dimerisation (Fig. 4.9). 
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4.6.3. Further Studies of the Potential Secondary TPRκ Binding Interface  
 
Although not directly relevant to the study of the Sgt1 mediated Hsp90: Skp1 interactions, 
a method to analyse the potential secondary binding domain is proposed here.  These data 
would potentially explain the extended oligomerisation behaviour observed during gas 
phase TPRκ analysis. 
Assuming continued concentration dependent oligomerisation, extending the TPRκ 
concentration range above 22.3 μM (at 150 mM AmAc) should promote increased levels of 
the tetramer and other higher order oligomers.  It is proposed that increased intensity 
species would enable analysis of the structural conformations of these oligomers.   
IM data would provide constraints for the computational modelling of TPRκ higher 
order oligomers.  Combining these IM constraints, with the crystal structure of the TPRκ 
binding interface and data presented by Krachler, Sharma & Kleanthous (2010), 
computational Sgt1 TPR models of the end-on of dimerisation can be produced.  
Sequentially these data would confirm or refute the potential end-on stacking interface that 
has been proposed to account for the appearance of higher order TPRκ oligomers including 
tetramers and pentamers.  If models refute the potential of this end-on oligomerisation 
behaviour, this would indicate that the proposed TPRκ C-terminal steric clashes  
(Willhöft 2013) are unable inhibit sequential stacking interactions. 
 
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
159 
 4.7. References 
 
Ali, M.M.U, et al. 2006 “Crystal Structure of an Hsp90-Nucleotide-p23/Sba1 Closed Chaperone Complex,” 
Nature, Vol.440, pp.1013-1017 
Austin, M.J., et al., 2002 “Regulatory Role of SGT1 in Early R Gene-Mediated Plant Defences,” Science, 
Vol.295 pp.2077-2080 
Azevedo, C., 2002 “The RAR1 Interactor SGT1, an Essential Component of R Gene-Triggered Disease 
Resistance,” Science, Vol.295 pp.2073-2076 
Bansal, P.K., Abdulle, R., & Kitagawa, K., 2004 “Sgt1 Associates with Hsp90: an Initial Step of Assembly of 
the Core Kinetochore Complex,” Molecular and Cellular Biology, Vol.24 pp.8069-8079  
Bansal, P., et al., 2009a “Sgt1 Dimerisation is Required for Yeast Kinetochore Assembly,” Journal of 
Biological Chemistry, Vol.284 pp.3585-3592 
Bansal, P., et al. 2009b “Sgt1 Dimerisation is Negatively Regulated by Protein Kinase CK2-Mediated 
Phosphorylation at Ser361,” Journal of Biological Chemistry, Vol.284 pp.18692-18698 
Borkovich, K., et al., 1989 “Hp82 Is an Essential Protein That Is Required in Higher Concentrations for 
Growth of Cells at Higher Temperatures,” Molecular & Cellular Biology, Vol.9 pp.3919-3930 
Brueker, K., McLafferty, F., 2008 “Stepwise Evolution of Protein Native Structure with Electrospray into the 
Gas Phase, 10
-12
 to 10
-2
 s” Publications of the National Academy of Sciences, Vol.105  
pp.18145-18152 
Camahort, R., et al. 2007 “Scm3 is Essential to Recruit the Histone h3 Variant cse4 to Centromeres and to 
Maintain a Functional Kinetochore,” Molecular Cell, Vol.26 pp.853-865 
Catlett, M., & Kaplan, K., 2006 “Sgt1p is a Unique Co-Chaperone that Acts as a Client Adaptor to Link 
Hsp90 to Skp1p,” Journal of Biological Chemistry, Vol.281 pp.33739-33748 
Cho, U., et al. 2011 “Molecular Structures and Interactions in the Yeast Kinetochore,” Cold Spring Harbour 
Symposia on Qualitative Biology, Vol.75 pp.395-401 
Cunningham, C.N., Krukenberg, K.A., & Agard, D.A., 2008 “Intra- and Intermonomer Interactions are 
Required to Synergistically Facilitate ATP Hydrolysis in Hsp90,” Journal of Biological Chemistry, 
Vol.283 pp.21170-21178 
Curtis, R.A., & Lue, L., 2006 “A Molecular Approach to Bioseparations: Protein-Protein and Protein-Salt 
interactions,” Chemical Engineering Science, Vol.61 pp.907-923 
Dollins, D.E., et al., 2007 “Structures of GRP94-Nucleotide Complexes Reveal Mechanistic Differences 
Between the Hsp90 Chaperones,” Molecular Cell, Vol.28 pp.41-56. 
Espelin, C.W., Kaplan, K.B., & Sorger, P.K., 1997 “Probing the Architecture of a Simple Kinetochore Using 
DNA-Protein Crosslinking,” Journal of Cell Biology, Vol.139 pp.1383-1396 
Flom, G., et al. 2006 “Effect of Mutation of the Tetratricopeptide Repeat and Asparatate-Proline 2 Domains 
of Sti1 on Hsp90 Signalling and Interaction in Saccharomyces cerevisiae,” Genetics, Vol.172  
pp.41-51 
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
160 
Gardner, R., et al. 2001 “The Spindle Checkpoint of the Yeast Saccharomyces cerevisiae Requires 
Kinetochore Function and Maps to the CBF3 Domain,” Genetics, Vol.157 pp.1493-1502 
Gasteiger, E., et al. 2005, “Protein Identification and Analysis Tools on the ExPASy Server; (In)” John M. 
Walker (Editor): The Proteomics Protocols Handbook, Humana Press pp.571-607 
Hartl, F.U., Bracher, A., & Hayer-Hartl, M., 2011 “Molecular Chaperones in Protein Folding and 
Proteostasis,” Nature, Vol.475 pp.324-332 
Hirano, T., et al., 1990 “A Repeating Amino Acid Motif in CDC23 Defines a Family of Proteins and a New 
Relationship Among Genes Required for Mitosis and RNA Synthesis,” Cell Vol.60 pp.319-328 
Jäschke, Y., et al. 2011 “Pleiotropic Corepressors Sin3 and Ssn6 Interact with Repressor Opi1 and Negatively 
Regulate Transcription of Genes Required for Phospholipid Biosynthesis in the Yeast 
Saccharomyces cerevisiae,” Molecular Genetics & Genomics, Vol.285 pp.91-100 
Jehn, B., Niedenthal, R., & Hegemann, J.H., 1991 “In Vivo Analysis of the Saccharomyces cerevisiae 
Centromere CDEIII Sequence: Requirements for Mitotic Chromosome Segregation,” Molecular Cell 
Biology, Vol.11 pp.5212-5221 
Jiang, W., Lechner, J., & Carbon, J., 1993 “Isolation and Characterization of a Gene (CBF2) Specifying a 
Protein Component of the Budding Yeast Kinetochore,” Journal of Cell Biology, Vol.121  
pp.513-519 
Johnson, J., 2012 “Evolution and Function of Diverse Hsp90 Homologs and Cochaperone Proteins,” 
Biochimica et Biophysica Acta, Vol.1823 pp.607-613 
Jones, L.J., Haugl, and R.P., & Singer, V.L., 2003 “Proteomic Technologies Product Application Focus 
Development and Characterization of the NanoOrange
®
 Protein Quantitation Assay: A Fluorescence-
Based Assay of Proteins in Solution,” BioTechniques, Vol.34 pp.850-861. 
Kaplan, K.B., Hyman A.A., & Sorger, P.K., 1997 “Regulating the Yeast Kinetochore by Ubiquitin-Dependent 
Degradation and Skp1p-Mediated Phosphorylation,” Cell, Vol.9 pp.491-500 
Kebarle, P., & Verkerk, U., 2009 “Electrospray: From Ions in Solution to Ions in the Gas Phase, What We 
Know,” Mass Spectrometry Reviews, Vol.28 pp.898-917 
Kim, N., et al., 2006 “A New Function of Skp1 in the Mitotic Exit of Budding Yeast Saccharomyces 
cerevisiae,” The Journal of Microbiology, Vol.44 pp.641-648 
Kitagawa, K., et al., 1999 “SGT1 Encodes an Essential Component of the Yeast Kinetochore Assembly 
Pathway and a Novel Subunit of the SCF Ubiquitin Ligase Complex,“ Molecular Cell, Vol.4  
pp.21-33 
Kitagawa, K., & Hieter, P., 2001 “Evolutionary Conservation Between Budding Yeast and Humans 
Kinetochores,” Nature Reviews; Molecular Cell Biology, Vol.2 pp.678-687 
Kitagawa, K., et al. 2003 “Requirement of Skp1-Bub1 Interaction for Kinetochore-Mediated Activation of the 
Spindle Checkpoint,” Molecular Cell, Vol.11 pp.1201-1213 
Krachler, A., Sharma, A., & Kleanthous, C., 2010 “Self-Association of TPR Domains: Lessons Learned from 
a Designed, Consensus-Based TPR Oligomer,” Proteins, Vol.78 pp.2131-2143 
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
161 
Krukenberg, K.A., et al., 2011 “Conformational Dynamics of the Molecular Chaperone Hsp90,” Quarterly 
Reviews of Biophysics, Vol.44 pp.229-225 
Lingelbach, L.B., & Kaplan, K.B., 2004 “The Interaction Between Sgt1p and Skp1p is Regulated by HSP90 
Chaperones and is Required for Proper CBF3,” Molecular and Cellular Biology, Vol.24  
pp.8938-8950 
Lee, Y., et al., 2004 “Humans Sgt1 Binds HSP90 through the CHORD-Sgt1 Domain and not the 
tetratricopeptide repeat domain, “The Journal of Biological Chemistry, Vol.279 pp.16511-16517 
Makhnevych, T., & Houry, W.A., 2012 “The Role of Hsp90 in Protein Complex Assembly,” Biochimica et 
Biophysica Acta, Vol.1823 pp.674-682 
Main, E.R.G., Jackson, S., and Regan, L., 2003 “The Folding and Design of Repeat Proteins: Reaching a 
Consensus” Current Opinion in Structural Biology, Vol.13 pp.482-489 
Main, E.R.G., et al. 2003 “Design of Stable α-Helical Arrays from an Idealized TPR Motif,” Structure, 
Vol.11 pp.497-508 
Mizuguchi, H., et al. 2007 “Scm3 is Essential to Recruit the Histone h3 Variant cse4 to centromeres and to 
Maintain a Functional Kinetochore,” Cell, Vol.129 pp.1153-1164 
Neckers, L., & Workman, P., 2012 “Hsp90 Molecular Chaperone Inhibitors: are we there yet?” Clinical 
Cancer Research, Vol.18 pp.64-76 
Niikura, Y., & Kitagawa, K., 2003 “Identification of a Novel Splice Variant: Humans SGT1B (SUGT1B),” 
DNA Sequence, Vol.14 pp.436-441 
Nyarko, A., et al. 2007 “TPR-Mediated self-association of plant SGT1,” Biochemistry, Vol.46  
pp.11331-11341 
Ortiz, J., 1999 “A Putative Protein Complex Consisting of Ctf19, Mcm21, and Okp1 Represents a Missing 
Link in the Budding Yeast Kinetochore,” Genes & Development, Vol.13 pp.1140-1155 
Pearl, L., & Prodromou, C., 2006 “Structure and Mechanism of the Hsp90 Molecular Chaperone Machinery,” 
Annual Review of Biochemistry, Vol.75 pp.271-294 
Peng, Y., et al. 2011 “Overlapping Kinetochore Targets of CK2 and Aurora B Kinases in Mitotic 
Regulation,” Molecular Biology of the Cell, Vol.22 pp. 2680-2689 
Perriches, T., & Singleton, M.R., 2012 “Structure of Yeast Kinetochore Ndc10 DNA-binding Domain 
Reveals Unexpected Evolutionary Relationship to Tyrosine Recombinases,” Journal of Biological 
Chemistry, Vol.287 pp.5173-5179 
Purvis, A., & Singleton, M.R., 2008 “Insights into Kinetochore-DNA Interactions from the Structure of 
Cep3Delta,” EMBO Reports, Vol.9 pp.56-62 
Richter, K., et al. 2001 “Coordinated ATP Hydrolysis by the Hsp90 Dimer,” Journal of Biological Chemistry, 
Vol.276 pp.33689-33696 
Rodrigo-Brenni, M.C., et al., 2004 “Sgt1p and Skp1p Modulate the Assembly and Turnover of CBF3 
Complexes Required for Proper Kinetochore Function,” Molecular Biology of the Cell, Vol.15 
pp.3366-3378 
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
162 
Russell, I.D., Russell, Grancell, A.S., & Sorger, P.K., 1999 “The Unstable F-box Protein p58-Ctf13 Forms the 
Structural Core of the CBF3 Kinetochore Complex,” Journal of Cell Biology, Vol.145 pp.933-950 
Salbo, R., et al. 2012 “Travelling-Wave Ion Mobility Mass Spectrometry of Protein Complexes: Accurate 
Calibrated Collision Cross-Sections of Human Insulin Oligomers,” Rapid Communications in Mass 
Spectrometry, Vol.26 pp.1181-1193 
Scarff, C., et al., 2008 “Travelling Wave Ion Mobility Mass Spectrometry Studies of Protein Structure 
Biological Significance and Comparison with X-ray Crystallography and Nuclear Magnetic 
Resonance Spectrometry,” Rapid Communications in Mass Spectrometry, Vol.22 pp.3297-3304 
Sikorski, R.S., et al. 1990 “A Repeating Amino Acid Motif in CDC23 Defines a Family of Proteins and a 
New Relationship Among Genes Required for Mitosis and RNA Synthesis,” Cell, Vol.60  
pp.307-317 
Sivalingam, G.N., et al. 2013 “Amphitrite A Program for Processing Travelling Wave Ion Mobility Mass 
Spectrometry Data” International Journal of Mass Spectrometry Special Edition, Vol.345-347  
pp.54-62 
Spiechowicz, M., et al., 2007 “Hsp70 is a New Target of Sgt1—An Interaction Modulated by S100A6,” 
Biochemical and Biophysical Research Communications, Vol.357 pp.1148-1153 
Stemmann, O., et al. 2002 “Hsp90 Enables Ctf13p/Skp1p to Nucleate the Budding Yeast Kinetochore,” 
Proceedings of the National Academy of Sciences, Vol.99 pp.8585-8590 
Sun, J., et al., 2007 “Method for identifying nonspecific protein-protein interactions in nanoelectrospray 
ionization mass spectrometry,” Analytical Chemistry, Vol.79 pp.8301-8311 
Taipale, M., et al., 2012 “Qualitative analysis of HSP90-client interactions reveals principles of substrate 
recognition,” Cell, Vol.150 pp.987-1001 
Vaughan, C., et al., 2006 “Structure of an Hsp90-Cdc37-Cdk4 complex,” Molecular Cell, Vol.23 pp.697-707 
Vaughan, C., et al., 2009 “A Common Conformationally Coupled ATPase Mechanism for Yeast and Humans 
Cytoplasmic HSP90s,” The FEBS Journal, Vol.276 pp.199-209 
Verghese, J., 2012 “Biology of the Heat Shock Response and Protein Chaperones: Budding Yeast 
(Saccharomyces cerevisiae) as a Model System,” Microbiology and Molecular Biology Reviews, 
Vol.76 pp.115-158 
Westermann, S., Drubin, D., & Barnes, G., 2007 “Structures and Functions of Yeast Kinetochore 
Complexes,” Annual Review of Biochemistry, Vol.76 pp.563-591 
Willhöft, O., 2012, Discussion Regarding the Oligomerisation of the Hsp90:Sgt1 wild type Oligomerisation 
Study, Including Theoretical Masses and Approximate Kd values, [Email] (Personal Communication 
24
th
 May 2012) 
Willhöft, O., 2013 “Structural and Biophysical Characterisation of Sgt1, an Essential Component in the 
Assembly of the Yeast Kinetochore,” Ph.D. Birkbeck College, University of London 
Willhöft, O., et al. In Preparation “Linking Hsp90 to E3 Ubiquitin Ligases and Kinetochore Assembly: 
Structure of the Sgt1-Skp1 Complex”  
4. Analysis of the Sgt1 Dimerisation Domain, Required for Yeast Kinetochore Assembly 
 
163 
Yoshida, Y., Murakami, A., Tanaka, K., 2011 “Skp1 Stabilizes the Conformation of F-Box Proteins,” 
Biochemical and Biophysical Research Communications, Vol.410 pp.24-28 
Zabka, M., et al., 2008 “Sgt1 has Co-Chaperone Properties and is Up-Regulated by Heat Shock,” 
Biochemical and Biophysical Research Communications, Vol.370 pp.179-183 
Zeytuni, N., & Zarivach, R., 2012 “Structural and Functional Discussion of the Tetra-Trico-Peptide Repeat, a 
Protein Interaction Module,” Structure, vol.20 pp.397-405  
Zhang, M., et al. 2008 “Structural and Functional Coupling of Hsp90- and Sgt1-Centred Multi-Protein 
Complexes,” EMBO Journal, Vol.27 pp.2789-2798 
Zhang, M., et al., 2010 “Structural Basis for Assembly of Hsp90-Sgt1-CHORD Protein Complexes: 
Implications for Chaperoning of NLR Innate Immunity Receptors,” Molecular Cell, Vol.39  
pp.269-281 
5. Analysis of CbpA’s Structure and DNA Binding Interactions 
 
164 
5. Analysis of CbpA’s Structure and DNA Binding Interactions 
-------------------------------------------------------------------------------------------------------------- 
 
The Escherichia coli DNA binding protein CbpA promotes chromosome compaction 
during the stationary cell cycle phase, and cellular phosphate starvation events, forming 
aggregates exceeding 60 nm.  The organisation of CbpA and DNA within these aggregates 
is currently unsolved.  Native mass spectrometry has been applied here to study these 
CbpA-DNA interactions. Although unsuccessful in our attempts to observe these 
interactions using native mass spectrometry, these studies support that the buffers required 
for electrospray ionization are suitable for CbpA-DNA binding.  Using IM-MS, we have 
additionally provided gas-phase constraints for computational modelling of the biologically 
relevant DNA binding CbpA dimer.   
 
5.1.1. CbpA Structure and Expression  
 
 
Figure 5.1. Domains of CbpA 
Consistent with all type II J-domain proteins CbpA contains three domains: DnaK binding J-domain (red, 
amino acids 1-75), DNA binding CTD I (blue, amino acids 118-201) and CTD II (yellow,  
amino acids 202-306) that promotes dimerisation (Bird et al. 2006, and Cosgriff et al. 2010).    
 
The Escherichia coli nucleoid associated DNA storage, and chaperone protein, CbpA 
(Curved binding protein A) (Uniprot ID; P36659, 34.5 kDa, 306 amino acids), is a type II 
J-domain protein (Fig. 5.1) observed in solution as a mixture of monomers and dimers 
(Bird et al. 2006, and Cosgriff et al. 2010).  Currently, no complete structure of CbpA has 
been solved using high-resolution structural techniques (e.g. NMR or X-ray 
crystallography), with only a partial NMR structure of the J-domain available (PDBe file; 
2KQX, amino acids 2-72) (Sarraf et al. 2010).  Other investigations have applied sequence 
alignments to produce homology models, including Bird and co-workers (2006) (Fig. 5.2).  
Excluding a model of the CTD II dimerisation domain by Cosgriff and co-workers (2010) 
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(Fig. 5.3), a complete model of the CbpA dimer required for DNA binding has not yet been 
solved.   
 
 
Figure 5.2. Sequence Alignment Based Model of CbpA 
Model developed using Swiss Model (Schwede et al. 2003) alignment against several J-domain proteins for 
the N terminal region, and the S. cerevisiae Hsp40 protein, Sis1, for CTD I and II alignment.  No structural 
homologues are known to exist for the proposed ‘flexible’ linker region (amino acids 76-117) (Bird et al. 
2006).  It is this linker region in addition with CTD I that represent the known DNA binding domain 
(Cosgriff et al. 2010). 
Figure reproduced from Bird et al. 2006 
 
The operon cbpA is under the control of σS (Yamashino et al. 1994) and Lrp 
(Chenoweth & Wickner 2008).  Both σS and Lrp are controlled by a σ38-associated RNA 
polymerase.  Expression of CbpA during the late growth to stationary phase occurs under 
the control of the σS operon (Yamashino et al. 1994).  σS promoted expression results in the 
translation of an estimated 3 000 to 15 000 copies of CbpA, per cell (Azam et al. 1999, 
Chae et al. 2004, and Cosgriff et al. 2010), equating to ~3 % of the overall cellular protein 
population during the stationary phase (Gur, Katz & Ron 2005).  Upon expression, CbpA 
rapidly (2 to 5 minutes) binds DNA, promoting chromosome compaction (Cosgriff et al. 
2010).   
Upregulated translation of cbpA by Lrp occurs during amino acid and phosphate 
starvation conditions, arresting the cell cycle through chromosome compaction events 
(Chenoweth & Wickner 2008, Wegrzyn et al. 1996, and Yamashino et al. 1994).  Whilst 
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Lrp promotes upstream of σS, it remains dependent on the latter to enable transcription. 
This is in line with the broad induction behaviour of Lrp, which can promote the translation 
of ~10 % of all E. coli genes (Tani et al. 2002). In strict contrast to Lrp, the σS is able to 
promote transcription independently of Lrp (Chenoweth & Wickner 2008).   
 
 
Figure 5.3. Model of the CbpA CTD II 
Dimerisation Interface 
a) Structural model of the CbpA CTD II only 
dimer, with the component monomers shown in 
yellow and green respectively.   
b) Dimerisation is stabilised by two sets of 
complementary L290-W287 interactions between 
neighbouring monomers (Cosgriff et al. 2010). 
Figure reproduced and adapted from Cosgriff et al. 2010 
 
5.1.2. Binding of DNA by CbpA  
 
The first observations of CbpA-DNA binding interactions were made by Ueguchi and co-
workers (1994), whereby CbpA was shown to bind preferentially to curved dsDNA  
(double stranded DNA).  Subsequent work has shown that the DNA binding activity of 
CbpA is sequence non-specific, as super compaction of plasmid DNA by CbpA prevents 
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nuclease degradation by DNAase I.  In contrast, sequence specific binding proteins do not 
regulate these degradation events (Cosgriff et al. 2010).   
Upon formation of CbpA dimers, DNA binding is stabilised by the CTD I, with 
additional contributions from the linker domain (Bird et al. 2006, and Cosgriff et al. 2010).  
These binding events occur in a strongly co-operative manner, whereby once one CbpA 
dimer has bound DNA this promotes further proteins to bind the same length of DNA 
(Azam & Ishihama 1999).  Due to this positive feedback mechanism of binding, CbpA is 
able to rapidly (2 to 5 minutes) produce aggregates of 60 nm in diameter (Fig. 5.4) 
(Cosgriff et al. 2010).  
 
 
Figure 5.4. Atomic Force Microscopy Analysis of 
CbpA in the Presence of Plasmid DNA 
a) AFM analysis of a 1.4 x 1.4 μm region of mica 
surface incubated in the presence of plasmid DNA, 
both with and without CbpA (Control = Plasmid 
only).  In the presence of protein, an observed level 
of protein-DNA aggregation is observed.   
b) Zooming in on a single aggregate, allows direct 
comparison of the aggregate against the control.  
Data indicates that the aggregate may contain more 
than one plasmid. Component concentrations: 
CbpA 100 nM, Plasmid DNA 20 ng (Cosgriff et al. 
2010). 
Figure reproduced and adapted from Cosgriff et al. 2010 
 
The characteristics of CbpA promoted DNA compaction are similar to the protein 
Dps (DNA protection during starvation).  Dps bends the nucleotide backbone to bridge 
distant loci promoting genome super-compaction (Browning et al. 2010, and Dame et al. 
2011).  Both CbpA and Dps share similar roles in protecting DNA during the stationary 
phase.  This is in addition to protective roles in acidic stress and phosphate/nucleotide 
starvation condition responses.  Similarly, organisation of both CbpA and Dps within these 
protein-DNA aggregates remains unsolved. 
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5.1.2.1. Comparative Binding of E. coli DNA by Dps  
 
Dps (Uniprot ID; P0ABT2, 18.7 kDa, 167 amino acids) expression is strongly upregulated 
during the stationary phase, exhibiting the highest copy number of any nucleoid protein 
during this time (up to 100 000 copies) (Cosgriff et al. 2010).  This is consistent with 
observations outlining the pre-requisite for Dps in bacterial chromosome compaction 
during this time point of the cell cycle (Wolf et al. 1999).  
Expression of the dps operon is controlled by a σ70-associated RNA polymerase 
(Grainger et al. 2008).  Once translated, Dps binds DNA non-sequence specifically, with 
uniform aggregate distribution and nucleoid biocrystallization (Wolf et al. 1999).  Down 
regulation of Dps by Fis and H-NS selectively mediates expression, either directly at the 
dps operon (Fis), or indirectly through inhibition of the promoter (H-NS) (Grainger et al. 
2008). 
Dps expression is further upregulated in response to a range of stress conditions: 
phosphate starvation (Almirón et al. 1992), high pressure, UV and gamma irradiation 
(Calhoun & Kwon 2011, and Zeth 2012).  These expressions protect DNA through binding 
events, and are able to inhibit the deleterious effects of fenton-mediated oxidation
32
 by 
trapping hydroxyl ions (Bellapadrona et al. 2010).  This is in addition to protection of DNA 
during acid stress conditions, which if unchecked can promote strand breakage (Jeong et al. 
2008).   
Azam & Ishihama (1999) have previously compared the DNA binding activity of 
Dps and CbpA.  Their results showed that Dps binds without preference to curved and 
linear DNA sequences (Kd = 172 nM and 178 nM respectively). In contrast, CbpA 
preferentially binds curved DNA at a Kd of 122 nM (linear DNA 175 nM)  
(Azam & Ishihama 1999).  These data indicate that in the presence of curved DNA, CbpA 
is able to bind more rapidly than Dps, with no observable differences in the presence of 
linear DNA.  
                                                 
32
 H2O2 + Fe
2+
 source, that produces a pool of ·OH & ·OOH free radicals 
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5.1.3. The Chaperone Protein DnaK and its Interactions with J-Domain Proteins 
 
In addition to promoting compaction of the cellular genome, CbpA is able to function as a 
DnaK co-chaperone.  The chaperone protein DnaK (Uniprot ID; P0A6Y8, 69.1 kDa,  
638 amino acids) is one of three E. coli Hsp70 (Heat shock protein 70 kDa) class proteins 
(Chae et al. 2004, and Ogata et al. 1996).  DnaK contains two domains, a nucleotide 
binding domain with ATPase activity (amino acids 1-370), and a C-terminal substrate 
binding domain (amino acids 390-600) (Bertelsen et al. 2009). Hydrolysis of ATP 
promotes conformational changes on the C-terminal substrate-binding domain opening a 
‘lid’ segment that enhances DnaK chaperone activity.  Chaperone binding at the  
C-terminus strongly promotes further ATPase activity in the N-terminus (Bertelsen et al. 
2009, and Srinivasan et al. 2012). 
  Within the heat shock response, DnaK binds to a variety of proteins in an ATP 
dependent manner (Bird et al. 2006).  These interactions include binding of DnaK to DNA 
Gyrase to protect cellular DNA under thermal stress conditions.  Ogata and co-workers 
(1996) proposed a model of protein expression to tackle the effects of heat shock through 
the regulation of DNA supercoiling. During heat shock, topoisomerase I and DNA Gyrase 
function together to relax super coiled DNA.  This relaxation induces the expression of 
proteins that are required to respond to, and tackle the effects of heat shock.  This relaxation 
promotes the induction of DnaK that interacts with DNA Gyrase to enhance the negative 
supercoiling of DNA preventing further transcription events (Ogata et al. 1996).  
DnaK interacts with three J-domain containing proteins
33
 to modulate stress 
responses: DnaJ, CbpA, and DjlA (Chae et al. 2004, and Sarraf et al. 2010).   J-domain 
proteins are classified into one of three groups (I, II and III).  Members of all three of these 
classes encode a ~75 amino acid J-domain that allows them to bind Hsp70 class proteins, 
stimulating their ATPase activity (Bird et al. 2006, and Sarraf et al. 2010).  In addition to 
this J-domain, Type I proteins are further classified by their phenylalanine rich region, 
cysteine rich zinc finger domain, and two similarly folded CTDs.  Unlike the type II and 
III, type I J-domain proteins are able to function independently of Hsp70 during heat shock.   
In contrast, Type II J-domain proteins, such as CbpA, lack the Zn finger domain indicative 
                                                 
33
 E. coli expresses a total of six J-domain containing proteins (Patury et al. 2009).   
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of the type I and are unable to prevent aggregation of non-native substrates in the absence 
of a co-chaperone (Bird et al. 2006, and Walsh et al. 2004).  Type-III proteins encode only 
the J-domain (Bird et al. 2006). 
 
5.1.3.1. DnaK: DnaJ Interactions 
 
DnaJ (Uniprot ID; C4ZPU1, 41.1 kDa, 376 amino acids) is an Hsp40 class protein, required 
to regulate E. coli Hsp70 homologues, including DnaK (Walsh et al. 2004).   
Peptide sequence analysis has shown that the binding site of 95 % of DnaK binding 
proteins overlap with DnaJ (Srinivasan et al. 2012).  One such example of these 
interactions is the co-operative binding between ClpB, DnaJ and DnaK.  Upon formation, 
this complex is able to disaggregate in the region of 250 proteins, sequentially promoting 
their correct refold.  DnaJ complexes such as these promote the recognition of 
conformational unfolding characteristics, and are critical to responses requiring the 
identification of a diverse range of substrates (Ballet et al. 2012, and Mogk et al. 1999) 
accelerating their refolding pathway (Srinivasan et al. 2012).   
 
5.1.3.2. DnaK: CbpA Interactions 
 
CbpA binds to DnaK to act as a co-chaperone in response to stress conditions including low 
pH (Tucker, Tucker & Conway 2002). Expression under these stress conditions is 
controlled by an unidentified operon.  CbpA subsequently promotes refolding of 
cytoplasmic proteins compatible with its DnaJ like refolding activity (Tucker, Tucker & 
Conway 2002).   
Observations made using cbpA deletion mutants have shown no influence on E. coli 
growth.  In contrast, dnaJ knockout mutants lead to strains that can be characterised by the 
inability to grow below 16 °C, or above 37 °C (Ueguchi et al. 1995).  Combined,  
dnaJ cbpA, double deletion mutants are unable to undergo either cell growth or division at 
permissive temperatures, similar to strains with dnaK deletions.  Insertion of a multicopy 
cbpA containing plasmid into these double deletion mutants effectively restores DnaK 
functionality enabling cell growth and division (Chenoweth, Trun & Wickner 2007, and 
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Ueguchi et al. 1995).  This indicates that in a DnaJ knockout strain, CbpA is able to act as a 
functional homologue essential for cell growth and division (Chenoweth, Trun & Wickner 
2007, and Ueguchi et al. 1995).  
 
5.1.4. The CbpA Modulator Protein: CbpM  
 
The E. coli modulator protein CbpM (Uniprot ID; P63264, 11.5 kDa, 101 amino acids) is a 
regulatory protein that inhibits with high specificity the co-chaperone and DNA binding 
activities of CbpA (Chae et al. 2004, and Chenoweth et al. 2007).   
Both the σS and Lrp operons that contain cbpA additionally encode the CbpA 
regulatory protein CbpM through the downstream (3’ end) cbpM (Synonym; yccD)  
(Chae et al. 2004, and Chenoweth & Wickner 2008).  This combined cbpAM operon is 
strongly conserved across all γ-proteobacteria (Chintakayala & Grainger 2011).   
Co-expression results in similar transcription and translation levels, promoting 
complementary cellular concentrations (Chenoweth & Wickner 2008). Work by other 
individuals has additionally shown that CbpA is required to maintain the stability of CbpM; 
otherwise, it is rapidly degraded by the Lon and ClpP proteases expressed under the σ32 
response factor
34
 (Chenoweth & Wickner 2008, and Meyer & Baker 2011).   
CbpM binds 1:1 to the CbpA J-domain (Bird et al. 2006, and Chae et al. 2004).  
Recent data presented by Chintakayala & Grainger (2011) has shown, using mutagenesis 
techniques, that this interaction is stabilised by a H33-E62 interaction between CbpA and 
CbpM respectively.  Substitutions of CbpA R26E and R30E have been additionally shown 
to disrupt the CbpM binding activity (Chintakayala & Grainger 2011).  As well as 
modifying CbpM binding, these R26E and R30E substitutions reduce CbpA dimerisation 
two fold.  This observation is inconsistent with the known CbpA dimerisation domain  
(CTD II) that occurs at the direct C-terminal opposite to these two mutations.  Therefore, 
the authors (Chintakayala & Grainger 2011) concluded that a level of structural regulation 
occurs between the two domains. 
In addition to inhibiting CbpA-DNA interactions through the CTD I domain, 
binding by CbpM also prevents the binding of DnaK.  This inhibition results from 
                                                 
34
 This σ32 response factor additionally regulates the expression of DnaK and DnaJ (Meyer & Baker 2011). 
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competitive interactions at the shared binding domain (Sarraf et al. 2010).  Subsequently, 
CbpM is able to regulate all forms of CbpA-ligand/co-chaperone activity (Chae et al. 2004, 
and Chenoweth et al. 2007) (Fig. 5.5).  How the CbpA binding activity of CbpM is 
regulated, modifying observed levels of DnaK/DNA binding has yet to be determined.  
 
 
Figure 5.5.  Regulation of CbpA Binding Activity by CbpM 
a)  CbpA: DnaK binding is mediated through the CbpA J-domain (J), stimulating the intrinsic ATPase 
activity of the DnaK.  b) Binding of CbpM to the J domain however, inhibits DnaK and DNA binding 
interactions.  c) Binding of DNA to the dimeric CbpA CTD I domain promotes the rapid formation of 
protein-DNA aggregation, further inhibiting co-chaperone-binding function (Chae et al. 2004, and  
Cosgriff et al. 2010).  Image not to scale, or indicative of the size and structure of CbpM and DnaK. DNA  
PDB ID; 3BSE. 
 
5.2. Experimental Aims and Objectives 
 
The first gas phase observations of native dsDNA using ESI were performed by  
Light-Wahl and co-workers (1993).  These observations were completed using a 20 bp 
length of dsDNA, and negative mode ionisation.  Using negative mode micro-ESI Cheng 
and co-workers (1996) would expand on these observations presenting the first application 
of mass spectrometry to observe intact protein-DNA oligomers of the f1 bacteriophage 
Gene V protein and a 15 base complex of ssDNA (single strand DNA).  Since these early 
experiments, mass spectrometry has been applied to the study of proteins that bind ssDNA 
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(Cheng et al. 1996), dsDNA (Arbely et al. 2011), and RNA (Basnak et al. 2010) constructs, 
all of varying length.  Studies such as these have been completed using proteins that bind 
specifically to specific amino acid sequences, and structures (Basnak et al. 2010, and  
Xu et al. 1999).  Both positive (Atmanene et al. 2010) and negative methods of ionisation  
(Cheng et al. 1996), as well as conformational studies using IM-MS (Atmanene et al. 2010) 
have been applied to complete these studies.  
Despite studies of aggregating proteins and protein-DNA interactions now 
widespread,
35
 research on systems combining both these characteristics, i.e. aggregating 
DNA binding proteins, using mass spectrometry based methods has not been currently cited 
within the literature.  Successful development of a method to allow the investigator to 
probe these interactions would therefore present a promising new direction within the fields 
of mass spectrometry and IM-MS. 
Investigations recently performed by Cosgriff and co-workers (2010) using atomic 
force microscopy (AFM) have shown that the E. coli nucleoid protein, CbpA, readily 
aggregates non-specifically on both linear, and plasmid DNA.  Incubations of plasmid 
DNA and CbpA have been shown to produce protein-DNA aggregates that exceeded 60 nm 
in diameter (Fig. 5.4).  The conformation of CbpA within these aggregates and the 
oligomerisation pathway that promotes their formation remains currently unidentified.  
Therefore, work presented here has targeted the study CbpA binding events using a number 
dsDNA constructs of varying lengths.  Initial experiments will apply native mass 
spectrometry to optimise the conditions required to observe CbpA-DNA oligomers.  These 
optimised conditions would sequentially allow the study of conformational changes 
exhibited by these oligomers using IM-MS. 
Of further scientific interest are the interactions between CbpA and CbpM known to 
regulate the DNA and co-chaperone binding activity of the former.  Although the binding 
interface supports a 1:1 interaction, the exact stoichiometry of this oligomer in addition to 
the influence of CbpM on the dimeric state of CbpA is not conclusively understood.   
Recent work by Chintakayala and Grainger (2011) has indicated a potential mode of 
J-domain regulation of the oligomeric state.  Substitutions of amino acids required for 
                                                 
35
 For a larger overarching review on the topic of aggregating protein studies by mass spectrometry the author 
directs the reader to the following review, Ashcroft (2010). 
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CbpM binding (R26E and R30E) additionally reduced the levels of observed CbpA dimers.  
Using mass spectrometry and MS/MS, in both the presence and absence of CbpM, the 
stability and organisation of CbpA dimers would be studied using a number of dimerisation 
domain mutants.  These mutations include the hypothesised increased dimerisation affinity 
mutants, L224A and M275A, and reduced affinity mutants, P219A and L286A. 
 
5.2.1. Average CCS Values for Computational Restraints  
 
IM-MS wave speed and amplitude conditions have been clustered according to their 
calibration curve R
2
 values.
36
  These clustered calibrations have been subsequently applied 
to produce an average CCS for the biologically relevant CbpA dimer.  This average CCS 
has been subsequently used by Harpal Sahota to apply constraints to computational models 
of the CbpA dimer.  A brief over-view of the methods applied to complete this work are 
outlined below, and excluding any mention of the IM-MS calculated CCS values is a 
representation of work being performed by Harpal Sahota, under the primary supervision of 
Dr. Maya Topf (Sahota Personal Communication 2013). 
The initial step in construction of the computational structure is the production of a 
homology alignment model.  This model simulates the protein at the atomic level, using 
alignments of identified homologous structures.  Identified PDB homologies are 2KQK, an 
NMR derived structure of the CbpA J-domain, and 3LZ8, which exhibits an 84 % sequence 
identity to the two CTDs. 
For sequences lacking identified homologous structures, such as the linker region 
(amino acids 76-117), I-Tasser (Roy, Kucukural & Zhang 2010) is applied for Ab-initio 
modelling methods.  Using I-Tasser, several secondary structure elements have been 
identified within the linker region and cross-correlated with other structure prediction 
methods, including, Psi-Pred (Jones 1999) and RaptorX (Peng & Xu 2011).  This cross-
comparison has indicated the presence of a potential helical structure toward the C-terminal 
end of the linker domain. 
                                                 
36
 The R
2
 value provides a measure of how well calibrant ions fit the power fit curve used to calculate the 
CCS of the unknown analyte.   
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After cross-correlation of identified linker region structures, the programs Modeller 
(Eswar et al. 2006) and I-Tasser were applied to refine the known and predicted structural 
elements of CbpA.  These methods have resulted in the production of 176 different models.  
Modeller and Chimera (Pettersen et al. 2004) were subsequently applied to refine these 176 
models, removing structures with sub-optimised backbone arrangement and/or steric 
clashes.  The remaining 114 models are currently being compared against the average 
experimental CCS value of the lowest charged dimer +15 ion, using the PA and EHSS 
methods, data forthcoming (Sahota et al. In Preparation). 
 
5.3. Materials and Methods 
5.3.1. Molecular Biology, Preparation, and Purification of CbpA 
 
All CbpA protein samples were purified by the Grainger research group, prior to buffer 
exchange and mass spectrometric analysis protocols, using the methods outlined below. 
cDNA fragments encoding CbpA were cloned into the vector pET21a and 
sequentially transfected into E. coli T7 express cells (New England Biolabs, MA, USA).  
Vector containing cultures were incubated at 37 ˚C to an OD650 of ~0.5 nm.  At this OD650 
value, over expression of CbpA was induced using IPTG, with incubation continuing for 
one hour prior to harvest.  
Post cell fraction recovery and lysis, pooled samples were purified using two 
chromatography steps: NaCl gradient over a HiTrap Heparin Sepharose column (> 95 % 
purity), and HiTrap QFF column (> 99 % purity). All columns purchased from GE 
Healthcare Life Sciences (Buckinghamshire, UK).   
Samples were supplied in the following final elution buffer: 20 mM Tris, 1 mM 
EDTA, 100 mM NaCl (pH 7.5).  Please note that for long term sample storage at -80 ˚C, 
certain samples contained an additional 10 % glycerol content.  Glycerol containing 
samples were dialysed using 6-8 kDa MWCO dialysis tubing (Spectrum Labs, 
Netherlands), immersed in 100 mM AmAc (pH 7.5) at 4 ˚C for 16 hours.  To ensure rapid 
solution equilibrium, samples were gently agitated over the time course using a magnetic 
stirrer. 
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5.3.1.1. De Novo DNA Construct Design  
 
De novo dsDNA constructs were optimised to minimise secondary structure elements and 
miss-aligned dimerisation between complementary forward and reverse ssDNA oligomers 
using OligoAnalyser v3.1 (Owczarzy et al. 2008).  These designed de novo ssDNA 
oligomers additionally encoded 2 to 3 GC bases at both the 5’ and 3’ end of the sequence to 
stabilise the dsDNA structure.   
Optimised dsDNA Tm (melting temperature) values were calculated using 
OligoCalc (Kibbe 2007).  Design refinements ensured that the Tm of correctly aligned 
dsDNA forward/reverse complementary sequences exceeded, by at least 10 ˚C, those of any 
stable secondary structural elements. 
 
5.3.2. Purification and Preparation of CbpA 
 
Prior to analysis using mass spectrometric methods, samples were buffer exchanged using a 
single Micro Bio-Spin column (BioRad, Hertfordshire, UK), and three sequential washes 
using a single Amicon 1.5 ml 10 kDa MWCO centrifugal concentrator column (Millipore, 
Dundee, UK).  If required, up to an additional two washes using a single Amicon 
centrifugal concentrator column were applied to improve mass spectra peak separation.  All 
columns were prepared using the experimental concentration of AmAc at pH 7.5. 
Buffer exchanged homogeneous samples were measured using the Qubit 2.0 
fluorometer (Invitrogen, Paisley, UK), with a 1 in 100 dilution of sample to running buffer.  
In contrast, heterogeneous CbpA-DNA samples were measured using serial dilution 
Nanodrop 1000 (Thermo-Scientific, DE, USA) analysis.  Extinction coefficients (table 5.1) 
were applied to correct Nanodrop 1000 mg/ml values.  Using the corrected mg/ml values, 
sample molarity was calculated using the experimentally calculated mass (from denatured 
protein mass analysis) (table 5.1) of the CbpA dimer. 
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5.3.2.1. Purification and Preparation of DNA Constructs 
 
Complementary forward and reverse ssDNA oligomers were purchased from Integrated 
DNA Technologies (IA, USA).  Prior to buffer exchange and annealing, forward and 
reverse ssDNA complements were mixed in equal molar ratios to minimise unbound 
ssDNA.  DNA buffer exchange utilised a modified version of the ethanol-sodium acetate 
precipitation method, replacing sodium cations with a source of ammonium ions (AmAc) 
more suitable for native ESI analysis.  This method, outlined below, was repeated three 
times to improve sample purity: 
1. DNA sample diluted with 0.1x volume of 7.5 M AmAc. 
2. DNA sample diluted with 2x volume of 100 % ethanol, and gently mixed. 
3. Sample centrifuged for 15 minutes at 12 000 g. 
4. Residual buffer discarded using a pipette. 
5. DNA pellet rinsed with 150 μL 70 % ethanol. 
6. Residual ethanol removed by evaporation. 
7. DNA pellet resuspended in a suitable volume of AmAc buffer. 
If required, an additional Amicon 1.5 ml 10 kDa MWCO centrifugal concentrator column 
(Millipore, Dundee, UK) was used after annealing the complementary ssDNA constructs to 
improve mass spectra peak separation. 
Diluted complementary ssDNA constructs were annealed using a Grant 
(Cambridge, UK) BTD dry block heating system, and the following incubation method:   
1. Diluted DNA sample incubated for ten minutes, at 2-5 ˚C above the calculated 
dsDNA Tm to ensure dissociation of all secondary structure elements.   
2. Incubation temperature dropped to 2-5 ˚C below the dsDNA Tm (ensuring this still 
exceeded undesirable secondary structure Tm).  
3. Incubation continued for ten minutes allowing complementary strands to anneal.   
4. Incubation temperature dropped by a further 5 ˚C. 
5. Incubation continued for ten minutes.  
6. Incubation returned to room temperature prior to measuring sample concentration. 
Tm values of dsDNA constructs were calculated using OligoCalc (Kibbe 2007) 
adjusted to the ionic strength of the buffer.  Post annealing of the forward and reverse 
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compliments, dsDNA sample concentration was measured using the Qubit 2.0 fluorometer 
(Invitrogen, Paisley, UK), and the theoretical mass values of the designed constructs  
(table 5.1).   
 
5.3.3. Ion Mobility Analysis of CbpA 
 
The following conditions are relevant to the work performed in section 5.4.1.  IM data 
acquisitions were performed using a broad range of TriWave mobility separator wave 
amplitude and velocity conditions.  Samples were buffer exchanged into 150 mM AmAc 
(pH 7.5) and diluted to 8 μM.  Wave amplitude conditions were acquired over a range of  
8 to 12 V in increments of 1 V.  These conditions were compared over a range of wave 
velocity values between 200 to 400 m/s, in increments of 50 m/s.  Combination of these 
values resulted in 25 analytical conditions. 
Calibration of the experimental tD values, to produce relevant CCS, was performed 
using the method outlined in section 2.2.  Denatured Equine myoglobin, native BSA and  
S. cerevisiae ADH (Sigma-Aldrich Ltd, Dorset, UK) were used as the CCS calibrants.  
Clustering of power fit calibration curve R
2
 values was applied to optimise the calculated 
average CCS values. 
Additional instrumental values for mass spectrometric analysis were: capillary  
voltage; 0.9 to 1.5 kV, nanoflow pressure; 0.00 to 0.5 Bar, sampling cone; 80 V, extraction  
cone; 1 V, source temperature; 40 ˚C, Trap collision; 10 V, transfer collision; 10 V,  
Trap DC bias; 20 V, Trap gas; 5 ml/min, IM separator gas flow; 20 ml/min.  Instrumental 
pressures: source backing; 6 mBar, Trap; 0.04 mBar, mobility separator; 0.52 mBar,  
ToF; 2x10
-6
 mBar.  The m/z range utilised for sample analysis was 1 000 to 16 000, over 
two minutes using two second scans. 
 
5.3.4. DNA Electrophoretic Mobility Shift Assay of CbpA-DNA Samples 
 
DNA gel-electrophoretic mobility shift assays (EMSA) analysis was performed using pre-
cast 6 % DNA retardation gels (Invitrogen, Paisley, UK), and 0.5 x Tris-Borate-EDTA 
buffer.  Prior to loading of sample onto the gel, incubations of CbpA: DNA were diluted 
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using 10 % glycerol.  Samples were measure against 100 bp DNA ladder (New England 
Biolabs, MA, USA), and control DNA samples.  Empty lanes were loaded with a 10 % 
glycerol solution diluted with doubly deionised H2O.  All samples were loaded onto the gel 
to a final volume of 15 μL. 
Electrophoretic separation was performed at 100 V 15 mA for 90 minutes.  To 
resolve DNA bands, the gel was soaked in a dilute ethidium bromide solution  
(< 0.1 mg/ml) for two hours.  Gel bands were resolved under UV light and photographed 
using the BioDoc-It imaging system (UVP, CA, USA). 
 
5.4. Results 
5.4.1. Control CbpA Analysis 
 
In solution, CbpA exists as a mixture of monomers and dimers (Cosgriff et al. 2010).  As a 
precursor to DNA and IM-MS analysis, control spectra were acquired to confirm the gas 
phase oligomeric state (Fig. 5.6).  This is in addition to the denatured protein mass analysis 
used to determine the experimental CbpA mass for molarity calculations (data not shown).  
Comparison of the CbpA theoretical and experimental mass values has shown a good 
agreement between both, with a mass loss of 30 Da (table 5.1).  The presence of phosphate 
bound cations is proposed to account for the DNA mass differences observed. 
Native CbpA mass analysis agrees with previous data indicating that the 
predominant CbpA oligomer is the dimer with observed levels of monomeric species.  
Unexpectedly tetramer and pentamer oligomers, not previously reported in the literature, 
were observed at high and low experimental concentrations (8 and 20 μM) (Fig. 5.6 a and b 
respectively).  Comparison of all control spectra acquired over this concentration range 
indicates no evidence of CbpA trimers.
37
  Including the effect of non-specific gas phase 
oligomerisation to promote the observed higher order oligomers, the lack of observed gas-
phase trimer is interesting and may highlight a potential oligomerisation pathway.   
 
  
                                                 
37
 Trimer (103.3 kDa) predicted to appear between +25 and +19 (4132 to 5436 m/z) using globular protein 
charge predictors (Kebarle & Verkerk 2009), and comparison with previously observed CSD for all other 
identified oligomers. 
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Figure 5.6. Control Mass 
Spectra of CbpA Showing 
Previously Unidentified 
Oligomers 
Control spectra of CbpA at  
150 mM AmAc pH 7.5, at  
(a) 8 μM and (b) 20 μM.  CbpA 
oligomers observed: monomer 
(purple), dimer (blue), tetramer 
(green), and pentamer (pink). 
 
Table 5.1. Theoretical and Experimentally Calculated Masses of CbpA, and DNA 
Constructs 
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CbpA N/A None 44 920 34 455 34 426.16 0.92 -29.84 
50[50] 50 N/A N/A 30 781 30 838.29 20.39 +57.29 
B100 100 N/A N/A 61 824.02 63 111.32 33.7 +1 287.3 
SOA 60 N/A N/A 37 102.14 37 391.27 41.65 +289.13 
SOB 64 N/A N/A 39 579.62 39 831.64 48.41 +252.02 
DNA masses represent values obtained from the mass spectra with the lowest Δm at FWHM, in the presence 
of AmAc.   
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5.4.1.1. R
2
 Clustered Ion Mobility Analysis of CbpA  
 
Currently no complete structures of either the CbpA monomer or DNA binding dimer have 
been produced.  Applying IM derived CCS constraints, attempts were to be made by Harpal 
Sahota to produce a computational model of the biologically relevant DNA binding CbpA 
dimer using the methods previously detailed above (section 5.2.1).  Additionally, the 
computed structure would target the incorporation of the alleged unstructured linker region 
(amino acids 76-117) lacking in current models. 
The methods used here to calculate CCS have based adapted from recent 
observations by Salbo and co-workers (2012).  This work described the requirement for 
multiple TriWave IM velocity separation parameters to improve the fitting between T-wave 
calibrants and their experimentally calculated drift tube Ω values.  This suitability is 
defined as a high R
2
 agreement between the power fit of the calibration curve and the 
calibrants required for calculating the CCS of the unknown tD (Salbo et al. 2012).   
Salbo and co-workers (2012) presented a good R
2
 agreement between eleven native 
and non-native calibrants at T-wave wave velocities of 200 to 300 m/s, at constant wave 
amplitudes of 5.8 and 8.5 V respectively (R
2
 0.99 and 0.93).  Additional increases or 
decreases of these TriWave velocity and amplitude conditions reduced the agreement 
between the T-wave and drift tube values, with R
2
 values of 0.83 and 0.76, at 100 (3.4 V) 
and 400 m/s (13 V) respectively.  These optimised conditions were used to calibrate the 
CCS of human insulin oligomers. 
Adapting these observations to the investigation presented here, our experimental 
design incorporated the observed suitable 200 and 300 m/s values, previously used, in 
addition to a mean value of 250 m/s.  Due to the increased mass of the native CbpA dimer 
(68.9 kDa) compared to native human insulin used for the study above (5.8 kDa monomer, 
11.6 kDa dimer), we additionally incorporated additional wave velocity conditions at  
350 and 400 m/s.  To compensate for the potential reduced R
2
 values at the increasing wave 
velocities, each condition was studied at five different wave amplitude conditions:  
7 to 12 V, in 1V increments.   
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Applying calibrants (section 5.3.3) that closely bracketed the tD of the lowest 
charged CbpA monomer and dimer ions, the R
2
 of the power fit curve for each of the IM 
separation conditions are presented in table 5.2.  Wave amplitude and velocity conditions 
values were manually clustered to R
2
 ≥ 0.975, ≥ 0.9 and > 0 to calculate and compare 
experimental average CCS values.  
Of the 25 mobility separation conditions used, 6 prevented the use of power fitted 
calibration curves (red, table 5.2) required for the CCS calibration of multiply charged 
species (Shvartsburg & Smith 2008).  Conditions unable to produce the power fit 
calibration curves occur at combinations of low wave velocities and high amplitudes.  
These therefore prevent suitable mobility separation. 
 
Table 5.2. Ion Mobility Calibration R
2
 Values  
  Wave Velocity (m/s) 
  200 250 300 350 400 
W
a
v
e 
a
m
p
li
tu
d
e 
(V
) 
8 0.8625 0.975 0.9635 0.9746 0.9646 
9 0 0.9585 0.9805 0.9901 0.9636 
10 0 0.7484 0.9672 0.9736 0.967 
11 0 0 0.9936 0.9778 0.9619 
12 0 0 0.9341 0.9338 0.9659 
Above data represents the calibration R
2
 values for all IM wave amplitude and velocity conditions obtained.  
Green values represent mobility conditions that return R
2
 values ≥ 0.975.  Yellow values represent conditions 
returning values between 0.975 > 0.9.  Orange values represent calibrations resulting in deviations < 0.9. 
Conditions unable to produce calibration curves that permitted power fitting, required for multiply charged 
species, are shown in red. 
 
IM analysis of the lowest charged CbpA dimer +15 ion (m/z 4591.2) supports the 
existence of two defined structural conformations (compact and extended) (Fig. 5.7c).  In 
comparison, only a single conformation is observed for the lowest charged monomer  
+11 ion (m/z 3133.3) (Fig. 5.7b).  Comparisons of the average CCS values calculated using 
these conformations, and clustered according to R
2
 values are presented in table 5.3.  
Accounting for MSD calibrated CCS values indicates no change in conformation accuracy 
across the R
2
 range studied.   
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Figure 5.7. Ion Mobility 
Analysis of CbpA  
a) Data represents extracted tD 
values for lowest charged 
monomer (red, b), and dimer 
(blue, c) ions, at 250 m/s and 
9 V.  c) 1 and 2 represent the 
tD of the compact and 
extended dimer 
conformations respectively.  
CCS values are determined 
from the FWHM of the 
lowest charged ions 
(monomer; +11, and dimer; 
+15), highlighted in the mass 
spectrum.  AmAc 
concentration; 150 mM,  
pH 7.5. Samples previously 
stored in glycerol. 
 
Table 5.3. Collision Cross Sections of Calibrated CbpA the Lowest charged Monomer 
and Dimer  
Conformation R
2
 ≥ 0.975 R2 ≥ 0.9 R2 > 0 
Monomer 2542.38 (
+
/- 77.13) Å
2
 2590.8 (
+
/- 69.4) Å
2
 2588.13 (
+
/- 68.1) Å
2
 
Compact 
Dimer 
4128.21 (
+
/- 97.6) Å
2
 4076.4 (
+
/- 119.76) Å
2
 4081.34 (
+
/- 125.31) Å
2
 
Extended 
Dimer 
4475.65 (
+
/- 195.88) Å
2
 4510.83 (
+
/- 151.91) Å
2
 4543.05 (
+
/- 152.53) Å
2
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5.4.2. CbpA DNA Binding  
 
Unless induced under the control of the Lrp operon, CbpA expression is strongly 
upregulated by σS during the stationary phase (Yamashino et al. 2005).  These expression 
events produce 3 000 to 15 000 copies of CbpA per cell, promoting compaction of the  
E. coli genome.  CbpA has been shown to bind DNA promoting the rapid (2 to 5 minutes) 
formation of aggregates greater than 60 nm in size (Cosgriff et al. 2010).  The organisation 
of CbpA and DNA within these aggregates is poorly understood.  Therefore, the methods 
and results presented here outline the various solution conditions and DNA constructs that 
have been applied to study these events using native mass spectrometric methods. 
 
5.4.2.1. Incubations of CbpA with a 50 Base Pair De Novo DNA Construct  
 
CbpA binds DNA non-specifically (Cosgriff et al. 2010).  In the absence of binding 
sequence preferences, initial investigations were performed using a designed de novo DNA 
construct.  Parameters for sequence design were a 50 bp construct length, encoding a 50 % 
GC content.  The 50 bp construct length exceeded the proposed 40 bp minimum length of 
DNA required for CbpA-DNA binding (Gur, Katz & Ron 2005).  This construct was 
identified as 50[50], with forward and reverse complementary ssDNA sequences presented 
in table 5.4.  A control mass spectrum of 50[50] is shown in figure 5.8. 
Initial incubations of CbpA and 50[50] were analysed over a range of incubation 
ratios, from 4:1 to 1:8.  Samples were buffer exchanged into 250 mM AmAc pH 7.5, and 
diluted to 13 μM CbpA concentration prior to addition of DNA and incubation.   
CbpA: 50[50] samples were incubated at room temperature and monitored at non-uniform 
time points over the course of three-hours.  Mass spectra were acquired over a m/z range of  
1 000 to 16 000 for two minutes using two second scans.   
Across all incubation ratios studied, data indicated a reduction of CbpA relative to 
the DNA construct over the stated period of time (Fig. 5.9).  At all incubation conditions 
and time points no CbpA: 50[50] oligomers were observed. 
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Table 5.4. Sequence Data of the 50[50] and B100 DNA Constructs 
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ssDNA Sequence (5’ to 3’) 
50[50] 94.6 50 Forward CACGAGTGAATGAGACCTAAGTGACGACG
AGAGTATGAGACCTGAGAGAG 
Reverse CTCTCTCAGGTCTCATACTCTCGTCGTCACT
TAGGTCTCATTCACTCGTG 
B100 99.1 50 Forward (GAAGAGAAGC)*10 
Reverse (GCTTCTCTTC)*10 
Tm values represent salt adjusted values; 50[50] at 250 mM AmAc, B100 at 150 mM. 
 
 
Figure 5.8. Control Mass 
Spectrum of the De novo 
50[50] dsDNA Construct 
Control analysis of the 
50[50] dsDNA construct 
(red).  AmAc 
concentration; 250 mM,  
pH 7.5. 
 
Due to the failure of observing CbpA-DNA oligomers using these conditions the 
experimental limitations were examined.  Two conditions were identified to be potentially 
limiting the promotion of observable protein-DNA oligomers.  The first identified 
limitation was that the ratio of protein to DNA was too narrow.  Therefore it was suggested 
that this range should be expanded to incorporate a broader incubation range (e.g. 20:1 to 
1:20).  The second identified limitation was the concentration of the AmAc buffer.  It was 
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suggested that this might be too high (250 mM AmAc) and therefore inhibiting binding 
interactions.  Studies progressed to study CbpA-DNA binding using a reduced AmAc 
buffer concentration of 150 mM (pH 7.5).   
It is known that magnesium cations stabilise the phosphate backbone of dsDNA 
(Hartwig 2001).  Therefore, in addition to the reduced concentration the AmAc, a source of 
magnesium cations was added to the buffer.  The use of magnesium cations are additionally 
supported by recent work presented by Guéroult and co-workers (2012).  This work showed 
that magnesium cations bound within the major groove stabilise protein-DNA complexes 
by “limiting the energetic and entropic costs of protein binding” (Guéroult et al. 2012).   
 
 
Figure 5.9. 4:1 Incubation 
of CbpA: 50[50]  
CbpA dimer (blue) in the 
presence of 50[50] (red) 
(4:1 ratio) (a) before and 
(b) after incubation (one 
hour, room temperature).  
Although no CbpA: 50[50] 
oligomers are observed, a 
reduction in CbpA dimers 
relative to DNA between 
time zero and one hour are 
noted.  AmAc 
concentration; 250 mM,  
pH 7.5. 
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Figure 5.10. 1:1:4 
Incubated CbpA: 50[50]: 
MgCl2  
1:1:4 incubation of CbpA 
(monomer = purple, dimer 
= blue), 50[50] (red) and 
MgCl2, (a) before and  
(b) after incubation (one 
hour, room temperature).  
Although no CbpA: 50[50] 
oligomers are observed, a 
reduction in CbpA 
oligomers relative to DNA 
between time zero and one 
hour are noted. AmAc 
concentration; 150 mM,  
pH 7.5. 
 
Lacking any indication of an optimal ratio of cations relative to DNA, initial work 
added a small content of MgCl2, equal to four times the concentration of DNA, to samples 
prior to incubation at room temperature.  Buffer exchanged (150 mM AmAc, pH 7.5) 
incubations of CbpA: 50[50]: MgCl2 were studied using ratios of 1:1:2 and 1:2:4  
(CbpA 11 μM).  Mass spectra were acquired over a m/z range of 1 000 to 16 000, for two 
minutes using two second scans.  Despite apparent reductions in CbpA relative to dsDNA, 
no CbpA: 50[50] oligomers were observed (Fig. 5.10). 
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5.4.2.2. Incubations of CbpA with a 100 Base Pair B-Form DNA Construct 
 
Despite failing to study broader incubation ratios of CbpA: DNA, both with and without a 
source of magnesium cations, concerns were raised regarding the length of the dsDNA 
construct used.  These concerns were the close relationship between the 50 bp length of the 
50[50] construct used above, and the 40 bp minimum length CbpA-DNA binding proposed 
by Gur and co-workers (2005).  It was hypothesised that a DNA construct of increased 
length may promote CbpA-DNA oligomers that can be resolved using native mass 
spectrometry methods.  
Follow up CbpA-DNA binding experiments incorporated a readily available 100 bp 
dsDNA construct identified as B100 (B-form, 100 bp dsDNA).  This 100 bp dsDNA 
construct was previously adapted from Gyi et al. (1998) for IM-MS studies by Jun Yan 
under the supervision of Dr Adam McKay (work unpublished).  Structurally B100 encodes 
a 10x10 bp sequence repeat, which forms the biologically relevant B-form
38
 dsDNA helix.  
Compatible with the 50[50] sequence previously studied this B100 construct encodes a  
50 % GC content.  Forward and reverse complementary sequences are presented in table 
5.4.  Control mass analysis of B100 is presented in figure 5.11. 
Analysis of CbpA: B100 targeted the recreation of sample and incubation 
conditions that had been previously used to successfully promote CbpA-DNA 
oligomerisation.  Work by Azam & Ishihama (1999) outlined suitable buffer and incubation 
conditions for analysis that had been previously applied to calculate CbpA-DNA Kd values 
using DNA EMSA.   
Using the methods presented by Azam & Ishihama (1999), CbpA and B100 were 
incubated in 10:1 ratio and buffer exchanged into 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 
100 mM NaCl and 1 mM DTT.  This sample was incubated for 25 minutes at 25 ˚C prior to 
buffer exchange into 100 mM AmAc (pH 7.5), equal to the NaCl concentration above.  
Buffer exchange was performed by five sequential washes using a single Amicon 1.5 ml  
10 kDa MWCO centrifugal concentrator column (Millipore, Dundee, UK).  Mass spectra 
were acquired over m/z range of 1 000 to 32 000 for two minutes using two second scans. 
 
                                                 
38
 Watson - Crick model of DNA.  Right hand rotation, 10.5 bp/turn that increases 3.32 Å in length per turn. 
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Figure 5.11. Control Mass Spectrum of the B100 dsDNA Construct 
Control analysis of the B100 dsDNA construct adapted from Gyi et al. (1998).  The monomeric dsDNA 
construct highlighted in red.  The repetitive nature of the forward and reverse complement ssDNA allows 
misaligned base pair matching of these complementary sequences and is used to account for the unexpected 
mass corresponding to B1002 (pink).  These misalignments are proposed to account for the poor spectra 
baseline resolution by enabling increased salt adductation, and are supported by a large increase in the 
experimental mass values compared to the theoretical (table 5.1).  AmAc concentration; 150 mM, pH 7.5. 
  
Mass spectrometric analysis of the CbpA: B100 sample after incubation are 
presented in figure 5.12.  Despite a nanodrop
39
 calculated dimer concentration of 30 μM 
(50 μM expected), exhibiting an excess in protein to DNA (DNA = 6.5 μM, therefore final 
ratio = 9:2), no CbpA oligomers were observed. 
Experimental observations by Azam & Ishihama (1999) noted a co-operative 
mechanism of CbpA-DNA binding. Applying these observations, DNA should remain 
observable in the absence of unbound protein, despite an excess of CbpA to B100.  To 
confirm this suggestion, using the same conditions as above, B100 was incubated with a 
protein exhibiting no known DNA binding affinity for control analysis.  It was 
hypothesised that if this protein was observed within mass spectra, post incubation and 
buffer exchange, these data would support that CbpA-DNA binding was occurring.  
Therefore, S. cerevisiae ADH (Sigma-Aldrich Ltd, Dorset, UK) was incubated with B100, 
at a ratio of 10:1.   
 
                                                 
39
 Nanodrop used in lieu of the Qubit method due to the presence of DNA. 
5. Analysis of CbpA’s Structure and DNA Binding Interactions 
 
190 
 
Figure 5.12. Incubation of CbpA: B100 Using the Azam & Ishihama Method 
a) CbpA incubated in the presence of B100 (red) (experimentally calculated ratio of 9:2).  Incubation of 
protein and DNA performed according to the method presented in Azam & Ishihama (1999) (see main body 
of text), prior to buffer exchange into 100 mM AmAc (pH 7.5).  No protein or protein-DNA oligomers are 
observed.  b) Repetition of the incubation using ADH (Monomer; purple, Dimer; Yellow, Tetramer; blue, 
Octamer; Green) in lieu of CbpA.  As expected no ADH: B100 oligomers are observed. 
 
Post incubation and buffer exchange, nanodrop analysis showed consistent 
experimental concentrations between incubations of B100 with CbpA or ADH.  Mass 
spectrometric analysis (Fig. 5.12b) showed that both ADH and B100 are observed within 
the gas phase. As no ADH: B100 oligomers are observed, and the similar concentrations of 
ADH/CbpA between experiments, analysis supports that the solution phase conditions are 
suitable to stabilise CbpA-DNA binding.  Concluding these observations with the positive 
feedback mechanism of CbpA-DNA binding (Azam & Ishihama 1999) a large CbpA 
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excess is therefore likely to be required to observe oligomers of unknown complexity.  In 
contrast, if no CbpA-DNA binding events were observed we would expect comparable 
relative intensities of CbpA compared to the incubations containing ADH. 
Considering the large-scale CbpA-DNA interactions, a collision voltage ramp was 
performed on the original CbpA: B100 sample.  Using this ramp, attempts were made to 
induce collisional decomposition of any unobserved/low intensity gas phase complexes to 
study their resultant dissociation products.   
At a TriWave Trap (see schematic in Fig. 1.13) collision voltage of 100 V 
(Transfer; 25 V) (Fig. 5.13), fragments with masses correlating to CbpA monomers and 
dimers were observed.  At these high collision voltages however, no masses correlating to 
ssDNA or dsDNA are observed, despite observations of the latter prior to dissociation 
studies.  These observations are proposed to occur due to the weaker covalent nature of 
ester bonds compared to the peptide bond.  These conclusions are supported by previous 
CID observation by Kjeldsen & Zubarev (2011).  Therefore, if these oligomers are 
dissociation products from the protein-DNA oligomers, these data support the prerequisite 
for CbpA dimers in the protein-DNA binding interaction.  
 
 
Figure 5.13. Collision Voltage Ramp of Incubated CbpA: B100 
Collisional dissociation condition (Trap 100 V, Transfer 25 V, not quadrupole isolated) analysis of incubated 
CbpA: B100 sample (same sample as Fig. 5.11a).  Spectrum confirms that an observable concentration of 
CbpA remains within the sample (solution concentration = 30 μM).  Observed ions are hypothesised to be 
dissociation product from CbpA-B100 oligomers (monomer = purple, dimer = blue). 
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5.4.2.3. Incubations of CbpA with a 62 Base Pair Curved DNA Construct 
  
Due to the repetitive nature of the B100 forward and reverse complements (10x10 bp) 
concerns were raised regarding the ability of these sequences to promote forward and 
reverse ssDNA sequence misalignments.  This is supported by a sequential dilution of 
B100 studied using 2 % PAGE analysis (Fig. 5.14).  PAGE analysis indicates that 
misalignments are able to promote a strong heterogeneous mixture of ssDNA and dsDNA 
elements along a single forward/reverse complement, in addition to a non-uniform 
construct length.  Despite a level of support for CbpA: B100 binding events, in the absence 
of evidence supporting CbpA: ssDNA binding events work progressed to study binding 
using a third dsDNA construct. 
 
 
Figure 5.14. 2 % Polyacrylamide Gel Electrophoresis Analysis of the B100 Construct 
Sequential dilution of B100 from 100 % to 8 % of the original concentration (22.3 μM) analysed using  
2 % PAGE and stained using dilute ethidium bromide solution (< 0.1 mg/ml).  Comparison with a 100 bp 
ladder (New England Biolabs, MA, USA) indicates heavy level of smearing consistent with misaligned base 
pairing.  Intense banding at 100 bp however supports that a relatively high concentration of correctly 
annealed forward reverse complements are formed, and is supported by mass spectrometric analysis 
presented here (Fig. 5.11). 
 
As a consequence of the above conclusions a literature search was initiated to obtain 
sequence data for a suitable dsDNA construct that had been previously shown to allow 
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CbpA binding.  This literature search identified three articles: Azam & Ishihama (1999), 
Cosgriff et al. (2010), and Gur, Katz & Ron (2005).  The dsDNA constructs applied by 
these studies are outlined in brief below, with sequence information presented (when 
available) in table 5.5. 
 
Table 5.5. Known CbpA Binding DNA Constructs 
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ssDNA Sequence (5’ to 3’) 
SOA 62 89.6 40 
Forward 
GGCAAAAAACGGCAAAAAACGGCAAA
AAACCGCAAAAAACCGCAAAAAAGCG
CAAAAAAG 
Reverse 
CTTTTTTGCGCTTTTTTGCGGTTTTTTG
CGGTTTTTTGCCGTTTTTTGCCGTTTTT
TGCC 
SOB 64 94.5 50 
Forward 
GGGGATCGCACGATCTGTATACTTATT
TGCCCGGGGATCGCACGATCTGTATAC
TTATTTGCCC 
Reverse 
GGGCAAATAAGTATACAGATCGTGCG
ATCCCCGGGCAAATAAGTATACAGATC
GTGCGATCCCC 
EL50 50 90.1 48 
Forward 
GCCGAGGATCCAATTTGCTGTCACTCC
CATTTAAACGCTAGATGCTGTCA* 
Reverse 
TGACAGCATCTAGCGTTTAAATGGGAG
TGACAGCAAATTGGATCCTCGGC 
Tm values represent salt adjusted values at 150 mM AmAc. * represents γ-32P end labelling.  
SOA and SOB sequences taken from Azam & Ishihama (1999), EL50 taken from Gur, Katz & Ron (2005) 
 
Azam & Ishihama (1999), studied CbpA-DNA binding using two dsDNA 
constructs, with known curved and linear structures, identified as SOA and SOB (table 5.5).  
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These constructs were 62 and 64 bp in length, with calculated Kd values  
of 122 and 175 nM respectively.  
Cosgriff et al. (2010) performed CbpA-DNA binding studies using an unspecified 
length of dsDNA, isolated from plasmids using restriction nucleases.  Although 
biologically relevant, production of a suitable stock concentration for analysis was deemed 
unsuitable due to the calculated low yield and sample purity.  
Gur, Katz & Ron (2005) observed CbpA-DNA binding using a single end labelled 
(γ-32P-ATP) 50 bp dsDNA construct (EL50, table 5.5), of unspecified structural 
conformation.   
 
 
Figure 5.15. Control 
Mass Spectra Analysis of 
SOA and SOB dsDNA 
Constructs 
Control analysis of the  
(a) SOA and (b) SOB 
dsDNA construct.  
Monomeric dsDNA are 
highlighted in red, along 
with unexpected masses 
corresponding to dimeric 
(pink) and trimeric 
(orange) SOA/SOB 
constructs.  AmAc 
concentration; 150 mM, pH 
7.5. 
 
As the constructs studied by Azam & Ishihama (1999) would allow direct 
comparison between CbpA curved and non-curved DNA binding, both SOA and SOB were 
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purchased without sequence modifications.  Control mass analysis of both SOA and SOB 
are presented in figure 5.15. 
Combining all previous observations the refined experimental conditions supported 
incubation of a large excess of CbpA to DNA due to co-operative mode of oligomerisation.  
Additional information further supported the use of a magnesium cation source to stabilise 
the DNA backbone (Hartwig 2001) and protein-DNA oligomers (Guéroult et al. 2012).  
Subsequent literature searches expanded to support the requirement of one magnesium 
cation per two phosphate groups (Sander & Ts’o 1971). 
 
 
Figure 5.16. Incubation of 
CbpA: SOA at a Ratio of 
10:1  
CbpA: SOA: MgCl2 
(10:1:62) (a) before and  
(b) after one hour 
incubation at 37 ˚C. Data 
shows that one hour 
incubation is suitable to 
promote CbpA (monomer; 
purple, dimer; red) binding 
of DNA (SOA; Red), with 
the loss of all resolvable 
protein. AmAc 
concentration; 150 mM,  
pH 7.5. CbpA samples 
previously stored with 
glycerol. 
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Figure 5.17. Incubation of CbpA: SOA at a Ratio of 20:1  
CbpA: SOA: MgCl2 (20:1:62) (a) before and (b) after seventeen hour incubation at 37 ˚C. Despite the large 
excess of CbpA (monomer = purple, dimer =red) and no resolvable SOA (red, and SOA2; purple) at the start 
of incubation, suitable incubation time allows all CbpA oligomers to bind.  This is supported by the observed 
excess of DNA within mass spectra after incubation. Acquisitions at one-hour further support the binding of 
all CbpA oligomers, these data are not shown due to low signal to noise ratio.   
AmAc concentration; 150 mM, pH 7.5. CbpA samples previously stored with glycerol. 
 
CbpA and SOA were individually buffer exchanged into 150 mM AmAc (pH 7.5) 
prior to mixing at the required ratio with Mg(CH3COO)2.
40
  CbpA: SOA: Mg(CH3COO)2 
samples were incubated at a temperature of 37 ˚C, at two different sample ratios: 10:1:62 
(Fig. 5.16), and 20:1:62 (Fig. 5.17).  Mass spectra were acquired at zero, one and seventeen 
                                                 
40
 Mg(CH3COO)2 was used in lieu of MgCl2, used previously, due to the proposed increased suitability of the 
acetate anion for mass spectrometric analysis. 
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hours over a m/z range of 1 000 to 25 000, for two to ten minutes using two second scans.  
Despite the low signal to noise ratio of all spectra, no CbpA: SOA oligomers were 
observed, at any time point, in either sample incubation ratio.   
As analysis using native mass spectrometric methods had been unable to resolve 
any protein-DNA oligomers using a construct known to bind CbpA, DNA-EMSA was 
applied to study if the conditions used were suitable to promote oligomerisation.  Two 10:1 
and 20:1 sample sets frozen at 1 and 17 hours (stored at -20 ˚C) previously studied using 
mass spectrometry were analysed.  These samples were compared against DNA control 
samples at concentrations equal to the 10:1 and 20:1 protein-DNA samples, used to observe 
changes in the levels of unbound DNA.   
 
 
Figure 5.18. Protein-DNA Electrophoretic Mobility Shift Assay Using 6 % DNA Retardation Gel 
DNA EMSA of incubated CbpA: SOA, measured against a 100 bp ladder. SOA controls representative of 
concentration equal to (a) 10:1 and (b) 20:1 dilutions with CbpA.  e and c) 1 and 17 hour incubations, 
respectively, of 10:1:62 CbpA: SOA: Mg(CH3COO)2.  f and d) 1 and 17 hour incubations, respectively, of 
10:1:62 CbpA: SOA: Mg(CH3COO)2.  Starting CbpA concentration in all wells 7.65 
+
/- 0.68 μM.  Samples 
incubated for seventeen hours (c and d) show higher levels of unbound DNA (increased intensity banding), 
indicating decomposition of oligomers between this time point and 1 hour. 
 
Analysis of the stained DNA-EMSA gel (Fig. 5.18) supports that the AmAc buffer 
required for electrospray ionisation is suitable for CbpA: SOA binding.  This is supported 
by the majority of observable DNA withheld at the top of the gel lane indicative of protein-
DNA binding.  Further analysis of solutions recovered from the gel well supports the 
existence of potential large protein complexes unable to migrate into the gel  
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(0.5 to 0.85 μM) despite clear evidence of unbound DNA.  These replicate similar 
observation made by both Azam & Ishihama (1999) and Cosgriff et al. (2010). 
Resulting from the combined limitations of native mass spectrometric methods to 
study intact CbpA: DNA interactions and the potential mass of CbpA: DNA oligomer, the 
experimental work was suspended whilst experimental redesign was performed.  Due to 
time constraints however, no further experimental work was performed. 
 
5.5. Discussion  
 
Although failing to observe CbpA-DNA binding events, data presented here has provided 
potential insights into the mode of protein-protein and protein-DNA oligomerisation 
mechanisms.  This is in addition to providing constraints for computational modelling 
approaches.  
 
5.5.1. Validity of R
2
 Refined CbpA CCS Values 
 
Work recently published by Salbo and co-workers (2012) has presented a logical step in the 
optimisation of protocols for producing IM calibration curves.  By applying T-wave 
calibration conditions optimised by their R
2
 values allows for increased accuracy CCS 
calculations of the analyte by reducing deviations that modify the curve distribution.  
Compared with the work presented by Salbo and co-workers the limiting factor of our 
investigation may be stated to be the number of standards applied to calculate the 
calibration curve.   
Across the R
2
 clustering range studied (table 5.3), accounting for MSD we observe 
no differences in CCS.  This absence of CCS changes is argued here to occur as a function 
of calibration methodology, by removing calibrant ions that deviate from published Ω 
values by 
+
/- 5 %.  Data presented here indicates that removal of these outlying points 
improves CCS replication by reducing deviations of the calibration curve that would 
otherwise affect this value.  This may represent a more suitable method for calculating CCS 
allowing analysis of a heterogeneous mixture of ions.  The use of optimised mobility 
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conditions to reduce the removal of these outlying points, whilst improving R
2
, should 
represent increased CCS accuracy. 
IM analysis has indicated the presence of two stable structural conformations for the 
CbpA lowest charged dimer ion.  If these two conformations are biologically relevant their 
role in the activity of CbpA remains unresolved.  Considering the nature of the alleged 
unstructured domain (amino acids 76-117) that links the J-domain to the two CTD domains 
however, it is hypothesised here that these two conformations represent open and compact 
states.  This conclusion is additionally supported by the single structural conformation of 
the CbpA monomer (Fig. 5.7b).  The function of these conformational species however has 
yet to be concluded but may indicate potential internal regulation of protein-DNA and 
protein-protein binding events.   
  
5.5.2. Studies of CbpA-DNA Binding 
 
Despite failing to observe CbpA-DNA oligomers using a range of DNA constructs and 
conditions, certain conclusions can be made regarding binding events.  One of the largest 
considerations is that per single 62 bp length of DNA (SOA) greater than twenty CbpA 
dimers can hypothetically bind.  This is supported by the absence of observable CbpA in 
mass spectra post incubation at both 10:1 and 20:1 solution ratios, whilst retaining 
resolvable DNA charge states (Fig. 5.17).  This conclusion is additionally supported by the 
proposed method of co-operative binding first presented by Azam & Ishihama (1999).   
These data however, are unable to resolve how CbpA dimers stack on the DNA, nor 
if they are able to stack sequentially on top of each other.  AFM studies of linear  
(non-plasmid) DNA have shown that CbpA: DNA aggregates can contain multiple DNA 
strands (Cosgriff et al. 2010), and suggests that cross-linking between CbpA dimers is 
possible.   
How CbpA cross-links DNA is again unknown, but may indicate the function of the 
observed tetrameric and pentameric oligomers in control analysis (Fig. 5.6).  If these 
oligomers are native conformations, this would potentially support a second mode of 
dimerisation to link neighbouring DNA bound dimers.  Orientation of these CbpA dimers 
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to form a plausible secondary dimerisation interface, along with the amino acids that 
mediate these interactions still to be cited within the literature. 
 
5.6. Future Directions 
5.6.1. Studying CbpA-DNA Interactions within the Gas Phase 
 
Considering the challenging nature of observing intact CbpA-DNA oligomers using native 
mass spectrometric methods, it is suggested that future work progresses to use proteomics 
based structural tools more typical of aggregating protein studies.  
Hydrogen/deuterium exchange is a mass spectrometric method currently applied to 
the study of aggregating proteins such as the structurally ordered amyloid fibril.  In studies 
such as these, the sample is incubated in a deuterated solvent for a specific period of time to 
allow hydrogen-deuterium exchange.  Samples are subsequently buffer exchanged to 
remove excess deuterium, and analysed to compare the difference in deuteration between a 
control (e.g. monomer) and the aggregate using proteolytic methods.  Comparison of 
hydrogen/deuterium mass shift indicates the level of solvent accessible area at the residue 
level, indicative of bound and unbound subunits (Ashcroft 2010).   
Despite providing information regarding the solvent accessible/inaccessible areas, 
hydrogen/deuterium exchange fails to indicate the local environment of the binding 
interface, including orientation of neighbour oligomers and their respective amino acids in 
the absence of known structures.  Using these structural data hydrogen/deuterium 
exchanges can be mapped onto X-ray crystal, NMR or computational structural models to 
calculate the environment (Jaswal 2013).  This therefore currently represents a limiting step 
for structural analysis of CbpA-DNA oligomers until computational modelling of the CbpA 
dimer is complete. 
In comparison, cross-linking connects two functional amino acid groups within a 
linker-derived distance allowing the study of the local environment relative to the initial 
binding group.  Applying a bottom-up proteomics approach
41
 for liquid chromatography 
mass spectrometry and MS/MS analysis, cross-linking enables the construction of a three 
                                                 
41
 In contrast to other mass spectrometry instrumentation, Fourier transform-ion cyclotron resonance can be 
also applied to top-down cross-linking studies (Sinz 2006). 
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dimensional model from peptide sequence data (Sinz 2006).  This is in addition to 
contributions from IM-MS methods to separate linker bound peptides using differences in 
CCS (Preston et al. 2012).   
Protein-DNA cross-linking, although not as regularly discussed in the literature as 
studies of protein-protein interactions, has been previously performed.  Known protein-
DNA chemical cross-linkers include, 1,2,3,4-Diepoxybutane.  1,2,3,4-Diepoxybutane 
promotes the alkylation of adenine and guanine bases, producing  
2-hydroxy-3,4-epoxybut-1-yl monoadducts.  These monoadducts are subsequently able to 
react with nucleophilic amino acid side chains, such as those present in serine, lysine and 
tyrosine producing protein-DNA cross-links.   Additionally 2-hydroxy-3,4-epoxybut-1-yl 
monoadducts are able to cross-link DNA through further hydrolysis and alkylation 
reactions (Gherezghiher et al. 2013).   
In addition to the above, 5-iodouracil labelled ssDNA has been previously used to 
cross-link DNA to proteins through UV photo catalysed reactions with aromatic amino acid 
side chains.  Under UV catalytic conditions 5-iodouracil is cleaved at the iodine-carbon 
bond producing a reactive vinyl radical.  This vinyl radical binds preferentially to aromatic 
rings such as those found in tryptophan residues, producing a carbon-carbon bond that 
cross-links the DNA to protein (Steen et al. 2001).  
The above represent two of only a handful of protein-DNA cross linking methods 
currently available which are stable under both the MS/MS, and proteolytic cleavage 
conditions required for analysis.  In contrast, studies of CbpA-CbpA oligomerisation in the 
presence of DNA, using protein-protein cross-linking methods, will allow for a more in 
depth structural analysis due to the range and specificities of protein cross-linkers 
available.
42
 
 
5.6.2. Studying CbpM Regulated CbpA Activity 
 
Although CbpA activity is regulated by CbpM, through its interactions with the J-domain 
of the former, the native stoichiometry CbpA: CbpM oligomer has not been fully resolved.  
                                                 
42
 For a larger overarching review on the topic of protein-protein cross linking studies the author directs the 
reader to the following review, Sinz (2006) 
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Forming part of the original project aims (section 5.2) these studies would probe CbpA: 
CbpM binding interactions, stability, and stoichiometry.   
Additional interest is the potential J-domain regulated CbpA oligomer stability, 
highlighted previously (section 5.1.4) (Chintakayala & Grainger 2011).  If CbpM binding 
to this domain promotes oligomer dissociation, this will support a model that inhibits DNA 
interactions through removal of the dimer dependent binding interface.  In contrast, if 
CbpA dimerisation remains stable, this would infer that CbpM inhibits dsDNA binding by 
restricting access to dimeric CTD I domain. 
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6. Project Conclusions 
-------------------------------------------------------------------------------------------------------------- 
 
6.1. Summary of Project 
 
The use of mass spectrometry and IM-MS to study protein-ligand interactions is becoming 
increasingly widespread, both in fundamental research, and as a clinical tool. The work 
presented here has used a combination of different mass spectrometric and IM-MS tools, 
including MS/MS and CIU, in addition to solution phase modifications.  These mass 
spectrometric methods, when compared to other structural methods, represent increases in 
mass sensitivity as well as dynamic range.  This is in addition to applications for 
determining the small changes in structural conformation, and the ability to study the 
organisation of complex multimeric sub complexes, with neither being readily achievable 
using other structural methods.  These methods have made it possible to investigate here 
the gas phase oligomers and structural conformations of three proteins that are required, 
within their respective organisms, to ensure cellular viability.   
Exhibiting a native metastable fold, mutations of α1-Antitrypsin can promote 
misfolding events increasing the susceptibility to aggregation events at sites of synthesis 
through toxic gain of function.  Promotions of increased stability AAT polymerogenic 
intermediates required for polymerisation are known to propagate under biologically 
relevant conditions.  Using IM-MS we have characterised the structure and stability of the 
slow polymerisation mutant K154N.  Our results have shown that this mutant populates a 
conformation intermediate under biologically relevant temperatures, corresponding to a 
significant 8.3 % gain in CCS.  Using CID we have shown that this K154N substitution 
promotes increases in AAT intermediate structural stability, common with other more 
severe polymerogenic mutations. 
Saccharomyces cerevisiae Sgt1 dimers mediate binding between Hsp90 and Skp1, 
to initiate chromosome separation.  Mutations of the Sgt1 TPR domain that prevent 
dimerisation further inhibit Sgt1 mediated Hsp90: Skp1 interactions, arresting the cell cycle 
at the G2/M interface.  Work here has shown that Sgt1 dimerisation is promoted by an 
Ascomycota specific structural loop within the TPR domain.  This observation is supported 
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by comparisons of the wt Sgt1 oligomeric state with H59A and D61R structural loop 
substitutions, studied under native conditions.  Our data has additionally shown that this 
loop is orientated in a manner that supports the formation of higher order oligomers under 
increasing sample concentrations, including previously unobserved tetramers and 
pentamers.  Analysis using MS/MS, combined with a recently resolved crystal structure 
however, has shown that these Sgt1 dimers do not represent the structural minimum for 
stable Skp1 binding.   
In addition to observations regarding the role of Ascomycota specific structural loop 
in Sgt1 dimerisation, work presented here has indicated, for the first time, that Sgt1 dimers 
are stabilised by contributions from the C-terminus.  Deletion mutants lacking this  
C-terminus have been shown to undergo concentration-dependent oligomerisation.  The 
results here have further indicated that in the absence of this C-terminal CS and SGS 
domains, the Sgt1 TPR domain may enable higher-order binding through a potential second 
mode of dimerisation.   
The Escherichia coli DNA binding protein CbpA is required to promote 
chromosome compaction during the stationary cell cycle phase, and cellular phosphate 
starvation events.  How CbpA oligomerizes on the DNA backbone, promoting genome 
compaction, is not currently understood.  It had been proposed that native mass 
spectrometry methods would enable the study of these interactions.  Although unsuccessful 
in observing protein-DNA interactions using native mass spectrometry, the studies 
presented have shown that the buffers required for nESI are suitable for CbpA-DNA 
binding.  IM-MS has however proved to be successful in providing gas-phase constraints 
for computational modelling of the biologically relevant DNA binding CbpA dimer by 
Harpal Sahota, results forthcoming.   
 
6.2. Of Mountains and Molehills: Towards Ever Higher Peaks 
 
As discussed in chapter 1, improvements in instrumentation and experimental methods 
made over the last century have allowed mass spectrometry, with contributions from IM, to 
evolve from a tool used to study the fundamental nature of the atom, to one that now allows 
us to study the basis of life itself.  The question then remains, what of the next century?  
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Where does a field that has impacted on our fundamental understanding of the universe go 
next?  Three topics of increasing interest within the wider biological mass spectrometry 
community that the author believes to be driving both the experimental and technological 
development of the field to ever greater ‘heights,’ are explored in brief below. 
 
6.2.1. Towards Ever Higher Peaks: Solution Phase Modified Protein Stabilisation 
 
A recent trend in native mass spectrometry and IM-MS analysis is the addition of salt 
additives to the electrospray buffer, in order to promote the solution modified gas phase 
stability of proteins and protein complexes.  Recent investigations using CID and CIU 
methods have shown that additions of tuned salts, at concentrations less than 2 mM, can be 
used to drastically modify the conformational stability of multimeric proteins in the gas 
phase (Fig. 6.1).  Interestingly, CIU studies of avidin in the presence of magnesium cations, 
has been reported to stabilise unique, additional co-populated structural conformations, not 
previously observed in the absence or presence of other salts (Han & Ruotolo 2013). 
Both anions and cations have been recently classified according to their influence 
on protein gas-phase stability.  Both classes of ions modulate stabilisation in a manner that 
mirrors the typical solution phase Hofmeister series.  The stability series of cations is 
currently denoted using the following order: NH4
+
 ~TMA
+
 < Rb
+
 < K
+
 < Na
+
 < Tris H
+
 < 
Ba
2+
 ~Li
+
 < Ca2
+
 < Mg
2+
 (Han, Hyung & Ruotolo 2013).
43
  The order of this ion series 
currently correlates positively to the charge per unit area; increased charge density ions 
promote improved stabilising effect compared to those with low charge density  
(Han, Hyung & Ruotolo 2012).  The hypothesised mechanisms of cation-mediated protein 
stability occurs through either multidentate cross linking interactions, or by replacing 
proton charge carriers with less mobile cation charge carriers restricting charge mobility 
and coulombic unfolding under dissociation conditions (Han, Hyung & Ruotolo 2013). 
In contrast to the direct high to low series of cations, anions are clustered into one of 
three groups based on their stabilising effects: high (Tartrate2
-
, Cl
-
, citrate2
-
, NO3
-
), medium 
(SO4
2-
, HPO4
2-
, SCN
-
, F
-), and ‘little to no’ (HCO3
-
, I
-
, ClO4
-
).  In further contrast to the 
                                                 
43
 Hofmeister cation series stabilizing affects: TMA
+
 > NH4
+
 > Rb
+
 > K
+
 > Na
+
 > Li
+
 > Ca2
+
 > Mg2
+
 > Ba2
+ 
(Han, Hyung & Ruotolo 2013) 
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cation series, increases in charge density do not represent increased protein stability  
(Han, Hyung & Ruotolo 2013).  Mechanistically, these negatively charged ions exhibit a 
dissociative cooling mechanism of protein stabilisation, dissociating to sequester excess 
protein rotational and vibrational energy.  Those failing to bind, or dissociate, contribute to 
the ‘little to no affect’ stability group above (Han, Hyung & Ruotolo 2013).  
 
 
Figure 6.1. Conformational Stability of 
Avidin in the Presence of Salt Additives 
CIU of avidin (+16, most intense peak 
across all solution conditions) with no salt 
(black), 4 mM NH4Cl (blue), 2 mM 
MgCH3CO2 (red), and 2 mM MgCl2 
(purple). Structure I is the native 
conformation; whilst II, III and IV 
represent co-populated unfolding 
intermediates.  Data shows that 
individually Mg
2+
 and Cl
-
 ions can 
stabilise protein folding (+10 % against 
control).  Simultaneous binding promotes 
co-operative stabilising effects (+50 % 
against control).  Interestingly in the 
presence of Mg
2+
 ions, avidin 
conformation II represents a reduced, 
unique, tD not previously accessed.  This 
may be additionally supported by a 
potential additional intermediate between 
II and III in the presence of MgCl2. 
Figure reproduced and adapted from Han & Ruotolo 
2013 
 
Progressing towards the future, studies such as these support a role for stabilising 
the native-like structure of proteins and protein-protein interactions within the gas phase.  
This area of work therefore has direct applications in studies including stabilising weak 
protein-ligand interactions, and membrane proteins.  Membrane proteins, due to their 
location require ‘sticky’ detergent clusters to enable sample recovery and ionisation of the 
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native like oligomers.  To resolve these proteins within mass spectra, high collision 
voltages are required to remove the detergent cluster and may destabilise their native like 
structure (Borysik & Robinson 2012).  Use of these tuned salt additives therefore may 
represent a method to stabilise the native like structure of these macro molecules under the 
harsh conditions required to remove detergent clusters. 
Of future interest with regards to work performed in chapter 5, is the potential 
adaptation of these tuned salt adducts to stabilise protein-DNA interactions.  Considering 
that divalent cations such as Mg
2+
 are required to stabilise the dsDNA phosphate backbone 
(Guéroult et al. 2012), this presents an interesting alternative application to the studies 
previously performed. 
  
6.2.2. Towards Ever Higher Peaks: Spatially Resolved Mass Analysis 
 
Although not directly connected with the work performed here, mass spectrometry imaging 
(MSI) has slowly progressed over the last twenty years into a method that enables ex vivo 
sample study, with spatial and chemical identification (Fig. 6.2).  This technique therefore 
has applications in a range of biological studies, including proteomic and metabolomic 
analysis, whilst additionally driving developments in mass spectrometric experimental 
methods, software and hardware (Chughtai & Heeren 2010).  
Combining suitable spatial resolution and dynamic mass quantitation range, MSI 
provides advantages over other commonly used experimental imaging methods such as 
AFM (Kiss et al. 2013).  MSI can therefore be readily adapted to studies which probe 
changes in molecular organisation and cellular biochemistry, including studies of 
neurodegenerative disorders and the progression of cancerous tissues (Chughtai & Heeren 
2010).   
Recent advances within the field of MSI have seen the adaptation of the Timepix, a 
hybrid active pixel sensor originally used for photon detection systems, for mass 
spectrometry applications.  Structurally, the basic Timepix assembly comprises a 256x256 
pixel semiconductor that, when activated, produces electron pairs to induce charge on a 
CMOS read out chip (Campbell 2011, and Jungmann & Heeren 2013).   
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Figure 6.2. Mass Spectrometry Imaging: Spatially 
Resolved Mass Values 
Overlay of Secondary ion ToF mass spectrometry 
resolved image of mouse testis cross section.  
Diagonal line represents the border between tissue 
and the indium containing glass slide. Colours denote 
masses correlating to: indium (m/z 115); red, unstated 
organic ion (m/z 358); blue, and cholesterol-OH  
(m/z 369); green.  
Figure reproduced from Kiss et al. 2013 
  
Used within mass spectrometric instrumentation, this assembly is combined with an 
MCP floated in front of the pixel sensor that upon ion impact discharges an electron ion 
cloud that can be detected by the Timepix (Jungmann & Heeren 2013).
44
  As each pixel 
functions as an independent detector, the MCP-Timepix assembly allows combination of 
three different ion measurement modes: ion counting, ToF, and time-over-threshold 
(measure of pixel activity above detection threshold) (Jungmann et al. 2013).  
Subsequently array detectors such as Timepix allow multiple ion measurements at 
any instant in time, with increases in both instrumental detection limits and the duty cycle 
repetition rate (Jungmann & Heeren 2013). Combined with additional software 
developments, MSI has the potential to accelerate diagnosis and prescription of therapeutics 
in the future, with the high-throughput required by clinical laboratories. 
 
6.2.3. Towards Ever Higher Peaks: Life in the Gas Phase 
 
By the time John B. Fenn presented his Nobel lecture on the eve of receiving his award 
(“Electrospray Wings for Molecular Elephants,” Fenn 2002), ESI had already been used to 
                                                 
44
 This single pixel activation requires ~650 electrons (Jungmann et al. 2013). 
6. Project Conclusions 
 
213 
ionise the tobacco mosaic virus.  Collections of the virus within the gas phase were 
sequentially used to successfully infect tobacco plants (Siuzdak et al. 1996).  Subsequent 
work presented ToF mass resolved values of the tobacco mosaic (Fig. 6.3), and rice yellow 
mottle, viruses.  The masses of these viruses were calculated using a combination of m/z 
peak centring and charge values, and equal to 39 to 42 MDa and 6 to 7 MDa respectively.  
These masses however were calculated with a mass error value of 
+
/- 15 %, and represents 
limited accuracy (Fuerstenau et al. 2001).   
 
 
Figure 6.3. Mass Analysis of the Intact Tobacco Mosaic Virus 
Earliest result of a tobacco mosaic virus, observed intact, using mass spectrometric methods (electron 
micrograph, top right).   Resolved mass values were produced using a combination of m/z peak centring 
(above) and charge values.  The molecular weight of the virus occurs between 39-42 MDa with a mass 
deviation error of 
+
/- 15 %, existing in line with the mass limitations of the instrument used.   
Figure reproduced and adapted Siuzdak et al. 1996 
 
Using a commercially available, quadrupole-ToF instrument (Q-ToF II, Waters, 
Manchester, UK) modified for high mass studies,  scientists within the Heck research group 
have recently calculated the mass of the intact HK97 bacteriophage capsid within suitable 
error; 17 942 kDa 
+
/- 4 kDa (Fig. 6.4) (Snijder et al. 2013).  The low error of this mass  
(
+
/- 4 kDa) is attributed to combining the use of Xe(g) for enhanced collisional desolvation 
(Snijder et al. 2012), and software algorithms that minimise mass standard deviation within 
the analyte CSD (LeastMass, Tseng et al. 2011).  These results are currently the largest 
mass resolved with suitable accuracy by any mass spectrometer within the literature.   
Studies such as these can be applied to the analysis of viral capsid assembly, and 
virus-host interactions models (Uetrecht & Heck 2011).  This is in addition to applications 
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within medicine and nanotechnology, in which these capsids are used for  
nano-reactors/containers (Snijder et al. 2013).  In tandem, with interest regarding the 
studies of these interactions, are the instrumental developments to improve the mass 
analysis range of mass spectrometry instrumentation.  Indeed Snijder and co-workers 
(2013) hypothesised that with the R of the instrument used (R = 7 000) for their above 
study, given a suitable desolvation period, analysis of ions of up to 40 Gigadaltons would 
theoretically be resolvable.  Above this mass limit, it is hypothesised that the peak width 
and separation would start to overlap so that they become irresolvable (Snijder et al. 2013).  
These desolvation events therefore represent a key limiting step in the high mass resolution 
of ToF instruments.  
 
 
Figure 6.4. Mass Analysis of the Intact HK97 Virus Capsid 
Recent data presented by Snijder and co-workers (2013) has resolved the mass of the HK97 bacteriophage 
viral capsid, to be 17 942 
+
/- 4 kDa, with a mass deviation of 1.3 % compared to the theoretical  
(17 742 kDa).  To date this represent the largest identifiable mass clearly resolved using mass spectrometry 
based methods. 
Figure reproduced and adapted from Snijder et al. 2013 
 
Developments to extend the mass range of Orbitrap mass analysers, which have 
greatly increased R values compared to ToF, have been recently applied to clearly resolve 
masses exceeding 800 kDa (E. coli, GroEL) to baseline.  This improved base line resolution 
(R value of 25 000 at m/z 5 000, 16 000 at m/z 10 000) reportedly occurs as a function of 
the increased desolvation time (Rose et al. 2012).  Therefore developments of Orbitrap 
instruments that allow high R, high m/z studies, may represent an alternative future route to 
clearly resolved high mass analytes.  
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Combination of these developments may therefore make it possible to one day 
study life within the gas phase.   
 
6.3. Final Remarks 
 
Although only using a fraction of biologically relevant mass spectrometric methods, the 
work presented here represents a broad application of several such techniques to studies of 
protein structure, conformation and stability.  These results additionally highlight the 
application of biological MS to study polymerogenic and deletion mutants, as well as their 
effect on inhibited/unregulated oligomerisation.  This is in addition to the potential to study 
protein-DNA gas phase interactions, using solution phase modulation techniques.   
Combination of the studies presented here, in tandem with literature highlighting 
both past progression and future applications, has shown that growth of both the biological 
and wider field of MS is far from reaching a plateau.  Indeed, although the comparison of 
‘mountains and molehills’ may be relevant to Thomson’s potential comparison of current 
MS techniques to his work more than a century ago, we may in future be increasingly able 
to paraphrase these words as ‘like comparing moons to molehills.’ 
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